{"users":[{"id":"2301781832","username":"maheih","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"M Heikkil√§-Hoikka","description":"","protected":false,"created_at":"2014-01-20T17:47:17.000Z","public_metrics":{"followers_count":4,"following_count":16,"tweet_count":1,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"116716199","username":"EMA_News","profile_image_url":"https://pbs.twimg.com/profile_images/855440526195261440/DLfsCtAz_normal.jpg","verified":true,"name":"EU Medicines Agency","description":"Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ‚â† endorsement.","protected":false,"created_at":"2010-02-23T11:05:21.000Z","public_metrics":{"followers_count":113072,"following_count":325,"tweet_count":21178,"listed_count":1738},"url":"http://t.co/wld9xoWe8y","location":"Amsterdam, Nederland","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/wld9xoWe8y","expanded_url":"http://www.ema.europa.eu","display_url":"ema.europa.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1497166321901056009"},{"id":"524685920","username":"Viglya","profile_image_url":"https://pbs.twimg.com/profile_images/478601163596517377/AIyCCYdr_normal.jpeg","verified":false,"name":"Viglya","description":"Regulatory Affairs and Pharmacovigilance services through drug development and post-autorization for the biopharmaceutucial industry","protected":false,"created_at":"2012-03-14T20:09:29.000Z","public_metrics":{"followers_count":294,"following_count":453,"tweet_count":7636,"listed_count":0},"url":"http://t.co/Qjd4D5gb7s","location":"Barcelona - Spain","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Qjd4D5gb7s","expanded_url":"http://www.viglya.com","display_url":"viglya.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"69232855","username":"myESMO","profile_image_url":"https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_normal.jpeg","verified":false,"name":"ESMO - Eur. Oncology","description":"The European Society for Medical Oncology (ESMO) supports oncology professionals in providing cancer patients  with the most effective treatment and care.","protected":false,"created_at":"2009-08-27T07:45:16.000Z","public_metrics":{"followers_count":56949,"following_count":734,"tweet_count":14993,"listed_count":700},"url":"http://t.co/d58pSFlZZR","location":"Lugano - Switzerland","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/d58pSFlZZR","expanded_url":"http://www.esmo.org","display_url":"esmo.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1492227448372703234"},{"id":"113148426","username":"Martinharvey100","profile_image_url":"https://pbs.twimg.com/profile_images/1135188412301041665/s4E2JTb3_normal.png","verified":false,"name":"Martin Harvey","description":"Head of International Affairs at @EMA_News. Tweets reflect my interests & what catches my eye, ‚â† official views of EMA. MCIPR FDIA","protected":false,"created_at":"2010-02-10T21:32:44.000Z","public_metrics":{"followers_count":695,"following_count":321,"tweet_count":546,"listed_count":32},"url":"https://t.co/0Q7qKxb8LI","location":"Amsterdam, The Netherlands","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/0Q7qKxb8LI","expanded_url":"http://www.ema.europa.eu","display_url":"ema.europa.eu"}]},"description":{"mentions":[{"start":33,"end":42,"username":"EMA_News"}],"hashtags":{},"urls":{}}}},{"id":"308356449","username":"pisanie7","profile_image_url":"https://pbs.twimg.com/profile_images/881054953220997120/97x4vUTu_normal.jpg","verified":false,"name":"Eduardo Pisani","description":"Connecting dots to achieve shared goals. CEO @AllCanGroup Working on #health, #biopharma policy and law for #GlobalHealth solutions. Music passionate","protected":false,"created_at":"2011-05-31T08:15:34.000Z","public_metrics":{"followers_count":1049,"following_count":935,"tweet_count":7349,"listed_count":68},"url":"","location":"Brussels","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":45,"end":57,"username":"AllCanGroup"}],"hashtags":[{"start":69,"end":76,"tag":"health"},{"start":78,"end":88,"tag":"biopharma"},{"start":108,"end":121,"tag":"GlobalHealth"}],"urls":{}}},"pinned_tweet_id":"1495020867813879816"},{"id":"134450541","username":"EVEPIE","profile_image_url":"https://pbs.twimg.com/profile_images/1454948330522480640/ii7TRvF2_normal.jpg","verified":false,"name":"EVELYNE ÏóêÎ∏îÎ¶∞ PIERRON #BlacklivesMatter","description":"#Docteure en m√©decine #SantePublique #produitsdesante #signal #vigilancessanitaires #pharmacovigilance #gestiondurisque  Compte personnel","protected":false,"created_at":"2010-04-18T13:07:28.000Z","public_metrics":{"followers_count":5639,"following_count":3927,"tweet_count":41462,"listed_count":372},"url":"https://t.co/QOQcnlZxmC","location":"Paris ","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/QOQcnlZxmC","expanded_url":"http://linkedin.com/in/evelynepierron","display_url":"linkedin.com/in/evelynepier‚Ä¶"}]},"description":{"mentions":{},"hashtags":[{"start":0,"end":9,"tag":"Docteure"},{"start":22,"end":36,"tag":"SantePublique"},{"start":37,"end":53,"tag":"produitsdesante"},{"start":54,"end":61,"tag":"signal"},{"start":62,"end":83,"tag":"vigilancessanitaires"},{"start":84,"end":102,"tag":"pharmacovigilance"},{"start":103,"end":119,"tag":"gestiondurisque"}],"urls":{}}},"pinned_tweet_id":"1385581239260876808"},{"id":"67413545","username":"FirstlinePR","profile_image_url":"https://pbs.twimg.com/profile_images/1387801073218465793/zIctXtcR_normal.jpg","verified":false,"name":"Firstline Media","description":"Firstline is a broadcast public relations firm with the media savvy to know what decision makers at networks and major market tv and radio stations want.","protected":false,"created_at":"2009-08-20T20:21:25.000Z","public_metrics":{"followers_count":192,"following_count":452,"tweet_count":882,"listed_count":4},"url":"http://t.co/QvlFxmy7PV","location":"Atlanta (Headquarters)","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/QvlFxmy7PV","expanded_url":"http://www.firstlinemedia.com","display_url":"firstlinemedia.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"964487156","username":"TAPBiosystems","profile_image_url":"https://pbs.twimg.com/profile_images/1230886883816886272/NooP5fm3_normal.jpg","verified":false,"name":"SartoriusRoyston","description":"Leading supplier of innovative cell culture systems and consumables for life science applications.","protected":false,"created_at":"2012-11-22T15:48:00.000Z","public_metrics":{"followers_count":1552,"following_count":1208,"tweet_count":6825,"listed_count":50},"url":"https://t.co/i7KtIB4qGI","location":"Cambridge, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/i7KtIB4qGI","expanded_url":"https://www.sartorius-stedim-tap.com/tap/news/pages/curr_news.asp?show=current","display_url":"sartorius-stedim-tap.com/tap/news/pages‚Ä¶"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"469324230","username":"isciencewriter","profile_image_url":"https://pbs.twimg.com/profile_images/743735975478595584/E_dCeJAo_normal.jpg","verified":false,"name":"IScienceWriter","description":"International Science Writer (ISW) creating and sharing up-to-the-minute  news about #lifescience, #biotech and #pharma industries.","protected":false,"created_at":"2012-01-20T13:39:56.000Z","public_metrics":{"followers_count":5766,"following_count":3862,"tweet_count":18720,"listed_count":166},"url":"http://t.co/MNLk1KNsZY","location":"Hitchin, UK","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/MNLk1KNsZY","expanded_url":"http://www.internationalsciencewriter.com","display_url":"internationalsciencewriter.com"}]},"description":{"mentions":{},"hashtags":[{"start":85,"end":97,"tag":"lifescience"},{"start":99,"end":107,"tag":"biotech"},{"start":112,"end":119,"tag":"pharma"}],"urls":{}}}},{"id":"45537659","username":"DrSuePearson","profile_image_url":"https://pbs.twimg.com/profile_images/748424176147566592/hmXmodzY_normal.jpg","verified":false,"name":"Sue Pearson","description":"Writer for @GENBio, @ISciencewriter, presenter @CambridgeTVnews and weight loss #blogger. Tweets about #stemcells #biotech #health and #menopause","protected":false,"created_at":"2009-06-08T10:19:29.000Z","public_metrics":{"followers_count":1328,"following_count":761,"tweet_count":11537,"listed_count":89},"url":"https://t.co/bLSgCbBCr5","location":"Hitchin","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/bLSgCbBCr5","expanded_url":"http://www.drsuepearson.blog","display_url":"drsuepearson.blog"}]},"description":{"mentions":[{"start":11,"end":18,"username":"GENBio"},{"start":20,"end":35,"username":"ISciencewriter"},{"start":47,"end":63,"username":"CambridgeTVnews"}],"hashtags":[{"start":80,"end":88,"tag":"blogger"},{"start":103,"end":113,"tag":"stemcells"},{"start":114,"end":122,"tag":"biotech"},{"start":123,"end":130,"tag":"health"},{"start":135,"end":145,"tag":"menopause"}],"urls":{}}}},{"id":"341251022","username":"RebelMouse","profile_image_url":"https://pbs.twimg.com/profile_images/1346111538751549440/F_jITuyi_normal.png","verified":false,"name":"RebelMouse","description":"The fastest sites on the web. ‚úåÔ∏è","protected":false,"created_at":"2011-07-24T02:13:40.000Z","public_metrics":{"followers_count":90016,"following_count":14496,"tweet_count":36667,"listed_count":1791},"url":"https://t.co/hGbU4stnQG","location":"Global","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/hGbU4stnQG","expanded_url":"http://rbl.ms/2qNoORC","display_url":"rbl.ms/2qNoORC"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1484602957840666626"},{"id":"376804644","username":"KathrinLudwig","profile_image_url":"https://pbs.twimg.com/profile_images/1201421198925746176/qyQkpQ4o_normal.jpg","verified":false,"name":"Kathrin Ludwig","description":"Passionate about public health & healthcare | travel | our planet & sustainable lifestyle | scuba diving || views are my own","protected":false,"created_at":"2011-09-20T14:36:25.000Z","public_metrics":{"followers_count":716,"following_count":993,"tweet_count":933,"listed_count":37},"url":"","location":"European Union / BRX","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"552617924","username":"ScripRegMaureen","profile_image_url":"https://pbs.twimg.com/profile_images/775989970913886208/aYt8PC5S_normal.jpg","verified":false,"name":"Maureen Kenny","description":"Executive editor at Informa Pharma Intelligence (Pink Sheet). All opinions are my own.","protected":false,"created_at":"2012-04-13T11:25:36.000Z","public_metrics":{"followers_count":1131,"following_count":579,"tweet_count":2222,"listed_count":48},"url":"https://t.co/TZvOK1sijS","location":"London","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/TZvOK1sijS","expanded_url":"https://pink.pharmamedtechbi.com/","display_url":"pink.pharmamedtechbi.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"31353538","username":"michelerhee","profile_image_url":"https://pbs.twimg.com/profile_images/1100194074043301888/wH4ddZkC_normal.jpg","verified":false,"name":"Michele Rhee","description":"#RareDisease & #AYACSM / #AYA Cancer #PatientAdvocate| Board of @CostsOfCare | #Sambassador for @TheSamfund | Overall enthusiastic person! | Tweets are my own.","protected":false,"created_at":"2009-04-15T06:01:33.000Z","public_metrics":{"followers_count":1769,"following_count":349,"tweet_count":10253,"listed_count":82},"url":"","location":"Boston, MA","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":64,"end":76,"username":"CostsOfCare"},{"start":96,"end":107,"username":"TheSamfund"}],"hashtags":[{"start":0,"end":12,"tag":"RareDisease"},{"start":15,"end":22,"tag":"AYACSM"},{"start":25,"end":29,"tag":"AYA"},{"start":37,"end":53,"tag":"PatientAdvocate"},{"start":79,"end":91,"tag":"Sambassador"}],"urls":{}}}},{"id":"962947430","username":"Lordsofdrinks","profile_image_url":"https://pbs.twimg.com/profile_images/413001402693079040/OQSeLWWN_normal.jpeg","verified":false,"name":"Lordsofthedrinks.com","description":"http://t.co/SrDHalgLL2 is a weblog that discusses all alcohol related stuff. THE place for people who love drinking and partying.","protected":false,"created_at":"2012-11-21T19:23:50.000Z","public_metrics":{"followers_count":595,"following_count":893,"tweet_count":3209,"listed_count":10},"url":"http://t.co/ndv3K32cpY","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/ndv3K32cpY","expanded_url":"http://lordsofthedrinks.com/","display_url":"lordsofthedrinks.com"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":0,"end":22,"url":"http://t.co/SrDHalgLL2","expanded_url":"http://lordsofthedrinks.com","display_url":"lordsofthedrinks.com"}]}}},{"id":"441940097","username":"Aifa_ufficiale","profile_image_url":"https://pbs.twimg.com/profile_images/1410593679299911689/cV-Qg8dx_normal.jpg","verified":false,"name":"AIFA","description":"Profilo ufficiale dell'Agenzia Italiana del Farmaco | #AIFA ‚úâ ufficiostampaaifa@aifa.gov.it | https://t.co/gCLzpL6nAb","protected":false,"created_at":"2011-12-20T15:44:17.000Z","public_metrics":{"followers_count":37867,"following_count":1042,"tweet_count":5999,"listed_count":355},"url":"https://t.co/X8Gax5dj4o","location":"Roma","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/X8Gax5dj4o","expanded_url":"http://www.aifa.gov.it","display_url":"aifa.gov.it"}]},"description":{"mentions":{},"hashtags":[{"start":54,"end":59,"tag":"AIFA"}],"urls":[{"start":94,"end":117,"url":"https://t.co/gCLzpL6nAb","expanded_url":"http://bit.ly/AIFA-SM-Policy","display_url":"bit.ly/AIFA-SM-Policy"}]}}},{"id":"1017044760","username":"animalhealthEU","profile_image_url":"https://pbs.twimg.com/profile_images/1468217923617673216/oHA98tT4_normal.png","verified":false,"name":"AnimalhealthEurope","description":"AnimalhealthEurope represents manufacturers of animal health products and services in Europe #AnimalHealthMatters #MorethanMedicine","protected":false,"created_at":"2012-12-17T09:14:15.000Z","public_metrics":{"followers_count":6925,"following_count":1002,"tweet_count":7582,"listed_count":87},"url":"https://t.co/WJdV3X5glJ","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/WJdV3X5glJ","expanded_url":"http://www.animalhealtheurope.eu","display_url":"animalhealtheurope.eu"}]},"description":{"mentions":{},"hashtags":[{"start":93,"end":113,"tag":"AnimalHealthMatters"},{"start":114,"end":131,"tag":"MorethanMedicine"}],"urls":{}}},"pinned_tweet_id":"1488156259174043650"},{"id":"606325697","username":"EU_Health","profile_image_url":"https://pbs.twimg.com/profile_images/907604041215201280/IuRPoVdN_normal.jpg","verified":true,"name":"EU Health","description":"EU Commission's DG Health & Food Safety (SANTE). We are building the foundations of a stronger European #HealthUnion RT ‚â† endorsement. Food tweets @Food_EU","protected":false,"created_at":"2012-06-12T13:41:08.000Z","public_metrics":{"followers_count":83156,"following_count":3182,"tweet_count":25006,"listed_count":1873},"url":"https://t.co/Xb07O4qmcC","location":"Brussels, Europe","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Xb07O4qmcC","expanded_url":"http://ec.europa.eu/health","display_url":"ec.europa.eu/health"}]},"description":{"mentions":[{"start":147,"end":155,"username":"Food_EU"}],"hashtags":[{"start":104,"end":116,"tag":"HealthUnion"}],"urls":{}}},"pinned_tweet_id":"1498207262346821632"},{"id":"156892827","username":"UnumCommunitas","profile_image_url":"https://pbs.twimg.com/profile_images/1776308080/blind_justice_33_normal.jpg","verified":false,"name":"Unum Communitas","description":"With a firm reliance on the protection of Divine Providence, we mutually pledge to each other our Lives, our Fortunes and Sacred Honor","protected":false,"created_at":"2010-06-18T06:37:01.000Z","public_metrics":{"followers_count":974,"following_count":1219,"tweet_count":64651,"listed_count":45},"url":"","location":"Undisclosed Underground Bunker","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"34732474","username":"Indiegogo","profile_image_url":"https://pbs.twimg.com/profile_images/1414958903754952705/wy4hRtad_normal.jpg","verified":true,"name":"Indiegogo Reads üìö","description":"Your go-to for all things #crowdfunding ‚Äî from community stories to educational resources.üí° PSA: Crowdfunding is not shopping! It's better.","protected":false,"created_at":"2009-04-23T21:18:31.000Z","public_metrics":{"followers_count":324760,"following_count":5484,"tweet_count":29961,"listed_count":4285},"url":"https://t.co/QBfjNgdgZO","location":"Worldwide","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/QBfjNgdgZO","expanded_url":"http://indiegogo.com/blog","display_url":"indiegogo.com/blog"}]},"description":{"mentions":{},"hashtags":[{"start":26,"end":39,"tag":"crowdfunding"}],"urls":{}}},"pinned_tweet_id":"1460317139454369792"},{"id":"243228907","username":"BioPharmaMike","profile_image_url":"https://pbs.twimg.com/profile_images/378800000308429980/0288ff3098daceff8672357bac3209fd_normal.jpeg","verified":false,"name":"Mike Ward","description":"Commentating on issues consequential to pharma, biotech, healthcare & medtech stakeholders","protected":false,"created_at":"2011-01-26T15:58:16.000Z","public_metrics":{"followers_count":5965,"following_count":1077,"tweet_count":13680,"listed_count":264},"url":"","location":"London, UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"144624330","username":"kerfors","profile_image_url":"https://pbs.twimg.com/profile_images/775021351262363648/qeB7Z25Z_normal.jpg","verified":false,"name":"Kerstin Forsberg","description":"Lifelong Learner and Information Architect caring about clinical trial data and metadata https://t.co/0JRDBXfXVk‚Ä¶","protected":false,"created_at":"2010-05-16T21:20:15.000Z","public_metrics":{"followers_count":2258,"following_count":569,"tweet_count":15309,"listed_count":297},"url":"https://t.co/Fg3X3mbA44","location":"Kung√§lv, Sweden","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Fg3X3mbA44","expanded_url":"http://kerfors.blogspot.se/","display_url":"kerfors.blogspot.se"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":89,"end":112,"url":"https://t.co/0JRDBXfXVk","expanded_url":"http://orcid.org/0000-0002-1491","display_url":"orcid.org/0000-0002-1491"}]}}},{"id":"140344419","username":"cancereu","profile_image_url":"https://pbs.twimg.com/profile_images/1367015286721957890/NBLDvvzN_normal.jpg","verified":false,"name":"ECPC","description":"We are the voice of over 450 cancer patient organisations, covering the most common to the rarest cancers.\n\nECPC is providing Secretariat for @ChallengeCAN","protected":false,"created_at":"2010-05-05T07:43:41.000Z","public_metrics":{"followers_count":6018,"following_count":1849,"tweet_count":13668,"listed_count":0},"url":"https://t.co/8PBLq9mnAU","location":"Europe","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/8PBLq9mnAU","expanded_url":"http://www.ecpc.org","display_url":"ecpc.org"}]},"description":{"mentions":[{"start":142,"end":155,"username":"ChallengeCAN"}],"hashtags":{},"urls":{}}},"pinned_tweet_id":"1447517527366643712"},{"id":"18474984","username":"English_Woman","profile_image_url":"https://pbs.twimg.com/profile_images/869476696654835712/7XlX4FKZ_normal.jpg","verified":false,"name":"Sue Jameson","description":"Mum/Grandmum, Gamer, IT, Libertarian Minarchist. Indigenous Heathen.","protected":false,"created_at":"2008-12-30T11:09:12.000Z","public_metrics":{"followers_count":3729,"following_count":4355,"tweet_count":96542,"listed_count":148},"url":"https://t.co/pqkwclo60r","location":"Dunstable, England","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/pqkwclo60r","expanded_url":"https://www.facebook.com/sue.muffv","display_url":"facebook.com/sue.muffv"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"745006285888819200"},{"id":"556679074","username":"URPLWMiPB","profile_image_url":"https://pbs.twimg.com/profile_images/2150354867/image_normal.jpg","verified":true,"name":"URPL","description":"The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products | UrzƒÖd Rejestracji Prod. Leczniczych, Wyrob√≥w Med. i Prod. Biob√≥jczych","protected":false,"created_at":"2012-04-18T08:30:51.000Z","public_metrics":{"followers_count":2133,"following_count":377,"tweet_count":6710,"listed_count":23},"url":"https://t.co/yOlqIh8cmt","location":"Poland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/yOlqIh8cmt","expanded_url":"http://www.urpl.gov.pl","display_url":"urpl.gov.pl"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"203357203","username":"EAHPtweet","profile_image_url":"https://pbs.twimg.com/profile_images/648845031965487104/TM1cuwrq_normal.jpg","verified":false,"name":"EAHP","description":"European Association of Hospital Pharmacists","protected":false,"created_at":"2010-10-16T02:42:15.000Z","public_metrics":{"followers_count":5053,"following_count":3472,"tweet_count":8274,"listed_count":131},"url":"https://t.co/7GCosREhd5","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/7GCosREhd5","expanded_url":"http://www.eahp.eu","display_url":"eahp.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"556859372","username":"GCessak","profile_image_url":"https://pbs.twimg.com/profile_images/1134087083709140993/nDgYr-uy_normal.jpg","verified":true,"name":"ùóöùóøùòáùó≤ùó¥ùóºùóøùòá ùóñùó≤ùòÄùòÄùóÆùó∏","description":"President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products; Member of the EMA‚Äôs Management Board & CHMP, Ph.D.","protected":false,"created_at":"2012-04-18T13:24:10.000Z","public_metrics":{"followers_count":4971,"following_count":799,"tweet_count":12829,"listed_count":82},"url":"https://t.co/jTYELiOaYt","location":"Poland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/jTYELiOaYt","expanded_url":"http://www.urpl.gov.pl","display_url":"urpl.gov.pl"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"2382044864","username":"JHJournalist","profile_image_url":"https://pbs.twimg.com/profile_images/790558282503036928/RnIBmJWP_normal.jpg","verified":false,"name":"Joseph Harvey","description":"Expect tweets on #animalhealth, #biotech, #pharma, #healthcare, #onehealth, #agriculture, #investment and #foodsafety... #journalist","protected":false,"created_at":"2014-03-10T12:07:54.000Z","public_metrics":{"followers_count":2551,"following_count":250,"tweet_count":3779,"listed_count":73},"url":"https://t.co/sJKlT8OaG4","location":"London, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/sJKlT8OaG4","expanded_url":"http://www.animalpharmnews.com","display_url":"animalpharmnews.com"}]},"description":{"mentions":{},"hashtags":[{"start":17,"end":30,"tag":"animalhealth"},{"start":32,"end":40,"tag":"biotech"},{"start":42,"end":49,"tag":"pharma"},{"start":51,"end":62,"tag":"healthcare"},{"start":64,"end":74,"tag":"onehealth"},{"start":76,"end":88,"tag":"agriculture"},{"start":90,"end":101,"tag":"investment"},{"start":106,"end":117,"tag":"foodsafety"},{"start":121,"end":132,"tag":"journalist"}],"urls":{}}}},{"id":"35511598","username":"Kieran_Research","profile_image_url":"https://pbs.twimg.com/profile_images/835168863637495808/oPq0DFKU_normal.jpg","verified":false,"name":"Kieran Breen","description":"Head of Research and Innovation at  St Andrew‚Äôs Healthcare - all views are my own","protected":false,"created_at":"2009-04-26T17:20:58.000Z","public_metrics":{"followers_count":1019,"following_count":298,"tweet_count":6601,"listed_count":0},"url":"https://t.co/SvfdVALzti","location":"Northampton, UK.","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/SvfdVALzti","expanded_url":"http://www.linkedin.com/in/kcbreen","display_url":"linkedin.com/in/kcbreen"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"64681292","username":"worldkidneyday","profile_image_url":"https://pbs.twimg.com/profile_images/1437695843411406848/_aq89UUR_normal.jpg","verified":true,"name":"World Kidney Day","description":"World Kidney Day's objective is to raise awareness globally of the importance of Kidney Health and to increase screening for chronic kidney disease","protected":false,"created_at":"2009-08-11T10:40:45.000Z","public_metrics":{"followers_count":22188,"following_count":1125,"tweet_count":5125,"listed_count":193},"url":"https://t.co/MTsaT9TgLM","location":"Brussels, Belgium","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/MTsaT9TgLM","expanded_url":"https://linktr.ee/WorldKidneyDay","display_url":"linktr.ee/WorldKidneyDay"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1438499037917827080"},{"id":"329999446","username":"gm901007","profile_image_url":"https://pbs.twimg.com/profile_images/1193161822888767490/qv_5QGKo_normal.jpg","verified":false,"name":"Georgiana","description":"This is now a personal account, which I seem to use to RT things. All views my own.","protected":false,"created_at":"2011-07-05T23:15:54.000Z","public_metrics":{"followers_count":442,"following_count":869,"tweet_count":4927,"listed_count":32},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"157981564","username":"EU_Commission","profile_image_url":"https://pbs.twimg.com/profile_images/1460560236138438659/UrnEa2g7_normal.jpg","verified":true,"name":"European Commission üá™üá∫","description":"News and information from the European Commission. Social media and data protection policy: https://t.co/S5WriNaXYZ‚Ä¶","protected":false,"created_at":"2010-06-21T12:28:34.000Z","public_metrics":{"followers_count":1615790,"following_count":634,"tweet_count":43353,"listed_count":13718},"url":"https://t.co/JooRnYJttM","location":"Brussels, Belgium","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/JooRnYJttM","expanded_url":"https://europa.eu/next-generation-eu/index_en","display_url":"europa.eu/next-generatio‚Ä¶"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":92,"end":115,"url":"https://t.co/S5WriNaXYZ","expanded_url":"http://ec.europa.eu/info/social-me","display_url":"ec.europa.eu/info/social-me"}]}}},{"id":"1125798749727539202","username":"GeoMurariu","profile_image_url":"https://pbs.twimg.com/profile_images/1402600640120041473/VC1sF22Z_normal.jpg","verified":false,"name":"Georgiana Murariu","description":"User researcher at @dwpdigital, background in social anthropology. Romanian in London. Views my own.","protected":false,"created_at":"2019-05-07T16:25:13.000Z","public_metrics":{"followers_count":436,"following_count":809,"tweet_count":1488,"listed_count":6},"url":"","location":"London","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":19,"end":30,"username":"dwpdigital"}],"hashtags":{},"urls":{}}}},{"id":"208120290","username":"US_FDA","profile_image_url":"https://pbs.twimg.com/profile_images/773141404860162061/WK4RgHMx_normal.jpg","verified":true,"name":"U.S. FDA","description":"Our tweets are FDA Approved!               Privacy Policy - https://t.co/LbTJXYRXVP","protected":false,"created_at":"2010-10-26T17:31:41.000Z","public_metrics":{"followers_count":529044,"following_count":161,"tweet_count":16596,"listed_count":4981},"url":"https://t.co/4XwENQl3Ov","location":"Silver Spring, MD","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/4XwENQl3Ov","expanded_url":"https://www.fda.gov/coronavirus","display_url":"fda.gov/coronavirus"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":60,"end":83,"url":"https://t.co/LbTJXYRXVP","expanded_url":"http://go.usa.gov/xFfG8","display_url":"go.usa.gov/xFfG8"}]}}},{"id":"226603998","username":"alanROYGBIV","profile_image_url":"https://pbs.twimg.com/profile_images/2511777070/4iume3veudmj2muqx9c8_normal.jpeg","verified":false,"name":"Alan Thomas","description":"Founder of @Ataxia_and_Me  to support #Ataxia (Rare Neuro. condition) from the #patient view. PASSIONATE about Inclusion for #disabled citizens - views are mine","protected":false,"created_at":"2010-12-14T16:06:15.000Z","public_metrics":{"followers_count":3313,"following_count":2111,"tweet_count":68368,"listed_count":562},"url":"","location":"Llanboidy  West Wales","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":11,"end":25,"username":"Ataxia_and_Me"}],"hashtags":[{"start":38,"end":45,"tag":"Ataxia"},{"start":79,"end":87,"tag":"patient"},{"start":125,"end":134,"tag":"disabled"}],"urls":{}}}},{"id":"335343087","username":"Em_L_Hughes","profile_image_url":"https://pbs.twimg.com/profile_images/2676192810/a9f4ef8f6c77dd6f5942bd110194dc91_normal.png","verified":false,"name":"Emma Hughes","description":"Policy & Engagement Manager for Wales @GeneticAll_UK and @rarediseaseuk , Trustee @CHWchildren, PPI Lead @WalesGenePark","protected":false,"created_at":"2011-07-14T14:54:38.000Z","public_metrics":{"followers_count":361,"following_count":394,"tweet_count":1654,"listed_count":12},"url":"http://t.co/OtQjz52EFe","location":"Swansea, Wales","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/OtQjz52EFe","expanded_url":"http://www.geneticalliance.org.uk","display_url":"geneticalliance.org.uk"}]},"description":{"mentions":[{"start":38,"end":52,"username":"GeneticAll_UK"},{"start":57,"end":71,"username":"rarediseaseuk"},{"start":82,"end":94,"username":"CHWchildren"},{"start":105,"end":119,"username":"WalesGenePark"}],"hashtags":{},"urls":{}}}},{"id":"37254356","username":"DawnieMorgan","profile_image_url":"https://pbs.twimg.com/profile_images/694515453113286657/0MjQ34DP_normal.jpg","verified":false,"name":"Dawn Morgan","description":"Hometown - St. Dogmaels, Pembs. I now live in the middle of nowhere in Wales with my Partner Alan who has Cerebellar Ataxia. Ex chocolatier","protected":false,"created_at":"2009-05-02T18:39:16.000Z","public_metrics":{"followers_count":424,"following_count":988,"tweet_count":5245,"listed_count":42},"url":"","location":"Carmarthenshire","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"21026095","username":"jccolyer","profile_image_url":"https://pbs.twimg.com/profile_images/1473663586799083522/uA_MiqBM_normal.jpg","verified":false,"name":"John JC Colyer","description":"Diagnosed with neurological disorder Cerebellar Ataxia - To Know the Joy of Giving ‚Äú\nWE ARE ALL IN THIS TOGETHER","protected":false,"created_at":"2009-02-16T20:50:59.000Z","public_metrics":{"followers_count":1662,"following_count":1949,"tweet_count":189870,"listed_count":223},"url":"","location":"Seaside Heights,NJ ,USA","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1497962968457297925"},{"id":"62116349","username":"PrescribingPrac","profile_image_url":"https://pbs.twimg.com/profile_images/1083042614037889024/Soi3qeoJ_normal.jpg","verified":false,"name":"Journal of Prescribing Practice","description":"The peer-reviewed, multidisciplinary journal for all non-medical prescribers","protected":false,"created_at":"2009-08-01T20:54:36.000Z","public_metrics":{"followers_count":4187,"following_count":858,"tweet_count":2137,"listed_count":48},"url":"https://t.co/TlaFCtq10i","location":"London","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/TlaFCtq10i","expanded_url":"https://www.prescribingpractice.com/","display_url":"prescribingpractice.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1490629165418229762"},{"id":"432519961","username":"Unclean__","profile_image_url":"https://pbs.twimg.com/profile_images/1233629037320425473/pNUyQIan_normal.jpg","verified":false,"name":"Unclean","description":"Designed to be Buried - Official Fucking Beast of @sheep_destroyer - he/him - #FriedBarry Evangelist","protected":false,"created_at":"2011-12-09T13:48:37.000Z","public_metrics":{"followers_count":648,"following_count":4192,"tweet_count":13617,"listed_count":6},"url":"https://t.co/zw7PRY0Epz","location":"Kansas","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/zw7PRY0Epz","expanded_url":"http://forums.somethingawful.com","display_url":"forums.somethingawful.com"}]},"description":{"mentions":[{"start":50,"end":66,"username":"sheep_destroyer"}],"hashtags":[{"start":78,"end":89,"tag":"FriedBarry"}],"urls":{}}}},{"id":"434758377","username":"HSVhayatsaglik","profile_image_url":"https://pbs.twimg.com/profile_images/1334567294110994448/8dB3lH9A_normal.jpg","verified":false,"name":"Hayatsaƒülƒ±k Dergisi","description":"Saƒülƒ±k ve Sosyal Bilimler Dergisi hayatsaglikdergisi@hayatvakfi.org.tr","protected":false,"created_at":"2011-12-12T08:28:01.000Z","public_metrics":{"followers_count":736,"following_count":169,"tweet_count":762,"listed_count":4},"url":"https://t.co/0EwYinBsVp","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/0EwYinBsVp","expanded_url":"http://hayatsaglik.hayatvakfi.org.tr/son-sayimiz/","display_url":"hayatsaglik.hayatvakfi.org.tr/son-sayimiz/"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1257025042040467456"},{"id":"1159798933","username":"KerryCasting","profile_image_url":"https://pbs.twimg.com/profile_images/1045608184432463872/-VXjOA_U_normal.jpg","verified":false,"name":"KerryTVProducer","description":"Casting Producer on new adult literacy programme for Shine TV.\nEmail spell@shine.tv for info","protected":false,"created_at":"2013-02-08T10:30:48.000Z","public_metrics":{"followers_count":1342,"following_count":1620,"tweet_count":5565,"listed_count":13},"url":"","location":"London, England","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"166942410","username":"ITVWales","profile_image_url":"https://pbs.twimg.com/profile_images/1166284135004028928/XxWv5YUy_normal.jpg","verified":true,"name":"ITV Wales News","description":"The latest news, sport & entertainment for Wales. Contact us: wales@itv.com - https://t.co/p0kGsvP13M - https://t.co/nDcD2LUq2d","protected":false,"created_at":"2010-07-15T10:59:09.000Z","public_metrics":{"followers_count":106138,"following_count":1527,"tweet_count":74952,"listed_count":679},"url":"http://t.co/CkDL0Cne9s","location":"Wales","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/CkDL0Cne9s","expanded_url":"http://itv.com/wales","display_url":"itv.com/wales"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":78,"end":101,"url":"https://t.co/p0kGsvP13M","expanded_url":"http://facebook.com/itvwales/","display_url":"facebook.com/itvwales/"},{"start":104,"end":127,"url":"https://t.co/nDcD2LUq2d","expanded_url":"http://instagram.com/itvwales","display_url":"instagram.com/itvwales"}]}}},{"id":"340331522","username":"BelenZafra","profile_image_url":"https://pbs.twimg.com/profile_images/988866272589963265/mNRgwEs__normal.jpg","verified":false,"name":"ASanfilippoBarcelona","description":"","protected":false,"created_at":"2011-07-22T14:41:39.000Z","public_metrics":{"followers_count":1044,"following_count":2636,"tweet_count":3925,"listed_count":13},"url":"https://t.co/50O0mMTj49","location":"Barcelona (Spain)","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/50O0mMTj49","expanded_url":"http://www.sanfilippobcn.es","display_url":"sanfilippobcn.es"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"318743706","username":"emilycfreeman","profile_image_url":"https://pbs.twimg.com/profile_images/1487476742373658624/RZqVRAMl_normal.jpg","verified":false,"name":"Emily Freeman, MSc, PhD üá®üá¶üá∫üá∏","description":"Social/behavioral scientist & meteorologist. Patient Focused Drug Development. Endometriosis Advocacy. Opinions are my own. #HailState #MissStateAlumni üè≥Ô∏è‚Äçüåà","protected":false,"created_at":"2011-06-17T00:05:59.000Z","public_metrics":{"followers_count":1100,"following_count":623,"tweet_count":16564,"listed_count":0},"url":"","location":"Carmel, IN","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":124,"end":134,"tag":"HailState"},{"start":135,"end":151,"tag":"MissStateAlumni"}],"urls":{}}}},{"id":"525474752","username":"MMGHealth","profile_image_url":"https://pbs.twimg.com/profile_images/1440331786362310656/-gfwzzjH_normal.jpg","verified":false,"name":"MMG","description":"Leaders in public health communications and clinical trial recruitment #PublicHealth #PatientRecruitment #ClinicalTrials #patientengagement","protected":false,"created_at":"2012-03-15T15:35:09.000Z","public_metrics":{"followers_count":590,"following_count":320,"tweet_count":2448,"listed_count":33},"url":"https://t.co/kbbhIigYNd","location":"Worldwide","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/kbbhIigYNd","expanded_url":"http://mmgct.com","display_url":"mmgct.com"}]},"description":{"mentions":{},"hashtags":[{"start":71,"end":84,"tag":"PublicHealth"},{"start":85,"end":104,"tag":"PatientRecruitment"},{"start":105,"end":120,"tag":"ClinicalTrials"},{"start":121,"end":139,"tag":"patientengagement"}],"urls":{}}},"pinned_tweet_id":"1281586344482013185"},{"id":"261573281","username":"mmadurga","profile_image_url":"https://pbs.twimg.com/profile_images/1380151738196459528/rbFfYoWN_normal.jpg","verified":false,"name":"Mariano Madurga","description":"Sanitario, experto en farmacovigilancia, tranquilo, sencillo, amigo de sus amigos y de sus enemigos","protected":false,"created_at":"2011-03-06T06:43:34.000Z","public_metrics":{"followers_count":1566,"following_count":1822,"tweet_count":9678,"listed_count":29},"url":"","location":"Madrid, Espa√±a/Spain","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"982666808","username":"Justice4Faroque","profile_image_url":"https://pbs.twimg.com/profile_images/3021413658/9170ea506e800523fd71da125f530a4c_normal.jpeg","verified":false,"name":"Justice4DrFaroque","description":"PhD in Actuarial Science (City University), Teacher, Loving Father and Grandfather","protected":false,"created_at":"2012-12-01T14:35:26.000Z","public_metrics":{"followers_count":7,"following_count":133,"tweet_count":327,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"2254792730","username":"CDeRede","profile_image_url":"https://pbs.twimg.com/profile_images/561111961971081216/0dCUBYl3_normal.jpeg","verified":false,"name":"Camille DR œü","description":"Communications Expert for @EU_SRB - üá™üá∫Agency. #Banking #EU #Digital #SocialMedia #Tech #Travels #Photography - Tweets are My Own (& mostly nerdy) üáßüá™","protected":false,"created_at":"2013-12-20T10:06:32.000Z","public_metrics":{"followers_count":877,"following_count":721,"tweet_count":1792,"listed_count":22},"url":"https://t.co/RbIqg8GFJn","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/RbIqg8GFJn","expanded_url":"http://www.linkedin.com/in/camillederede","display_url":"linkedin.com/in/camilledere‚Ä¶"}]},"description":{"mentions":[{"start":26,"end":33,"username":"EU_SRB"}],"hashtags":[{"start":46,"end":54,"tag":"Banking"},{"start":55,"end":58,"tag":"EU"},{"start":59,"end":67,"tag":"Digital"},{"start":68,"end":80,"tag":"SocialMedia"},{"start":81,"end":86,"tag":"Tech"},{"start":87,"end":95,"tag":"Travels"},{"start":96,"end":108,"tag":"Photography"}],"urls":{}}}},{"id":"19982434","username":"rarediseaseday","profile_image_url":"https://pbs.twimg.com/profile_images/1355077533553680390/MqIWPy9F_normal.png","verified":false,"name":"Rare Disease Day","description":"28 February 2022 is Rare Disease Day. Raising awareness for patients, families and carers around the world that are affected by rare diseases. #RareDiseaseDay","protected":false,"created_at":"2009-02-03T16:44:43.000Z","public_metrics":{"followers_count":39380,"following_count":3519,"tweet_count":2038,"listed_count":479},"url":"https://t.co/7Ijl6jH6gu","location":"Worldwide","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/7Ijl6jH6gu","expanded_url":"http://www.rarediseaseday.org","display_url":"rarediseaseday.org"}]},"description":{"mentions":{},"hashtags":[{"start":143,"end":158,"tag":"RareDiseaseDay"}],"urls":{}}}},{"id":"274030199","username":"rarediseaseuk","profile_image_url":"https://pbs.twimg.com/profile_images/1346027276346007552/DHf4Qjo2_normal.jpg","verified":false,"name":"Rare Disease UK","description":"National campaign run by @GeneticAll_UK to improve the lives of those affected by rare conditions and all who support them #RareDisease. Monitored weekdays 9-5.","protected":false,"created_at":"2011-03-29T15:57:09.000Z","public_metrics":{"followers_count":21217,"following_count":2193,"tweet_count":16498,"listed_count":306},"url":"https://t.co/0Os4YEqeWT","location":"UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/0Os4YEqeWT","expanded_url":"http://www.raredisease.org.uk/","display_url":"raredisease.org.uk"}]},"description":{"mentions":[{"start":25,"end":39,"username":"GeneticAll_UK"}],"hashtags":[{"start":123,"end":135,"tag":"RareDisease"}],"urls":{}}},"pinned_tweet_id":"1498214256512315392"},{"id":"413849446","username":"GeneticAll_UK","profile_image_url":"https://pbs.twimg.com/profile_images/1346027149371834368/IbA4l8U6_normal.jpg","verified":false,"name":"Genetic Alliance UK","description":"National charity working for everyone affected by genetic, rare and undiagnosed conditions. We run the campaign @rarediseaseuk and support network @SWAN_UK.","protected":false,"created_at":"2011-11-16T10:07:51.000Z","public_metrics":{"followers_count":14774,"following_count":2182,"tweet_count":18341,"listed_count":216},"url":"https://t.co/mGSf3EEsi6","location":"London","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/mGSf3EEsi6","expanded_url":"http://www.geneticalliance.org.uk","display_url":"geneticalliance.org.uk"}]},"description":{"mentions":[{"start":112,"end":126,"username":"rarediseaseuk"},{"start":147,"end":155,"username":"SWAN_UK"}],"hashtags":{},"urls":{}}}},{"id":"330993102","username":"MHRAgovuk","profile_image_url":"https://pbs.twimg.com/profile_images/1359177868870311936/ooRMF1mW_normal.jpg","verified":true,"name":"MHRAgovuk","description":"The MHRA is a global leader in protecting and improving public health and supporting innovation through scientific research and development.","protected":false,"created_at":"2011-07-07T13:47:46.000Z","public_metrics":{"followers_count":29459,"following_count":541,"tweet_count":5190,"listed_count":314},"url":"http://t.co/Ec7fWJf5Zu","location":"United Kingdom","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Ec7fWJf5Zu","expanded_url":"http://gov.uk/mhra","display_url":"gov.uk/mhra"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1484528605849862146"},{"id":"250163834","username":"JanetWilliams99","profile_image_url":"https://pbs.twimg.com/profile_images/1465462297728626695/Od6MvFXJ_normal.jpg","verified":false,"name":"janet williams  INFACT","description":"Co-Founder of National Trust & Reg charity for AEDs in Pregnancy, campaigner, lobbyist, songwriter & Supermum..!! These are my personal views #valproatecrisis","protected":false,"created_at":"2011-02-10T15:10:42.000Z","public_metrics":{"followers_count":624,"following_count":1115,"tweet_count":19796,"listed_count":28},"url":"https://t.co/6akbPHWv9q","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/6akbPHWv9q","expanded_url":"http://www.infactuk.com","display_url":"infactuk.com"}]},"description":{"mentions":{},"hashtags":[{"start":142,"end":158,"tag":"valproatecrisis"}],"urls":{}}},"pinned_tweet_id":"1491756309066223621"},{"id":"277466861","username":"Emma4facs","profile_image_url":"https://pbs.twimg.com/profile_images/1475965222175264777/OB0lxnGi_normal.jpg","verified":false,"name":"Emma Murphy (INFACT) ‚òòÔ∏èüíïüòòü¶ã","description":"Official Campaign & Trust @Infactuk for AEDs in Pregnancyü§∞#epilepsy Mum of 6 diagnosed with FVSD üíä Award Winning Campaigner üèÜüèÜ #Valproatecrisis","protected":false,"created_at":"2011-04-05T12:43:19.000Z","public_metrics":{"followers_count":3636,"following_count":5000,"tweet_count":114433,"listed_count":125},"url":"https://t.co/hwin8axImt","location":"Manchester/London/Worldwide ","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/hwin8axImt","expanded_url":"http://www.infactuk.com","display_url":"infactuk.com"}]},"description":{"mentions":[{"start":26,"end":35,"username":"Infactuk"}],"hashtags":[{"start":58,"end":67,"tag":"epilepsy"},{"start":127,"end":143,"tag":"Valproatecrisis"}],"urls":{}}},"pinned_tweet_id":"1282265702775259138"},{"id":"51282370","username":"BioMarin","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"BioMarin","description":"","protected":false,"created_at":"2009-06-27T00:03:06.000Z","public_metrics":{"followers_count":344,"following_count":0,"tweet_count":0,"listed_count":13},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"380500399","username":"redacre","profile_image_url":"https://pbs.twimg.com/profile_images/893112881008463872/Zitiyh_B_normal.jpg","verified":false,"name":"Red Acre Investments","description":"Binary Event Specialists & Fund Managers, Macro-trend Analysis.  Get Ahead of the Curve with our Actionable Analysis: Subscribe at http://t.co/v7P2mXJP","protected":false,"created_at":"2011-09-26T19:11:09.000Z","public_metrics":{"followers_count":5852,"following_count":599,"tweet_count":21889,"listed_count":138},"url":"http://t.co/Cdv01739TD","location":"Connecticut","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Cdv01739TD","expanded_url":"http://www.redacre.com","display_url":"redacre.com"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":131,"end":151,"url":"http://t.co/v7P2mXJP","expanded_url":"http://www.redacre.com","display_url":"redacre.com"}]}}},{"id":"1171477128","username":"BegoLopezGo","profile_image_url":"https://pbs.twimg.com/profile_images/678334233191030784/qblkGkzf_normal.jpg","verified":false,"name":"Bego√±a L√≥pez","description":"","protected":false,"created_at":"2013-02-12T09:54:03.000Z","public_metrics":{"followers_count":143,"following_count":228,"tweet_count":437,"listed_count":24},"url":"https://t.co/ssn4HAVvHh","location":"MADRID","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/ssn4HAVvHh","expanded_url":"http://www.linkedin.com/in/begolopez1","display_url":"linkedin.com/in/begolopez1"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"224614927","username":"SusanWer","profile_image_url":"https://pbs.twimg.com/profile_images/970960336663777285/ZZZ6cadE_normal.jpg","verified":false,"name":"Susanne Karin Werner","description":"Advisor in strategic communication. Passionate about volunteering @OsloRodeKors Resource Center for Youth #Groruddalen #Fellesverket","protected":false,"created_at":"2010-12-09T12:41:28.000Z","public_metrics":{"followers_count":1209,"following_count":2436,"tweet_count":1715,"listed_count":37},"url":"https://t.co/O4BKFwU6fJ","location":"Oslo, Norway","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/O4BKFwU6fJ","expanded_url":"https://www.linkedin.com/in/susannekwerner/","display_url":"linkedin.com/in/susannekwer‚Ä¶"}]},"description":{"mentions":[{"start":66,"end":79,"username":"OsloRodeKors"}],"hashtags":[{"start":106,"end":118,"tag":"Groruddalen"},{"start":119,"end":132,"tag":"Fellesverket"}],"urls":{}}}},{"id":"267831890","username":"ampariu","profile_image_url":"https://pbs.twimg.com/profile_images/1870485251/359_29575888642_748548642_844337_7258_n_normal.jpg","verified":false,"name":"Amparo Iraola Lliso","description":"Castell√≥ 1975. M√©dico de Familia y Onc√≥loga en la Fundaci√≥n Instituto Valenciano de Oncologia (FIVO) Adicciones incurables: lectura/escritura/viajes","protected":false,"created_at":"2011-03-17T16:36:01.000Z","public_metrics":{"followers_count":1745,"following_count":1519,"tweet_count":12061,"listed_count":0},"url":"https://t.co/cAoEZoChS5","location":"Valencia, Espa√±a","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/cAoEZoChS5","expanded_url":"http://wwwlabelleechape.blogspot.com/","display_url":"wwwlabelleechape.blogspot.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"555051765","username":"_SEOM","profile_image_url":"https://pbs.twimg.com/profile_images/1361302838404595716/vip6ZIWW_normal.jpg","verified":true,"name":"SEOM","description":"Somos una sociedad cient√≠fica, referente en c√°ncer. Nuestra misi√≥n: mejorar la prevenci√≥n, el diagn√≥stico, el tratamiento y el seguimiento del c√°ncer.","protected":false,"created_at":"2012-04-16T08:38:44.000Z","public_metrics":{"followers_count":29986,"following_count":2000,"tweet_count":28104,"listed_count":537},"url":"https://t.co/3CxDC5u3K9","location":"Spanje","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/3CxDC5u3K9","expanded_url":"http://www.seom.org","display_url":"seom.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1497131842557861912"},{"id":"1193633406","username":"CRCTU","profile_image_url":"https://pbs.twimg.com/profile_images/1489603298109890563/bcX7Ocd3_normal.jpg","verified":false,"name":"Birmingham Cancer Research UK Clinical Trials Unit","description":"@CR_UK Clinical Trials Unit @unibirmingham is one of largest UK units running phase I-III adult & paediatric trials including @Tap_Clin_Trials @impactstemcell","protected":false,"created_at":"2013-02-18T15:44:45.000Z","public_metrics":{"followers_count":1955,"following_count":625,"tweet_count":2069,"listed_count":0},"url":"https://t.co/TL3NlVuhUx","location":"University of Birmingham","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/TL3NlVuhUx","expanded_url":"http://www.birmingham.ac.uk/CRCTU","display_url":"birmingham.ac.uk/CRCTU"}]},"description":{"mentions":[{"start":0,"end":6,"username":"CR_UK"},{"start":28,"end":42,"username":"unibirmingham"},{"start":126,"end":142,"username":"Tap_Clin_Trials"},{"start":143,"end":158,"username":"impactstemcell"}],"hashtags":{},"urls":{}}},"pinned_tweet_id":"1489552533731389441"},{"id":"53023973","username":"uicc","profile_image_url":"https://pbs.twimg.com/profile_images/1116646002763665408/uYP9DxpE_normal.png","verified":false,"name":"Union for International Cancer Control","description":"Uniting the cancer community to reduce the #globalcancer burden, promote #equity, & ensure #cancercontrol remains a priority in the #health & dev agenda","protected":false,"created_at":"2009-07-02T10:06:16.000Z","public_metrics":{"followers_count":19033,"following_count":1922,"tweet_count":12292,"listed_count":297},"url":"https://t.co/8Hx4YxDGgT","location":"Geneva, Switzerland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/8Hx4YxDGgT","expanded_url":"http://www.uicc.org","display_url":"uicc.org"}]},"description":{"mentions":{},"hashtags":[{"start":43,"end":56,"tag":"globalcancer"},{"start":73,"end":80,"tag":"equity"},{"start":91,"end":105,"tag":"cancercontrol"},{"start":132,"end":139,"tag":"health"}],"urls":{}}}},{"id":"1030110686","username":"docjavip","profile_image_url":"https://pbs.twimg.com/profile_images/1201576694743781380/Jcw-XGqw_normal.jpg","verified":false,"name":"Javier Puente","description":"Medical oncologist. Clinical researcher focused in GU tumors. Director Institute of Oncology. Associate Professor UCM. Hospital Clinico San Carlos Madrid, Spain","protected":false,"created_at":"2012-12-23T08:00:23.000Z","public_metrics":{"followers_count":2852,"following_count":848,"tweet_count":4668,"listed_count":68},"url":"","location":"Madrid","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"65594160","username":"giasison","profile_image_url":"https://pbs.twimg.com/profile_images/1446076589419085827/o0uVWCsG_normal.jpg","verified":true,"name":"Dr. Gia Sison","description":"Doctor. Host. MH Advocate. Breast CA Survivor. PH Leader Livestrong Foundation. Co-Founder #HealthXPh. G Talks Host, https://t.co/HaIEFdp7q3 / giasison@gmail.com","protected":false,"created_at":"2009-08-14T08:29:54.000Z","public_metrics":{"followers_count":160645,"following_count":4722,"tweet_count":141073,"listed_count":865},"url":"https://t.co/yTqZLxNJvo","location":"Manila, Philippines","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/yTqZLxNJvo","expanded_url":"http://padayonph.com","display_url":"padayonph.com"}]},"description":{"mentions":{},"hashtags":[{"start":91,"end":101,"tag":"HealthXPh"}],"urls":[{"start":117,"end":140,"url":"https://t.co/HaIEFdp7q3","expanded_url":"http://cnn.ph","display_url":"cnn.ph"}]}},"pinned_tweet_id":"1321760087988264961"},{"id":"65461631","username":"wild_diva","profile_image_url":"https://pbs.twimg.com/profile_images/1438232611567067136/1mJ2kYo4_normal.jpg","verified":false,"name":"Eddy Ver√≥nica Mora","description":"I'm a Pathologist. I left my Hospital IOMPC. No Surgery, no radiotherapy. #SOSVenezuela","protected":false,"created_at":"2009-08-13T20:39:39.000Z","public_metrics":{"followers_count":1740,"following_count":1248,"tweet_count":66949,"listed_count":0},"url":"","location":"Venezuela","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":74,"end":87,"tag":"SOSVenezuela"}],"urls":{}}},"pinned_tweet_id":"1437381256875069442"},{"id":"31432586","username":"_M_Masa","profile_image_url":"https://pbs.twimg.com/profile_images/1214425640/avatar_marc_normal.jpg","verified":false,"name":"Marc Masa","description":"Health & Biomedicine Department Head at Leitat. -Opinions are my own-","protected":false,"created_at":"2009-04-15T15:25:14.000Z","public_metrics":{"followers_count":647,"following_count":991,"tweet_count":4438,"listed_count":51},"url":"https://t.co/qnNAy4qZtx","location":"Barcelona, Catalunya","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/qnNAy4qZtx","expanded_url":"https://es.linkedin.com/in/marcmasa","display_url":"es.linkedin.com/in/marcmasa"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"30891529","username":"ONAcom","profile_image_url":"https://pbs.twimg.com/profile_images/1471220620205690883/tzHaSFE-_normal.jpg","verified":false,"name":"OncologyNurseAdvisor","description":"Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.","protected":false,"created_at":"2009-04-13T16:01:25.000Z","public_metrics":{"followers_count":4253,"following_count":307,"tweet_count":16422,"listed_count":125},"url":"https://t.co/0efvi93XcR","location":"New York, NY","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/0efvi93XcR","expanded_url":"http://www.oncologynurseadvisor.com/","display_url":"oncologynurseadvisor.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"847536019","username":"CASMIorg","profile_image_url":"https://pbs.twimg.com/profile_images/1177604466629140480/miEQapls_normal.jpg","verified":false,"name":"CASMI","description":"The Collaboration for the Advancement of Sustainable Medical Innovation aims to develop better and more sustainable means of effecting medical innovation","protected":false,"created_at":"2012-09-26T14:43:47.000Z","public_metrics":{"followers_count":569,"following_count":484,"tweet_count":839,"listed_count":19},"url":"https://t.co/LfjDx7eZUk","location":"UCL","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/LfjDx7eZUk","expanded_url":"http://www.ucl.ac.uk/slms/research/casmi","display_url":"ucl.ac.uk/slms/research/‚Ä¶"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"2198604157","username":"AdriausWorld","profile_image_url":"https://pbs.twimg.com/profile_images/433025931167289344/GpNxluTK_normal.jpeg","verified":false,"name":"AdrianaStefancic","description":"","protected":false,"created_at":"2013-11-17T00:00:43.000Z","public_metrics":{"followers_count":12,"following_count":19,"tweet_count":38,"listed_count":0},"url":"http://t.co/OA0pIJbBge","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/OA0pIJbBge","expanded_url":"http://adriaus.com","display_url":"adriaus.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"49340629","username":"thechris73","profile_image_url":"https://pbs.twimg.com/profile_images/1300473110882390016/baRq3B-V_normal.jpg","verified":false,"name":"Chris Thubron","description":"Dad of 3 passionate about tech,running and recovery since 05/01/2016 #wedorecover #recovery #odatt","protected":false,"created_at":"2009-06-21T15:28:38.000Z","public_metrics":{"followers_count":489,"following_count":1862,"tweet_count":1337,"listed_count":0},"url":"https://t.co/GslMKP7znE","location":"Washington Tyne and Wear UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/GslMKP7znE","expanded_url":"https://www.strava.com/athletes/55220748","display_url":"strava.com/athletes/55220‚Ä¶"}]},"description":{"mentions":{},"hashtags":[{"start":69,"end":81,"tag":"wedorecover"},{"start":82,"end":91,"tag":"recovery"},{"start":92,"end":98,"tag":"odatt"}],"urls":{}}}},{"id":"1242516320","username":"PharmaExpertise","profile_image_url":"https://pbs.twimg.com/profile_images/3339928235/a3cf62ebbafbef02c100d17b062ff30a_normal.png","verified":false,"name":"PharmaExpertise","description":"PharmaExpertise is the proactive online community for pharma-biotech industry news and careers for life science professionals.","protected":false,"created_at":"2013-03-05T00:30:18.000Z","public_metrics":{"followers_count":198,"following_count":105,"tweet_count":2773,"listed_count":36},"url":"http://t.co/i7w44IlCLS","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/i7w44IlCLS","expanded_url":"http://www.pharmaexpertise.com","display_url":"pharmaexpertise.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"514255564","username":"QPQuandary","profile_image_url":"https://pbs.twimg.com/profile_images/2840697714/9645fba30104ca233c120f21e6f04745_normal.png","verified":false,"name":"Alex Hallüíô","description":"QPQuandary Training Solutions offers a bespoke service to the pharma industry, for Qualified Person training. All opinions are my own.","protected":false,"created_at":"2012-03-04T11:50:45.000Z","public_metrics":{"followers_count":441,"following_count":171,"tweet_count":9878,"listed_count":37},"url":"https://t.co/7vTDMynHgL","location":"UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/7vTDMynHgL","expanded_url":"http://www.QPQuandary.com","display_url":"QPQuandary.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"377336516","username":"PierrikFaure","profile_image_url":"https://pbs.twimg.com/profile_images/547916393908535297/3UDno1JQ_normal.jpeg","verified":false,"name":"Faure pierrik","description":"#teamchaman #teamhomeo #teamosteo #teametjerro #teammagie  #teamteam","protected":false,"created_at":"2011-09-21T12:21:59.000Z","public_metrics":{"followers_count":426,"following_count":544,"tweet_count":3227,"listed_count":10},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":0,"end":11,"tag":"teamchaman"},{"start":12,"end":22,"tag":"teamhomeo"},{"start":23,"end":33,"tag":"teamosteo"},{"start":34,"end":46,"tag":"teametjerro"},{"start":47,"end":57,"tag":"teammagie"},{"start":59,"end":68,"tag":"teamteam"}],"urls":{}}}},{"id":"51445321","username":"ANDREAFERRAIOLO","profile_image_url":"https://pbs.twimg.com/profile_images/1328088973537906691/tE5glGun_normal.jpg","verified":false,"name":"ANDREA FERRAIOLO","description":"I 'm Pharmacist and i work in Gsk Medical Affair.These views are my own and do not necessarily reflect the views of GSK","protected":false,"created_at":"2009-06-27T14:02:36.000Z","public_metrics":{"followers_count":262,"following_count":713,"tweet_count":3899,"listed_count":13},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"830901563543711744"},{"id":"286245228","username":"juanhidal","profile_image_url":"https://pbs.twimg.com/profile_images/597055554306048000/fmOr0FD9_normal.jpg","verified":false,"name":"Juan Hidalgo Cabrera","description":"‚ÄúSe puede llegar al mismo sitio de formas distintas‚Äù #Farmac√©utico #FarmaciaHospital","protected":false,"created_at":"2011-04-22T16:33:43.000Z","public_metrics":{"followers_count":611,"following_count":681,"tweet_count":3545,"listed_count":24},"url":"","location":"Lucena, C√≥rdoba. Spain","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":53,"end":66,"tag":"Farmac√©utico"},{"start":67,"end":84,"tag":"FarmaciaHospital"}],"urls":{}}}},{"id":"2208098471","username":"EspinCano","profile_image_url":"https://pbs.twimg.com/profile_images/378800000834032936/4cf91c749a89707625f647e9d3ba78d3_normal.jpeg","verified":false,"name":"Cristina Cano ","description":"Tecnico de Farmacia del Hospital de Jerez","protected":false,"created_at":"2013-12-05T00:17:02.000Z","public_metrics":{"followers_count":53,"following_count":113,"tweet_count":30,"listed_count":0},"url":"","location":"Hospital de Jerez","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"914462377","username":"sefh_","profile_image_url":"https://pbs.twimg.com/profile_images/875695863267557378/wAJmcQOY_normal.jpg","verified":false,"name":"S.E.F.H","description":"Sociedad Espa√±ola de Farmacia Hospitalaria, SEFH.\n\nPol√≠tica de privacidad ‚û°Ô∏è https://t.co/69mnkTxXo5","protected":false,"created_at":"2012-10-30T11:43:26.000Z","public_metrics":{"followers_count":22451,"following_count":533,"tweet_count":25265,"listed_count":344},"url":"http://t.co/AJLNPY7rRm","location":"C/ Serrano, 40 ‚Äì 2¬∫ Dcha. 28001 Madrid","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/AJLNPY7rRm","expanded_url":"http://www.sefh.es","display_url":"sefh.es"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":77,"end":100,"url":"https://t.co/69mnkTxXo5","expanded_url":"http://ow.ly/Bqxk50C2qZP","display_url":"ow.ly/Bqxk50C2qZP"}]}},"pinned_tweet_id":"1498200841815212035"},{"id":"328653957","username":"SynergyVision","profile_image_url":"https://pbs.twimg.com/profile_images/1153333162178678785/8B6j1OB4_normal.jpg","verified":false,"name":"Synergy Vision","description":"Synergy Vision | award winning agency | delivering the difference in medical communications | Fresh. Smart. Open. Real. |","protected":false,"created_at":"2011-07-03T19:44:27.000Z","public_metrics":{"followers_count":973,"following_count":1759,"tweet_count":2538,"listed_count":34},"url":"http://t.co/OlAJSp7BpU","location":"London","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/OlAJSp7BpU","expanded_url":"http://www.synergy-vision.com","display_url":"synergy-vision.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1367076329267601410"},{"id":"16947313","username":"trished","profile_image_url":"https://pbs.twimg.com/profile_images/1006242945236918272/jPLFvR93_normal.jpg","verified":false,"name":"Trish Groves","description":"Traveller, optimist, sceptic, retired medical journal editor ORCID 0000-0001-7915-6419","protected":false,"created_at":"2008-10-24T10:52:31.000Z","public_metrics":{"followers_count":9846,"following_count":1767,"tweet_count":32009,"listed_count":339},"url":"https://t.co/GxawoU0hYo","location":"UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/GxawoU0hYo","expanded_url":"https://uk.linkedin.com/in/trishgroves","display_url":"uk.linkedin.com/in/trishgroves"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"22255878","username":"sTuDiO54x","profile_image_url":"https://pbs.twimg.com/profile_images/3358179519/c9fe58b5447853c9b562441bc1e91954_normal.jpeg","verified":false,"name":"Fab","description":"‚ô´‚ô´ ‚ùùI ‚ô• ELEKTRO‚ùû ‚ô´‚ô´ ‚ôÇ","protected":false,"created_at":"2009-02-28T13:45:06.000Z","public_metrics":{"followers_count":13,"following_count":60,"tweet_count":501,"listed_count":2},"url":"https://t.co/3u5CnPCaEB","location":"K√∂ln [GER/ EU]","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/3u5CnPCaEB","expanded_url":"http://facebook.com/sTuDiO54x","display_url":"facebook.com/sTuDiO54x"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"2178765794","username":"ZamboninMarco","profile_image_url":"https://pbs.twimg.com/profile_images/378800000864093355/OLrVIYsU_normal.jpeg","verified":false,"name":"Marco Zambonin","description":"Farmacista e Informatore","protected":false,"created_at":"2013-11-06T20:38:13.000Z","public_metrics":{"followers_count":66,"following_count":151,"tweet_count":893,"listed_count":9},"url":"","location":"Padova, Italy","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"220854424","username":"not4every1","profile_image_url":"https://pbs.twimg.com/profile_images/905817654618984449/Xgr4MuF3_normal.jpg","verified":false,"name":"AlbertK","description":"Tra Napoli e Milano; Project Manager Pharma, Appassionato di Politica,Surfer apprendista, Neofita della cucina,Tifoso,Twitter-based,Cosmopolita. #tuttocambia","protected":false,"created_at":"2010-11-29T01:15:41.000Z","public_metrics":{"followers_count":149,"following_count":374,"tweet_count":3021,"listed_count":0},"url":"","location":"Milano, Italia","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":145,"end":157,"tag":"tuttocambia"}],"urls":{}}},"pinned_tweet_id":"845546098433372160"},{"id":"1548804618","username":"louis_ide","profile_image_url":"https://pbs.twimg.com/profile_images/1465701438642819079/4q4uzG7e_normal.jpg","verified":true,"name":"Louis Ide","description":"MD microbiologie, antibioticabeleid & infectiecontrole & nationaal secretaris van N-VA. Auteur ‚ÄòHet Project‚Äô & ‚ÄòHoly Land‚Äô. Niemands meester, niemands knecht.","protected":false,"created_at":"2013-06-26T18:35:21.000Z","public_metrics":{"followers_count":7254,"following_count":960,"tweet_count":17057,"listed_count":143},"url":"https://t.co/ogdSEw90Ok","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/ogdSEw90Ok","expanded_url":"https://www.n-va.be/wie-is-wie/louis-ide","display_url":"n-va.be/wie-is-wie/lou‚Ä¶"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1258428531656228865"},{"id":"318584391","username":"BCDPIC","profile_image_url":"https://pbs.twimg.com/profile_images/1293228021042692097/JvXh-id2_normal.png","verified":false,"name":"BC Drug and Poison Information Centre","description":"If you suspect you're poisoned, call 1-800-567-8911 or 604-682-5050 in BC and the Yukon to reach a poison expert for help 24/7. Multilingual, fast, free.","protected":false,"created_at":"2011-06-16T18:27:14.000Z","public_metrics":{"followers_count":509,"following_count":237,"tweet_count":3884,"listed_count":23},"url":"https://t.co/NSK76j7kHK","location":"Vancouver, British Columbia","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/NSK76j7kHK","expanded_url":"http://www.dpic.org/","display_url":"dpic.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1374020591511072768"},{"id":"20815041","username":"Roche","profile_image_url":"https://pbs.twimg.com/profile_images/1477333982949826560/_SMvcV5v_normal.png","verified":true,"name":"Roche","description":"Doing now what patients need next! Read our community guidelines: https://t.co/7k1HdbdrYL","protected":false,"created_at":"2009-02-13T22:52:00.000Z","public_metrics":{"followers_count":240334,"following_count":1462,"tweet_count":13532,"listed_count":2810},"url":"https://t.co/Xv8kEDkzYX","location":"Basel, Switzerland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Xv8kEDkzYX","expanded_url":"http://www.roche.com","display_url":"roche.com"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":66,"end":89,"url":"https://t.co/7k1HdbdrYL","expanded_url":"http://go.roche.com/CG","display_url":"go.roche.com/CG"}]}},"pinned_tweet_id":"1489192047630290946"},{"id":"307539793","username":"al_mercier","profile_image_url":"https://pbs.twimg.com/profile_images/378800000525982772/2181821d035a9dc21dec16d573a31417_normal.jpeg","verified":false,"name":"Mercier Anne-Laure","description":"Re-tweete tr√®s bien. \nJournaliste @ContexteESante, ex-@mindHealthfr, bilingue #L√©gifrance\nüçø DM ouverts, Signal, Telegram, etc.\nAussi team @SOSMedFrance","protected":false,"created_at":"2011-05-29T20:35:59.000Z","public_metrics":{"followers_count":400,"following_count":1667,"tweet_count":1762,"listed_count":11},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":34,"end":49,"username":"ContexteESante"},{"start":54,"end":67,"username":"mindHealthfr"},{"start":138,"end":151,"username":"SOSMedFrance"}],"hashtags":[{"start":78,"end":89,"tag":"L√©gifrance"}],"urls":{}}}},{"id":"1339508364","username":"PharmaciendeF","profile_image_url":"https://pbs.twimg.com/profile_images/1183030227104161792/jcThos6m_normal.jpg","verified":false,"name":"Le Pharmacien de France","description":"","protected":false,"created_at":"2013-04-09T15:46:33.000Z","public_metrics":{"followers_count":5005,"following_count":9,"tweet_count":4653,"listed_count":81},"url":"http://t.co/NN0f29nwg6","location":"Paris","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/NN0f29nwg6","expanded_url":"http://www.lepharmaciendefrance.fr","display_url":"lepharmaciendefrance.fr"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1481580368293728257"},{"id":"96485229","username":"s_travis_king","profile_image_url":"https://pbs.twimg.com/profile_images/960005067901427712/I7qFlByr_normal.jpg","verified":false,"name":"Travis King","description":"#InfectiousDiseases PharmD; @OleMissRebels grad. Mississippi ‚û°Ô∏è NOLA. All things Antibiotics, Transplant ID and #SEC sports. @OchsnerID @UQMedicine","protected":false,"created_at":"2009-12-13T04:35:26.000Z","public_metrics":{"followers_count":1051,"following_count":1583,"tweet_count":5794,"listed_count":28},"url":"https://t.co/9D0r9aj1VI","location":"New Orleans, LA","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/9D0r9aj1VI","expanded_url":"https://www.researchgate.net/profile/Travis_King","display_url":"researchgate.net/profile/Travis‚Ä¶"}]},"description":{"mentions":[{"start":28,"end":42,"username":"OleMissRebels"},{"start":125,"end":135,"username":"OchsnerID"},{"start":136,"end":147,"username":"UQMedicine"}],"hashtags":[{"start":0,"end":19,"tag":"InfectiousDiseases"},{"start":112,"end":116,"tag":"SEC"}],"urls":{}}},"pinned_tweet_id":"1236451774808100864"},{"id":"362772214","username":"FinansciCenk","profile_image_url":"https://pbs.twimg.com/profile_images/3764152669/aea93214e72bc72e210967dfea16758e_normal.jpeg","verified":false,"name":"FinansciCenk","description":"","protected":false,"created_at":"2011-08-26T23:39:46.000Z","public_metrics":{"followers_count":62,"following_count":363,"tweet_count":774,"listed_count":1},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"614450788","username":"thedanalyst","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"thedanalyst","description":"","protected":false,"created_at":"2012-06-21T17:30:21.000Z","public_metrics":{"followers_count":83,"following_count":278,"tweet_count":492,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"344763008","username":"Arrrrmatey","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"Arrrr Matey","description":"","protected":false,"created_at":"2011-07-29T15:07:49.000Z","public_metrics":{"followers_count":0,"following_count":2,"tweet_count":3,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"423776545","username":"KaiGriebenow","profile_image_url":"https://pbs.twimg.com/profile_images/779460252068515840/1tnzFsHN_normal.jpg","verified":false,"name":"KHG","description":"Biochemistry Professor, Kite Maker, Photographer, Ultramarathon Runner","protected":false,"created_at":"2011-11-28T22:46:03.000Z","public_metrics":{"followers_count":234,"following_count":315,"tweet_count":5117,"listed_count":7},"url":"","location":"Puerto Rico","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"597154294","username":"Masdeutaff","profile_image_url":"https://pbs.twimg.com/profile_images/465808428796219392/rtlmNWAb_normal.jpeg","verified":false,"name":"MigTaff","description":"Looking for clues","protected":false,"created_at":"2012-06-02T06:31:06.000Z","public_metrics":{"followers_count":100,"following_count":229,"tweet_count":446,"listed_count":6},"url":"","location":"Barcelona & Banyoles","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"200109222","username":"JBTrethowan","profile_image_url":"https://pbs.twimg.com/profile_images/1193846046809624577/_yTU6I2Q_normal.jpg","verified":false,"name":"Jonathan Trethowan","description":"Pharma #Regulatory Affairs Professional. Tweets about #healthcare, #regulatory, #biotech, #business and #Cornwall.","protected":false,"created_at":"2010-10-08T13:32:25.000Z","public_metrics":{"followers_count":369,"following_count":226,"tweet_count":1142,"listed_count":11},"url":"https://t.co/gNcsUJFuLQ","location":"UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/gNcsUJFuLQ","expanded_url":"https://www.linkedin.com/in/jonathan-trethowan-9399009/","display_url":"linkedin.com/in/jonathan-tr‚Ä¶"}]},"description":{"mentions":{},"hashtags":[{"start":7,"end":18,"tag":"Regulatory"},{"start":54,"end":65,"tag":"healthcare"},{"start":67,"end":78,"tag":"regulatory"},{"start":80,"end":88,"tag":"biotech"},{"start":90,"end":99,"tag":"business"},{"start":104,"end":113,"tag":"Cornwall"}],"urls":{}}}},{"id":"1171771501","username":"Wolf_S_Punk","profile_image_url":"https://pbs.twimg.com/profile_images/3437816264/fb7da1dcb358c416808ba9ded828bbb9_normal.png","verified":false,"name":"Wolfspunk ‚ò†","description":"#Suizid als #Nebenwirkung. #Lariam¬Æ (#Mefloquin) von @roche_de Kritische Betrachtung der Umsetzung von Richtlinien zur #Arzneimittelsicherheit @bfarm_de","protected":false,"created_at":"2013-02-12T12:02:42.000Z","public_metrics":{"followers_count":225,"following_count":2017,"tweet_count":3098,"listed_count":0},"url":"http://t.co/Nwgc0hZIpK","location":"Internet","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Nwgc0hZIpK","expanded_url":"http://www.nebenwirkung-suizid.de","display_url":"nebenwirkung-suizid.de"}]},"description":{"mentions":[{"start":53,"end":62,"username":"roche_de"},{"start":143,"end":152,"username":"bfarm_de"}],"hashtags":[{"start":0,"end":7,"tag":"Suizid"},{"start":12,"end":25,"tag":"Nebenwirkung"},{"start":27,"end":34,"tag":"Lariam"},{"start":37,"end":47,"tag":"Mefloquin"},{"start":119,"end":142,"tag":"Arzneimittelsicherheit"}],"urls":{}}},"pinned_tweet_id":"1340008570327330818"},{"id":"223456379","username":"agesnews","profile_image_url":"https://pbs.twimg.com/profile_images/1042678557061906432/CMUKc0oY_normal.jpg","verified":true,"name":"AGES","description":"√ñsterreichische Agentur f√ºr Gesundheit und Ern√§hrungssicherheit | Austrian Agency for Health and Food Safety","protected":false,"created_at":"2010-12-06T12:58:47.000Z","public_metrics":{"followers_count":10363,"following_count":693,"tweet_count":5701,"listed_count":116},"url":"http://t.co/2Nyvg7YkJw","location":"Wien","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/2Nyvg7YkJw","expanded_url":"http://www.ages.at","display_url":"ages.at"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"883240026863226886"},{"id":"261643662","username":"tomayates","profile_image_url":"https://pbs.twimg.com/profile_images/911204854072143872/qeUYSvI5_normal.jpg","verified":false,"name":"Tom Yates","description":"Health, politics, chess, outdoor stuff","protected":false,"created_at":"2011-03-06T11:17:17.000Z","public_metrics":{"followers_count":1334,"following_count":1385,"tweet_count":14381,"listed_count":36},"url":"https://t.co/B6krJp4cnz","location":"London","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/B6krJp4cnz","expanded_url":"https://www.researchgate.net/profile/Tom_Yates","display_url":"researchgate.net/profile/Tom_Ya‚Ä¶"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1490735184215486465"},{"id":"1003782248","username":"frosa_farma","profile_image_url":"https://pbs.twimg.com/profile_images/1252929730682269697/-2XPa8ic_normal.jpg","verified":false,"name":"Francisco Rosa","description":"Periodista con vocaci√≥n social","protected":false,"created_at":"2012-12-11T10:47:41.000Z","public_metrics":{"followers_count":1029,"following_count":1313,"tweet_count":2313,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"14648460","username":"Yenenga","profile_image_url":"https://pbs.twimg.com/profile_images/972052702514511872/B1QIe5jS_normal.jpg","verified":false,"name":"Dubididada","description":"","protected":false,"created_at":"2008-05-04T14:36:48.000Z","public_metrics":{"followers_count":56,"following_count":139,"tweet_count":105,"listed_count":0},"url":"","location":"wanna b ","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"9751972","username":"GoodOne","profile_image_url":"https://pbs.twimg.com/profile_images/760865832905957377/1G6ThvVw_normal.jpg","verified":false,"name":"Glm.","description":"All false love and affection","protected":false,"created_at":"2007-10-28T11:43:41.000Z","public_metrics":{"followers_count":79,"following_count":262,"tweet_count":324,"listed_count":1},"url":"","location":"Paris","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"16842175","username":"RK_PassingCloud","profile_image_url":"https://pbs.twimg.com/profile_images/1944539967/art_caesar_ap_normal.jpg","verified":false,"name":"RichKEngland","description":"I.T. Cloud guru. Open Source.\r\nPicture is the oldest known bust of Julius Ceaser. He looks how I feel...","protected":false,"created_at":"2008-10-18T19:08:34.000Z","public_metrics":{"followers_count":52,"following_count":276,"tweet_count":1001,"listed_count":5},"url":"http://t.co/Hw8wcfBaxu","location":"Southampton England UK","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Hw8wcfBaxu","expanded_url":"http://passingclouditservices.com","display_url":"passingclouditservices.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"355424757","username":"Rayafadil","profile_image_url":"https://pbs.twimg.com/profile_images/378800000346991866/c5b4dad69ab50533763fc2666eb87335_normal.jpeg","verified":false,"name":"Raya Fadil","description":"MSc.pharmaceutical Sci-RSC. Love my Family. Proud of my son, love peace,hope and faith. Reading,healthy style & fashion are my passion. Respect +ve thinkers!","protected":false,"created_at":"2011-08-15T10:07:43.000Z","public_metrics":{"followers_count":184,"following_count":554,"tweet_count":1721,"listed_count":9},"url":"","location":"London, England","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1361869286","username":"UCB_Challenge","profile_image_url":"https://pbs.twimg.com/profile_images/413615629648687105/oyjzduee_normal.png","verified":false,"name":"UCB Challenge","description":"UCB is searching the planet for rare phenotypes (traits or natural abilities), but the planet is a big place so we will need some help!","protected":false,"created_at":"2013-04-18T13:00:07.000Z","public_metrics":{"followers_count":57,"following_count":489,"tweet_count":350,"listed_count":4},"url":"http://t.co/4WaZmyx0iW","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/4WaZmyx0iW","expanded_url":"http://ucbinnovationchallenge.com","display_url":"ucbinnovationchallenge.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"554667907","username":"alljoinjack","profile_image_url":"https://pbs.twimg.com/profile_images/1189843798832095232/IBdSgK7d_normal.jpg","verified":false,"name":"Joining Jack","description":"We are joining Jack in the fight to find a cure for duchenne muscular dystrophy. Will you?","protected":false,"created_at":"2012-04-15T21:55:47.000Z","public_metrics":{"followers_count":65334,"following_count":1762,"tweet_count":19425,"listed_count":74},"url":"https://t.co/iF6KodmXIH","location":"Wigan","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/iF6KodmXIH","expanded_url":"http://www.joiningjack.org","display_url":"joiningjack.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"633978297","username":"jagasquet","profile_image_url":"https://pbs.twimg.com/profile_images/2546173677/by2macf06eid3l83z0eb_normal.jpeg","verified":false,"name":"Jose Antonio Gasquet","description":"Pharmaceutical/Biotechnology Professional focused on Oncology. \r\nOpinions are my own","protected":false,"created_at":"2012-07-12T17:24:56.000Z","public_metrics":{"followers_count":658,"following_count":330,"tweet_count":3162,"listed_count":63},"url":"http://t.co/vp3JIdZzuF","location":"Barcelona, Spain","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/vp3JIdZzuF","expanded_url":"http://es.linkedin.com/in/jagasquet","display_url":"es.linkedin.com/in/jagasquet"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1588972196","username":"HTACanada","profile_image_url":"https://pbs.twimg.com/profile_images/378800000601349581/f997b6fd6156d0dadd7b228389470685_normal.jpeg","verified":false,"name":"HTACanada","description":"Research and insights on HTA in Canada. Join our group on LinkedIn for networking opportunities.","protected":false,"created_at":"2013-07-12T17:14:43.000Z","public_metrics":{"followers_count":1319,"following_count":222,"tweet_count":4276,"listed_count":89},"url":"","location":"Canada","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"261891519","username":"o_halvardo","profile_image_url":"https://pbs.twimg.com/profile_images/1014163538380718080/Q1uyVzSp_normal.jpg","verified":false,"name":"Halvard - Halvari.","description":"Til og med Trond Giske har sin Runkedame han noen ganger er i kontakt med.Fiskerne har f√•tt Radio p√• Havet. Mat; Man tager en Hval. Lever & Hvalgryte,Synonymer.","protected":false,"created_at":"2011-03-06T22:45:25.000Z","public_metrics":{"followers_count":129,"following_count":2150,"tweet_count":24551,"listed_count":3},"url":"https://t.co/DkbAUt8djU","location":"Skaun, Norge","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/DkbAUt8djU","expanded_url":"https://www.linkedin.com/in/pazqualli-nk-vx-halvard-lea-partisan-98aa11128/","display_url":"linkedin.com/in/pazqualli-n‚Ä¶"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"137970368","username":"JillesHeringa","profile_image_url":"https://pbs.twimg.com/profile_images/544393600696455169/Z5QBRDky_normal.jpeg","verified":false,"name":"Jilles Heringa","description":"Communicatie en recht | Gezondheidsrecht | Boeken | Films | Jilles¬Æ - Advies in de zorg","protected":false,"created_at":"2010-04-28T08:03:53.000Z","public_metrics":{"followers_count":453,"following_count":341,"tweet_count":3895,"listed_count":10},"url":"https://t.co/LaNnaBgl48","location":"The Hague","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/LaNnaBgl48","expanded_url":"http://www.jilles.nu","display_url":"jilles.nu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"294028805","username":"EURLex","profile_image_url":"https://pbs.twimg.com/profile_images/876708307859378178/7YshLWim_normal.jpg","verified":true,"name":"EUR-Lex","description":"The official #EULaw database & home of the EU Official Journal. Tips & tricks with #eurlextip Public service from the Publications Office of the European Union.","protected":false,"created_at":"2011-05-06T12:08:13.000Z","public_metrics":{"followers_count":27651,"following_count":9177,"tweet_count":15632,"listed_count":890},"url":"https://t.co/Xgcz1zkfXx","location":"Luxembourg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Xgcz1zkfXx","expanded_url":"https://eur-lex.europa.eu","display_url":"eur-lex.europa.eu"}]},"description":{"mentions":{},"hashtags":[{"start":13,"end":19,"tag":"EULaw"},{"start":83,"end":93,"tag":"eurlextip"}],"urls":{}}}},{"id":"71542880","username":"ThePharmaLetter","profile_image_url":"https://pbs.twimg.com/profile_images/1286243845659856897/vbFCz4-e_normal.jpg","verified":false,"name":"The Pharma Letter","description":"Breaking news and analysis for the global pharmaceutical and biotechnology industries","protected":false,"created_at":"2009-09-04T14:07:54.000Z","public_metrics":{"followers_count":22188,"following_count":1959,"tweet_count":18074,"listed_count":533},"url":"http://t.co/jdUQkYartj","location":"London","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/jdUQkYartj","expanded_url":"http://www.thepharmaletter.com","display_url":"thepharmaletter.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"17411532","username":"epilepsyaction","profile_image_url":"https://pbs.twimg.com/profile_images/1474365483776454658/WAl_nUo9_normal.jpg","verified":true,"name":"Epilepsy Action","description":"The UK's leading member-led epilepsy charity, providing information for the 600,000 people with epilepsy in the UK and anyone with an interest in the condition","protected":false,"created_at":"2008-11-15T19:16:43.000Z","public_metrics":{"followers_count":30797,"following_count":2177,"tweet_count":33216,"listed_count":471},"url":"https://t.co/OxabsAjpf2","location":"Leeds, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/OxabsAjpf2","expanded_url":"http://www.epilepsy.org.uk","display_url":"epilepsy.org.uk"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"2201973482","username":"SmokinSlimSala","profile_image_url":"https://pbs.twimg.com/profile_images/489833028177248256/bAP4nZtw_normal.jpeg","verified":false,"name":"S Slim-ee Salabiminy","description":"Where the stalk of sensimilla meets the grape vine.","protected":false,"created_at":"2013-11-18T20:58:49.000Z","public_metrics":{"followers_count":28,"following_count":221,"tweet_count":477,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1299643704","username":"EFA_Patients","profile_image_url":"https://pbs.twimg.com/profile_images/1198937001929650176/pmFZo7pu_normal.png","verified":false,"name":"EFA Patients","description":"We are a federation of 42 associations representing allergy, asthma and COPD patients in 25 European countries. Our work pillars: #InformPreventCare","protected":false,"created_at":"2013-03-25T14:16:29.000Z","public_metrics":{"followers_count":2456,"following_count":1120,"tweet_count":5818,"listed_count":98},"url":"https://t.co/gQUBQm2bpr","location":"Brussels, Belgium","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/gQUBQm2bpr","expanded_url":"https://efanet.org/inform/youth-parliament","display_url":"efanet.org/inform/youth-p‚Ä¶"}]},"description":{"mentions":{},"hashtags":[{"start":130,"end":148,"tag":"InformPreventCare"}],"urls":{}}},"pinned_tweet_id":"1455831231942340610"},{"id":"1536274003","username":"AlzheimerEurope","profile_image_url":"https://pbs.twimg.com/profile_images/1117717426735652864/nRrKu78A_normal.png","verified":false,"name":"Alzheimer Europe","description":"Non-profit NGO making #dementia a European priority\nGet news https://t.co/K7PH2uUs6i\nConference #32AEC \nOur channels https://t.co/BJJNMlWsQL","protected":false,"created_at":"2013-06-21T10:48:43.000Z","public_metrics":{"followers_count":12810,"following_count":5431,"tweet_count":22630,"listed_count":293},"url":"https://t.co/RCmEWR0fxD","location":"Luxembourg, Luxembourg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/RCmEWR0fxD","expanded_url":"http://www.alzheimer-europe.org","display_url":"alzheimer-europe.org"}]},"description":{"mentions":{},"hashtags":[{"start":22,"end":31,"tag":"dementia"},{"start":96,"end":102,"tag":"32AEC"}],"urls":[{"start":61,"end":84,"url":"https://t.co/K7PH2uUs6i","expanded_url":"http://bit.ly/AE_news_signup","display_url":"bit.ly/AE_news_signup"},{"start":117,"end":140,"url":"https://t.co/BJJNMlWsQL","expanded_url":"http://linktr.ee/AlzheimerEurope","display_url":"linktr.ee/AlzheimerEurope"}]}},"pinned_tweet_id":"1493198297225441285"},{"id":"300289123","username":"JPNDeurope","profile_image_url":"https://pbs.twimg.com/profile_images/1148535065640611840/nS_jAk3a_normal.png","verified":false,"name":"JPND Research","description":"JPND is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases.","protected":false,"created_at":"2011-05-17T14:27:51.000Z","public_metrics":{"followers_count":2520,"following_count":1360,"tweet_count":1373,"listed_count":62},"url":"http://t.co/VeUCLBT39L","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/VeUCLBT39L","expanded_url":"http://www.jpnd.eu","display_url":"jpnd.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"77047226","username":"LV_MPA","profile_image_url":"https://pbs.twimg.com/profile_images/434253778/Lakemedelsverket_normal.jpg","verified":false,"name":"L√§kemedelsverket LV","description":"LV arbetar med l√§kemedel, kosmetika & medicinteknik. 8-18 m√•-fr svarar L√§kemedelsupplysningen p√• l√§kemedelsfr√•gor 0771-46 70 10. √Ñrenden: registrator@mpa.se","protected":false,"created_at":"2009-09-24T21:30:22.000Z","public_metrics":{"followers_count":6197,"following_count":211,"tweet_count":2753,"listed_count":133},"url":"http://t.co/64KbbhfHCs","location":"Uppsala, Sweden","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/64KbbhfHCs","expanded_url":"http://www.lakemedelsverket.se/","display_url":"lakemedelsverket.se"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1458715946504306689"},{"id":"19394390","username":"FEDER_ONG","profile_image_url":"https://pbs.twimg.com/profile_images/1491699442554126337/j1SvLuN4_normal.png","verified":false,"name":"FEDER","description":"Somos la voz de 3 millones de personas con #enfermedadesraras en Espa√±a. Representamos a 387 asociaciones de pacientes y a 1.313 patolog√≠as poco frecuentes","protected":false,"created_at":"2009-01-23T13:48:35.000Z","public_metrics":{"followers_count":35111,"following_count":8215,"tweet_count":76381,"listed_count":825},"url":"https://t.co/tQ0Tj1drwA","location":"Espa√±a","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/tQ0Tj1drwA","expanded_url":"http://www.enfermedades-raras.org","display_url":"enfermedades-raras.org"}]},"description":{"mentions":{},"hashtags":[{"start":43,"end":61,"tag":"enfermedadesraras"}],"urls":{}}},"pinned_tweet_id":"1498180014281576451"},{"id":"1392501529","username":"INFARMED_IP","profile_image_url":"https://pbs.twimg.com/profile_images/3672803012/f16d5bdb04d2f2dc11f3c41e53c7ea80_normal.jpeg","verified":true,"name":"INFARMED, I. P.","description":"Twiiter oficial do INFARMED, I.P. Pedidos de informa√ß√£o para cimi@infarmed.pt.","protected":false,"created_at":"2013-04-30T16:39:51.000Z","public_metrics":{"followers_count":10061,"following_count":24,"tweet_count":3571,"listed_count":68},"url":"https://t.co/LbGbUn6bK3","location":"Portugal","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/LbGbUn6bK3","expanded_url":"http://www.infarmed.pt","display_url":"infarmed.pt"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"105275296","username":"loicrigal","profile_image_url":"https://pbs.twimg.com/profile_images/1102562281764868096/MkU3kM6n_normal.jpg","verified":false,"name":"Dr Lo√Øc Rigal","description":"Doctor in public law @Univ_Paris | Member @instidroitsante @EURORDIS @Assedea | #orphandrugs üß¨ #patientaccess ü¶æ #chronicpain ü•≤ | #velotaf üåø| Views my own |","protected":false,"created_at":"2010-01-15T22:27:27.000Z","public_metrics":{"followers_count":422,"following_count":437,"tweet_count":4093,"listed_count":14},"url":"https://t.co/0cmgNd8UAj","location":"French Alps","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/0cmgNd8UAj","expanded_url":"http://www.assedea.fr","display_url":"assedea.fr"}]},"description":{"mentions":[{"start":21,"end":32,"username":"Univ_Paris"},{"start":42,"end":58,"username":"instidroitsante"},{"start":59,"end":68,"username":"EURORDIS"},{"start":69,"end":77,"username":"Assedea"}],"hashtags":[{"start":80,"end":92,"tag":"orphandrugs"},{"start":95,"end":109,"tag":"patientaccess"},{"start":112,"end":124,"tag":"chronicpain"},{"start":129,"end":137,"tag":"velotaf"}],"urls":{}}},"pinned_tweet_id":"1252230714239541249"},{"id":"253672396","username":"scalisabelle","profile_image_url":"https://pbs.twimg.com/profile_images/970678120415154179/tb6HP-ln_normal.jpg","verified":false,"name":"IssyScali","description":"Moments & movement creator. Global health comms professional & passionate dance teacher.","protected":false,"created_at":"2011-02-17T18:45:14.000Z","public_metrics":{"followers_count":77,"following_count":172,"tweet_count":860,"listed_count":1},"url":"https://t.co/ExkNuFpsYO","location":"London, England","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/ExkNuFpsYO","expanded_url":"https://www.linkedin.com/in/isabelle-scali-2a34654","display_url":"linkedin.com/in/isabelle-sc‚Ä¶"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"40722651","username":"xOneStepBehind","profile_image_url":"https://pbs.twimg.com/profile_images/890225425099743236/jRz0tJ3s_normal.jpg","verified":false,"name":"xOneStepBehind","description":"Biomedical scientist working on finding a cure for cancer, samt vikarierende omsorgsminister. Kritisk_Personell_TM","protected":false,"created_at":"2009-05-17T19:46:26.000Z","public_metrics":{"followers_count":1522,"following_count":2524,"tweet_count":29012,"listed_count":26},"url":"https://t.co/swYgHLaetk","location":"Oslo","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/swYgHLaetk","expanded_url":"http://intoyoureyes.com/blog/","display_url":"intoyoureyes.com/blog/"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"256435789","username":"FarmaMadridAP","profile_image_url":"https://pbs.twimg.com/profile_images/1480454486380449793/k-7ujPhE_normal.jpg","verified":false,"name":"Farmacia Madrid AP","description":"Primary Care Pharmacist, Madrid (Spain) #Farmac√©uticos de Atenci√≥n Primaria del Servicio Madrile√±o de Salud #Informaci√≥n para profesionales sanitarios.","protected":false,"created_at":"2011-02-23T09:43:24.000Z","public_metrics":{"followers_count":5242,"following_count":426,"tweet_count":19172,"listed_count":0},"url":"","location":"Comunidad de Madrid","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":40,"end":54,"tag":"Farmac√©uticos"},{"start":108,"end":120,"tag":"Informaci√≥n"}],"urls":{}}},"pinned_tweet_id":"1494626994553819137"},{"id":"1857882480","username":"LeSecretdesR","profile_image_url":"https://pbs.twimg.com/profile_images/378800000448042583/df6f48aaa5ca8b695816b85d4dcda401_normal.jpeg","verified":false,"name":"SecretdesR√¥tisseurs","description":"A French \u0003restaurant in London‚Äôs Canary Wharf serving perfectly cooked \u0003r√¥tisserie-roasted chicken.","protected":false,"created_at":"2013-09-12T16:47:11.000Z","public_metrics":{"followers_count":234,"following_count":351,"tweet_count":488,"listed_count":12},"url":"http://t.co/Xk7zSG6PN5","location":"37 Westferry circus - E14 8RR","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/Xk7zSG6PN5","expanded_url":"http://eatlesecret.co.uk","display_url":"eatlesecret.co.uk"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1566153090","username":"_TomasKB","profile_image_url":"https://pbs.twimg.com/profile_images/1295288542806118400/SLj0iM4Q_normal.jpg","verified":false,"name":"Tom√°s üò∑","description":"SustainableDevelopment Innovation Media Budo Travel Mediterranean","protected":false,"created_at":"2013-07-03T16:35:51.000Z","public_metrics":{"followers_count":360,"following_count":427,"tweet_count":6097,"listed_count":18},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"50802199","username":"Geckoella","profile_image_url":"https://pbs.twimg.com/profile_images/702484199123632128/PplDifxQ_normal.jpg","verified":false,"name":"Jenna // Follow me for TB news & research","description":"I'm an IR Graduate and Digital Marketing Specialist with a passion to help #EndTB. Follow me for everything #Tuberculosis, #AMR, #PublicHealth & #Zoonoses.","protected":false,"created_at":"2009-06-25T22:57:16.000Z","public_metrics":{"followers_count":856,"following_count":1885,"tweet_count":1827,"listed_count":33},"url":"","location":"London","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":75,"end":81,"tag":"EndTB"},{"start":108,"end":121,"tag":"Tuberculosis"},{"start":123,"end":127,"tag":"AMR"},{"start":129,"end":142,"tag":"PublicHealth"},{"start":145,"end":154,"tag":"Zoonoses"}],"urls":{}}}},{"id":"73774967","username":"AlecGaffney","profile_image_url":"https://pbs.twimg.com/profile_images/1225168849705848834/54rMiVoS_normal.jpg","verified":false,"name":"Alexander Gaffney","description":"Executive Director, Life Sci @Politico's AgencyIQ. Alum: @PwCUS, @RAPSorg, @umsop. Tweets about #FDA regulation of #Pharma, #MedicalDevice, #Biotech, #Health.","protected":false,"created_at":"2009-09-13T00:52:31.000Z","public_metrics":{"followers_count":7234,"following_count":916,"tweet_count":22421,"listed_count":0},"url":"https://t.co/9nob9FC1nz","location":"Washington, DC","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/9nob9FC1nz","expanded_url":"https://www.agencyiq.com/subscribe-fda-today/","display_url":"agencyiq.com/subscribe-fda-‚Ä¶"}]},"description":{"mentions":[{"start":29,"end":38,"username":"Politico"},{"start":57,"end":63,"username":"PwCUS"},{"start":65,"end":73,"username":"RAPSorg"},{"start":75,"end":81,"username":"umsop"}],"hashtags":[{"start":96,"end":100,"tag":"FDA"},{"start":115,"end":122,"tag":"Pharma"},{"start":124,"end":138,"tag":"MedicalDevice"},{"start":140,"end":148,"tag":"Biotech"},{"start":150,"end":157,"tag":"Health"}],"urls":{}}},"pinned_tweet_id":"963783894595235840"},{"id":"210934369","username":"HenkJanOut","profile_image_url":"https://pbs.twimg.com/profile_images/1416569310877822976/mXgbBwX5_normal.jpg","verified":false,"name":"Henk Jan Out","description":"MD PhD | Chief Scientific Officer Asia-Pacific, Ferring Pharmaceuticals | Author 'Leve het Geneesmiddel!' | Piano | Church Organ | Tweets are my own","protected":false,"created_at":"2010-11-01T20:50:13.000Z","public_metrics":{"followers_count":2881,"following_count":591,"tweet_count":13690,"listed_count":95},"url":"https://t.co/8PjiAGZrQk","location":"Shanghai, China","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/8PjiAGZrQk","expanded_url":"http://www.henkjanout.nl","display_url":"henkjanout.nl"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"440170995","username":"DGPreece","profile_image_url":"https://pbs.twimg.com/profile_images/716318318831996930/XKvT0_1H_normal.jpg","verified":false,"name":"David Preece","description":"Pharmacist with a passion for all things European. Loves travelling and exploring the world. A midlander working in the North and enjoying the pies!","protected":false,"created_at":"2011-12-18T17:18:04.000Z","public_metrics":{"followers_count":1291,"following_count":2445,"tweet_count":5003,"listed_count":19},"url":"","location":"York, England","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1455665373240565763"},{"id":"104839524","username":"EPSA_Online","profile_image_url":"https://pbs.twimg.com/profile_images/834078575125024768/TjE_-5l7_normal.jpg","verified":false,"name":"EPSA","description":"European Pharmaceutical Students' Association represents over 100 000 pharmaceutical students from 36 European countries through 42 member associations.","protected":false,"created_at":"2010-01-14T15:21:10.000Z","public_metrics":{"followers_count":5151,"following_count":1013,"tweet_count":5799,"listed_count":75},"url":"https://t.co/lCeTVMvwNs","location":"Europe","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/lCeTVMvwNs","expanded_url":"http://www.epsa-online.org","display_url":"epsa-online.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1489210020671758338"},{"id":"443963165","username":"emsa_europe","profile_image_url":"https://pbs.twimg.com/profile_images/1281294846175608833/xZxJ7FbS_normal.jpg","verified":false,"name":"EMSA","description":"European Medical Students' Association (EMSA) is an organization that represents medical students across Europe.","protected":false,"created_at":"2011-12-22T18:51:18.000Z","public_metrics":{"followers_count":1985,"following_count":240,"tweet_count":3491,"listed_count":40},"url":"https://t.co/DfX3qXoyML","location":"Brussels, Europe","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/DfX3qXoyML","expanded_url":"http://www.emsa-europe.eu","display_url":"emsa-europe.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1600732507","username":"RoshersT","profile_image_url":"https://pbs.twimg.com/profile_images/943465478172872705/Rp1I7DQr_normal.jpg","verified":false,"name":"Roshni Morjaria","description":"Favourite pass time; eating üßÄ","protected":false,"created_at":"2013-07-17T11:09:11.000Z","public_metrics":{"followers_count":235,"following_count":436,"tweet_count":3276,"listed_count":4},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"56493220","username":"EUnetHTA","profile_image_url":"https://pbs.twimg.com/profile_images/1384085535694589962/2G5cU-bV_normal.jpg","verified":false,"name":"EUnetHTA","description":"Official account for the European Network for Health Technology Assessment. Retweets are not endorsements.","protected":false,"created_at":"2009-07-13T21:07:32.000Z","public_metrics":{"followers_count":2795,"following_count":194,"tweet_count":1073,"listed_count":37},"url":"","location":"Europe","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"180728609","username":"IAPOvoice","profile_image_url":"https://pbs.twimg.com/profile_images/537914224299626496/jKE63aZ8_normal.png","verified":false,"name":"IAPO","description":"A global alliance representing patients of all nations across all disease areas and promoting patient-centred healthcare across the world.","protected":false,"created_at":"2010-08-20T09:46:24.000Z","public_metrics":{"followers_count":3569,"following_count":1660,"tweet_count":7776,"listed_count":106},"url":"https://t.co/1Y2RCgHRz9","location":"London","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/1Y2RCgHRz9","expanded_url":"http://www.iapo.org.uk","display_url":"iapo.org.uk"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"432633912","username":"pharmacjw","profile_image_url":"https://pbs.twimg.com/profile_images/718192955752910848/u9mgsLQC_normal.jpg","verified":false,"name":"Christopher Wooden","description":"#Pharma sales & marketing insights. Advising Big Pharma on what works. Work for @IQVIA_global @IQVIA_GMI | views my own. RTs don't = endorsements.","protected":false,"created_at":"2011-12-09T16:20:42.000Z","public_metrics":{"followers_count":1004,"following_count":902,"tweet_count":3783,"listed_count":52},"url":"https://t.co/hqdbWkEaQS","location":"Paris","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/hqdbWkEaQS","expanded_url":"https://www.iqvia.com/","display_url":"iqvia.com"}]},"description":{"mentions":[{"start":80,"end":93,"username":"IQVIA_global"},{"start":94,"end":104,"username":"IQVIA_GMI"}],"hashtags":[{"start":0,"end":7,"tag":"Pharma"}],"urls":{}}}},{"id":"59842124","username":"colinpurrington","profile_image_url":"https://pbs.twimg.com/profile_images/1185154205595701248/fPkbqWGn_normal.jpg","verified":false,"name":"colinpurrington","description":"Nature and photography fan.","protected":false,"created_at":"2009-07-24T17:42:53.000Z","public_metrics":{"followers_count":2877,"following_count":714,"tweet_count":17820,"listed_count":73},"url":"https://t.co/APFMz2IkmR","location":"Swarthmore, PA USA","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/APFMz2IkmR","expanded_url":"http://colinpurrington.com/","display_url":"colinpurrington.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"829162375","username":"ami89_pharma","profile_image_url":"https://pbs.twimg.com/profile_images/1064259667096993792/HWxA6dE2_normal.jpg","verified":false,"name":"ami89","description":"Pharmacien adjoint. Je dispense donc tu suis - Ren√© DesCartes Vitales.","protected":false,"created_at":"2012-09-17T14:23:21.000Z","public_metrics":{"followers_count":1511,"following_count":891,"tweet_count":32451,"listed_count":53},"url":"https://t.co/82ZJZrSqdR","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/82ZJZrSqdR","expanded_url":"http://ami89-pharma.blogspot.fr/","display_url":"ami89-pharma.blogspot.fr"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1482076938424438792"},{"id":"115990590","username":"Pirouette4","profile_image_url":"https://pbs.twimg.com/profile_images/3519647575/3915775476020f925695112e0248328c_normal.jpeg","verified":false,"name":"Pirouette","description":"MG √† la campagne.\nG1P3. Maman de Tanguy, Speedy et la P√©pine. \nJardinage en √©t√©, couture en hiver, et p√¢tisserie quand il me reste du temps.","protected":false,"created_at":"2010-02-20T18:31:10.000Z","public_metrics":{"followers_count":1481,"following_count":525,"tweet_count":23593,"listed_count":39},"url":"","location":"La t√™te dans les nuages","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1285591051","username":"FloodBreda","profile_image_url":"https://pbs.twimg.com/profile_images/926884217673474048/WtW-NMdH_normal.jpg","verified":false,"name":"Breda Flood","description":"Teacher still learning.\nAssoc. memb @IPCRG\nFormer President @EFA_Patients\nVolunteer @AsthmaIreland\nH/C Officer @OulartBallagh \nAll views my own","protected":false,"created_at":"2013-03-21T09:58:05.000Z","public_metrics":{"followers_count":976,"following_count":1557,"tweet_count":13316,"listed_count":42},"url":"","location":"Wexford, Ireland","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":36,"end":42,"username":"IPCRG"},{"start":60,"end":73,"username":"EFA_Patients"},{"start":84,"end":98,"username":"AsthmaIreland"},{"start":111,"end":125,"username":"OulartBallagh"}],"hashtags":{},"urls":{}}}},{"id":"17485749","username":"karlosponders","profile_image_url":"https://pbs.twimg.com/profile_images/705886024640110593/rJT4ZFs5_normal.jpg","verified":false,"name":"Karl Hamilton","description":"Irish travel lover living in Amsterdam, posting my musings on life, news, politics and technology. All tweets are posted in a personal capacity.","protected":false,"created_at":"2008-11-19T13:35:29.000Z","public_metrics":{"followers_count":163,"following_count":245,"tweet_count":2630,"listed_count":21},"url":"https://t.co/RzDt2cDySu","location":"Amsterdam, Nederland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/RzDt2cDySu","expanded_url":"http://karlhamilton.com","display_url":"karlhamilton.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"560986046","username":"RomainCasanova","profile_image_url":"https://pbs.twimg.com/profile_images/378800000484039959/237c3c7c845ed31f5e9d050f56bf0eaa_normal.jpeg","verified":false,"name":"romain casanova","description":"","protected":false,"created_at":"2012-04-23T09:48:18.000Z","public_metrics":{"followers_count":2,"following_count":20,"tweet_count":7,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"53039176","username":"FDA_Drug_Info","profile_image_url":"https://pbs.twimg.com/profile_images/774289732582903808/kU8p7iWI_normal.jpg","verified":true,"name":"FDA Drug Information","description":"Receive the latest drug information from the US FDA. Contact us at 1.855.543.3784 or druginfo@fda.hhs.gov. Privacy Policy - http://t.co/DUce95M3Ty.","protected":false,"created_at":"2009-07-02T11:39:43.000Z","public_metrics":{"followers_count":334535,"following_count":68,"tweet_count":7565,"listed_count":4338},"url":"http://t.co/KF8gl4wGzV","location":"Silver Spring","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/KF8gl4wGzV","expanded_url":"http://www.fda.gov/AboutDDI","display_url":"fda.gov/AboutDDI"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":124,"end":146,"url":"http://t.co/DUce95M3Ty","expanded_url":"http://www.fda.gov/privacy","display_url":"fda.gov/privacy"}]}},"pinned_tweet_id":"1482032594053214209"},{"id":"36329597","username":"Europarl_EN","profile_image_url":"https://pbs.twimg.com/profile_images/1438085505128837121/VIGsR6R-_normal.png","verified":true,"name":"European Parliament","description":"Follow for the latest information from the European Parliament. Account managed by the Parliament's web team. Privacy statement: https://t.co/pgMRBckG2S","protected":false,"created_at":"2009-04-29T10:32:40.000Z","public_metrics":{"followers_count":827075,"following_count":9047,"tweet_count":21544,"listed_count":6590},"url":"https://t.co/kD49qgstGP","location":"Brussels/Strasbourg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/kD49qgstGP","expanded_url":"https://www.europarl.europa.eu/news/en","display_url":"europarl.europa.eu/news/en"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":129,"end":152,"url":"https://t.co/pgMRBckG2S","expanded_url":"http://eptwitter.eu/privacy","display_url":"eptwitter.eu/privacy"}]}},"pinned_tweet_id":"1493145567425449988"},{"id":"951333319","username":"EP_Environment","profile_image_url":"https://pbs.twimg.com/profile_images/878207909099966468/NQWrGXMW_normal.jpg","verified":true,"name":"ENVI Committee Press","description":"European Parliament Committee on Environment, Public Health and Food Safety. Managed by Thomas Haahr & Dana Popp. RTs ‚â† endorsement.","protected":false,"created_at":"2012-11-16T09:19:50.000Z","public_metrics":{"followers_count":26430,"following_count":444,"tweet_count":3783,"listed_count":824},"url":"https://t.co/EOor1hh5VV","location":"Brussels/Strasbourg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/EOor1hh5VV","expanded_url":"http://bit.ly/1nuMkcu","display_url":"bit.ly/1nuMkcu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1495699145985769474"},{"id":"784869524","username":"AIM_Healthcare","profile_image_url":"https://pbs.twimg.com/profile_images/880731060987940865/c98Og85X_normal.jpg","verified":false,"name":"AIM","description":"AIM, The International Association of non-for-profit healthcare payers represents health mutuals and health insurance funds in Europe and in the world.","protected":false,"created_at":"2012-08-27T15:15:12.000Z","public_metrics":{"followers_count":1836,"following_count":1294,"tweet_count":6933,"listed_count":105},"url":"https://t.co/vKDDEF6TTg","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/vKDDEF6TTg","expanded_url":"http://www.aim-mutual.org","display_url":"aim-mutual.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1403359865762942977"},{"id":"15536425","username":"edarutechoes","profile_image_url":"https://pbs.twimg.com/profile_images/1298539875688488961/8iiY_hrT_normal.jpg","verified":false,"name":"Emmanuelle Darut - French translation services","description":"Business, Legal & Life Sciences #translation ‚Ä¢ #French human #translator at Echoes translation ‚Ä¢\nüá¨üáß üá™üá¶ into üá®üáµ","protected":false,"created_at":"2008-07-22T20:07:44.000Z","public_metrics":{"followers_count":2802,"following_count":911,"tweet_count":6801,"listed_count":126},"url":"https://t.co/i9VjuRvoQC","location":"Woking, Surrey, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/i9VjuRvoQC","expanded_url":"http://www.echoestranslation.com","display_url":"echoestranslation.com"}]},"description":{"mentions":{},"hashtags":[{"start":32,"end":44,"tag":"translation"},{"start":47,"end":54,"tag":"French"},{"start":61,"end":72,"tag":"translator"}],"urls":{}}},"pinned_tweet_id":"1301816279905566721"},{"id":"34651221","username":"healthglobal","profile_image_url":"https://pbs.twimg.com/profile_images/178913770/362929633_152bf73b59_s.jpg_normal.jpeg","verified":false,"name":"eHealthGlobalHealth","description":"Global & Public Health, Health Equity, Disparities, #eHealth, Health Promotion, #ParticipatoryMedicine, #CBPR #SDOH #COVID19","protected":false,"created_at":"2009-04-23T16:06:35.000Z","public_metrics":{"followers_count":16357,"following_count":7474,"tweet_count":12677,"listed_count":794},"url":"","location":"Boston, MA","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":52,"end":60,"tag":"eHealth"},{"start":80,"end":102,"tag":"ParticipatoryMedicine"},{"start":104,"end":109,"tag":"CBPR"},{"start":110,"end":115,"tag":"SDOH"},{"start":116,"end":124,"tag":"COVID19"}],"urls":{}}}},{"id":"3314634701","username":"HAIEurope","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"HAI Europe","description":"We've moved our Twitter account to @HAImedicines. Please follow us there!","protected":false,"created_at":"2015-06-09T07:55:13.000Z","public_metrics":{"followers_count":2,"following_count":0,"tweet_count":1,"listed_count":3},"url":"","location":"Amsterdam, Nederland","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":35,"end":48,"username":"HAImedicines"}],"hashtags":{},"urls":{}}}},{"id":"1734766740","username":"MeadowcroftRob","profile_image_url":"https://pbs.twimg.com/profile_images/569923890164817920/-wZdwQ9w_normal.jpeg","verified":false,"name":"Robert Meadowcroft","description":"Interests: Integrity in public life and good governance; role of nonprofits supporting individuals and communities.\nBy the river #FFC\nViews strictly my own.","protected":false,"created_at":"2013-09-06T11:13:45.000Z","public_metrics":{"followers_count":2098,"following_count":1347,"tweet_count":25489,"listed_count":80},"url":"","location":"London","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":129,"end":133,"tag":"FFC"}],"urls":{}}},"pinned_tweet_id":"1171315301071433728"},{"id":"250753435","username":"bilgeceydilek","profile_image_url":"https://pbs.twimg.com/profile_images/1477675368786059264/0pTIMB-1_normal.jpg","verified":false,"name":"bilge ceydilek","description":"ƒ∞stanbul‚Äôda bir Ankarasever - Hekim - Endokrinoloji - ü¶Öü¶Öü¶Ö- #VamosRafa - #bakƒ±pg√∂rd√ºklerim - #hi√ß≈üiirsizolurmu","protected":false,"created_at":"2011-02-11T18:49:18.000Z","public_metrics":{"followers_count":751,"following_count":654,"tweet_count":9792,"listed_count":1},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":59,"end":69,"tag":"VamosRafa"},{"start":72,"end":89,"tag":"bakƒ±pg√∂rd√ºklerim"},{"start":92,"end":109,"tag":"hi√ß≈üiirsizolurmu"}],"urls":{}}},"pinned_tweet_id":"770010347386314752"},{"id":"129802718","username":"turquoisejulia","profile_image_url":"https://pbs.twimg.com/profile_images/726048288529592320/gM6BTsQb_normal.jpg","verified":false,"name":"Julia McKenzie üíô","description":"Dundee Uni Grad, living life by the sea, Christian #MentalHealth #Diabeties #insulin #BPD #Fibro #Endo #osteoarthritis #AcuteMacularNeuroretinopathy","protected":false,"created_at":"2010-04-05T12:57:57.000Z","public_metrics":{"followers_count":860,"following_count":2292,"tweet_count":10778,"listed_count":13},"url":"https://t.co/VDPeRZp6A2","location":"Weston-super-Mare, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/VDPeRZp6A2","expanded_url":"http://www.facebook.com/TropQwsm","display_url":"facebook.com/TropQwsm"}]},"description":{"mentions":{},"hashtags":[{"start":51,"end":64,"tag":"MentalHealth"},{"start":65,"end":75,"tag":"Diabeties"},{"start":76,"end":84,"tag":"insulin"},{"start":85,"end":89,"tag":"BPD"},{"start":90,"end":96,"tag":"Fibro"},{"start":97,"end":102,"tag":"Endo"},{"start":103,"end":118,"tag":"osteoarthritis"},{"start":119,"end":148,"tag":"AcuteMacularNeuroretinopathy"}],"urls":{}}}},{"id":"138820530","username":"WilliamPShelley","profile_image_url":"https://pbs.twimg.com/profile_images/378800000077893945/b00d5da27e35470693ab294859a41112_normal.jpeg","verified":false,"name":"William P. Shelley","description":"I love GOD then i'm a biotrader","protected":false,"created_at":"2010-04-30T18:01:33.000Z","public_metrics":{"followers_count":240,"following_count":472,"tweet_count":4047,"listed_count":12},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"21079030","username":"PharmaScrip","profile_image_url":"https://pbs.twimg.com/profile_images/1131185938200170496/_sxqPSn3_normal.jpg","verified":false,"name":"Scrip","description":"Scrip goes beyond the headlines and focuses on delivering insight & analysis on the whole of the drug discovery, development and product life cycle value chain.","protected":false,"created_at":"2009-02-17T10:33:29.000Z","public_metrics":{"followers_count":21916,"following_count":1624,"tweet_count":36001,"listed_count":658},"url":"","location":"Global","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"221009551","username":"LucGroot","profile_image_url":"https://pbs.twimg.com/profile_images/1081450480251723777/At9hC8kn_normal.jpg","verified":false,"name":"Luc Groot","description":"#Europeaan #Heracles #landbouw #landschap #cooperatiefü§ù- werkt @De_FPG - voorzitter MR Julianaschool - voetbaltrainer @dvov_nl - #3 #GR2022 @CDAArnhem","protected":false,"created_at":"2010-11-29T13:53:06.000Z","public_metrics":{"followers_count":2626,"following_count":788,"tweet_count":12336,"listed_count":57},"url":"","location":"Arnhem, Nederland","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":63,"end":70,"username":"De_FPG"},{"start":118,"end":126,"username":"dvov_nl"},{"start":140,"end":150,"username":"CDAArnhem"}],"hashtags":[{"start":0,"end":10,"tag":"Europeaan"},{"start":11,"end":20,"tag":"Heracles"},{"start":21,"end":30,"tag":"landbouw"},{"start":31,"end":41,"tag":"landschap"},{"start":42,"end":54,"tag":"cooperatief"},{"start":132,"end":139,"tag":"GR2022"}],"urls":{}}}},{"id":"25950355","username":"NEJM","profile_image_url":"https://pbs.twimg.com/profile_images/893483773362393088/US3DliFV_normal.jpg","verified":true,"name":"NEJM","description":"The New England Journal of Medicine (http://t.co/YKINVyRNEl) is the world‚Äôs leading medical journal and website.","protected":false,"created_at":"2009-03-23T04:10:07.000Z","public_metrics":{"followers_count":875263,"following_count":397,"tweet_count":25056,"listed_count":10066},"url":"http://t.co/MskhpINH4c","location":"Boston, MA","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/MskhpINH4c","expanded_url":"http://NEJM.org","display_url":"NEJM.org"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":37,"end":59,"url":"http://t.co/YKINVyRNEl","expanded_url":"http://NEJM.org","display_url":"NEJM.org"}]}},"pinned_tweet_id":"1496847553685426177"},{"id":"1108967047","username":"M_Pajewska","profile_image_url":"https://pbs.twimg.com/profile_images/1106557716884017152/BJeYU3jG_normal.png","verified":false,"name":"Magdalena Pajewska Lewandowska","description":"","protected":false,"created_at":"2013-01-21T12:54:45.000Z","public_metrics":{"followers_count":254,"following_count":657,"tweet_count":1377,"listed_count":11},"url":"","location":"Canada, Ottawa","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"326845755","username":"AEMPSGOB","profile_image_url":"https://pbs.twimg.com/profile_images/1369221235838775299/6RotinPV_normal.jpg","verified":true,"name":"AEMPS","description":"Agencia Espa√±ola de Medicamentos y Productos Sanitarios","protected":false,"created_at":"2011-06-30T15:49:14.000Z","public_metrics":{"followers_count":49966,"following_count":139,"tweet_count":2070,"listed_count":812},"url":"https://t.co/yW8X0gBz8i","location":"Espa√±a","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/yW8X0gBz8i","expanded_url":"https://www.aemps.gob.es/","display_url":"aemps.gob.es"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1496833431937953798"},{"id":"596292370","username":"albertoporrasc","profile_image_url":"https://pbs.twimg.com/profile_images/2682706229/cac06e483cc2ad59a427c66ef5e0db16_normal.jpeg","verified":false,"name":"Alberto Porras","description":"Doctor en Medicina  #investigaci√≥n, #gesti√≥n, #docencia","protected":false,"created_at":"2012-06-01T09:14:28.000Z","public_metrics":{"followers_count":314,"following_count":176,"tweet_count":1636,"listed_count":21},"url":"","location":"Madrid","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":[{"start":20,"end":34,"tag":"investigaci√≥n"},{"start":36,"end":44,"tag":"gesti√≥n"},{"start":46,"end":55,"tag":"docencia"}],"urls":{}}}},{"id":"1482049878","username":"TomA_Riq","profile_image_url":"https://pbs.twimg.com/profile_images/1042868633045803008/T3tVJNMe_normal.jpg","verified":false,"name":"Thomas Riquier","description":"consultant sant√©  Pharmacien hospitalier ex-charg√© de mission √† la DGOS et ancien co-pr√©sident 2014-2015 de la FNSIP-BM mes tweets n'engagent que moi","protected":false,"created_at":"2013-06-04T11:43:37.000Z","public_metrics":{"followers_count":615,"following_count":1096,"tweet_count":1903,"listed_count":9},"url":"","location":"Paris","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1255880755454115841"},{"id":"515837126","username":"ciarakirke","profile_image_url":"https://pbs.twimg.com/profile_images/1256253163658764291/X-6jqgpz_normal.jpg","verified":false,"name":"Ciara Kirke","description":"Trying to improve patient safety and quality in healthcare. Clinical lead, medication safety with HSE. Likes sweet treats and gumption","protected":false,"created_at":"2012-03-05T20:31:08.000Z","public_metrics":{"followers_count":2182,"following_count":1116,"tweet_count":13101,"listed_count":0},"url":"https://t.co/en15fGFFdD","location":"Dublin, Ireland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/en15fGFFdD","expanded_url":"http://www.safermeds.ie","display_url":"safermeds.ie"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"23810643","username":"rabarg","profile_image_url":"https://pbs.twimg.com/profile_images/1485233266856759301/JKTDrb2s_normal.jpg","verified":false,"name":"Edda Grabar","description":"#Journalistin & #Autorin  versteht etwas von Biochemie #Medicine #Pharma √ºberzeugt f√ºr die #EU und den @fckoeln","protected":false,"created_at":"2009-03-11T19:13:44.000Z","public_metrics":{"followers_count":800,"following_count":219,"tweet_count":7710,"listed_count":75},"url":"","location":"K√∂lner Gro√üraum","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":103,"end":111,"username":"fckoeln"}],"hashtags":[{"start":0,"end":13,"tag":"Journalistin"},{"start":16,"end":24,"tag":"Autorin"},{"start":55,"end":64,"tag":"Medicine"},{"start":65,"end":72,"tag":"Pharma"},{"start":91,"end":94,"tag":"EU"}],"urls":{}}},"pinned_tweet_id":"1485232872353058824"},{"id":"17994531","username":"dennisandre","profile_image_url":"https://pbs.twimg.com/profile_images/284144225/twitterpic_normal.jpg","verified":false,"name":"Dennis Ballwieser","description":"Chefredakteur @AU_de // Arzt & Redakteur // fr√ºher @spiegelonline @djsde @lmu_uniklinikum // #KlartextCorona #NeDosisWissen // d.ballwieser@apotheken-umschau.de","protected":false,"created_at":"2008-12-09T16:21:47.000Z","public_metrics":{"followers_count":1169,"following_count":3858,"tweet_count":2091,"listed_count":47},"url":"https://t.co/HVLgKlqwXt","location":"Munich, Germany","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/HVLgKlqwXt","expanded_url":"https://www.apotheken-umschau.de/","display_url":"apotheken-umschau.de"}]},"description":{"mentions":[{"start":14,"end":20,"username":"AU_de"},{"start":51,"end":65,"username":"spiegelonline"},{"start":66,"end":72,"username":"djsde"},{"start":73,"end":89,"username":"lmu_uniklinikum"}],"hashtags":[{"start":93,"end":108,"tag":"KlartextCorona"},{"start":109,"end":123,"tag":"NeDosisWissen"}],"urls":{}}}},{"id":"597167039","username":"drdjpanchal","profile_image_url":"https://pbs.twimg.com/profile_images/774549158615257088/9RfYwLU1_normal.jpg","verified":false,"name":"Yeh Desh Pardesh","description":"Nationalist","protected":false,"created_at":"2012-06-02T07:00:21.000Z","public_metrics":{"followers_count":10,"following_count":43,"tweet_count":563,"listed_count":1},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"17966242","username":"trinevillemann","profile_image_url":"https://pbs.twimg.com/profile_images/992811045550002176/y12TiDu5_normal.jpg","verified":false,"name":"trinevillemann","description":"#Danish  director of #documentary #MalcolmisaLittleUnwell.See link below. Author.Journalist.TV-producer.All views mine.","protected":false,"created_at":"2008-12-08T16:50:16.000Z","public_metrics":{"followers_count":486,"following_count":405,"tweet_count":2609,"listed_count":16},"url":"https://t.co/ZMWGY1KReU","location":"London, England","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/ZMWGY1KReU","expanded_url":"https://vimeo.com/288990058","display_url":"vimeo.com/288990058"}]},"description":{"mentions":{},"hashtags":[{"start":0,"end":7,"tag":"Danish"},{"start":21,"end":33,"tag":"documentary"},{"start":34,"end":57,"tag":"MalcolmisaLittleUnwell"}],"urls":{}}},"pinned_tweet_id":"1216339619228332033"},{"id":"1430840870","username":"RareDiseasesEU","profile_image_url":"https://pbs.twimg.com/profile_images/1214536863366569984/tzJ1peJx_normal.png","verified":false,"name":"Rare Disease Policy","description":"@RareDiseasesEU is currently managed by Victoria Hedley, RD Policy Manager @ Newcastle University (formerly account  4 RD-ACTION & EUCERD JA). Views now my own","protected":false,"created_at":"2013-05-15T15:58:58.000Z","public_metrics":{"followers_count":3377,"following_count":957,"tweet_count":2891,"listed_count":100},"url":"","location":"Newcastle, UK","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":0,"end":15,"username":"RareDiseasesEU"}],"hashtags":{},"urls":{}}}},{"id":"362672893","username":"GBRChris_A","profile_image_url":"https://pbs.twimg.com/profile_images/797991661800452096/O97j26qc_normal.jpg","verified":false,"name":"Christopher Anton","description":"Pharmacovigilante, Cox at Birmingham RC, World Rowing umpire, British Rowing Regional Chair. All thoughts mine.","protected":false,"created_at":"2011-08-26T19:58:48.000Z","public_metrics":{"followers_count":1134,"following_count":827,"tweet_count":44625,"listed_count":30},"url":"","location":"Birmingham, UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"14433267","username":"wouterhavinga","profile_image_url":"https://pbs.twimg.com/profile_images/476319940770009089/9PBDjxOY_normal.jpeg","verified":false,"name":"Wouter Havinga","description":"retired family doctor","protected":false,"created_at":"2008-04-18T14:03:24.000Z","public_metrics":{"followers_count":1375,"following_count":4940,"tweet_count":16801,"listed_count":66},"url":"","location":"United Kingdom","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"52084584","username":"EFPIA","profile_image_url":"https://pbs.twimg.com/profile_images/600282411314712576/oSBUt3G9_normal.jpg","verified":false,"name":"EFPIA","description":"EFPIA is the voice of the research-based pharmaceutical industry in Europe \n#WeWontRest #TeamVaccines\nhttps://t.co/y1FLniUcoT","protected":false,"created_at":"2009-06-29T15:16:42.000Z","public_metrics":{"followers_count":25740,"following_count":3888,"tweet_count":27435,"listed_count":608},"url":"http://t.co/kGrDP4le","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":20,"url":"http://t.co/kGrDP4le","expanded_url":"http://www.efpia.eu","display_url":"efpia.eu"}]},"description":{"mentions":{},"hashtags":[{"start":76,"end":87,"tag":"WeWontRest"},{"start":88,"end":101,"tag":"TeamVaccines"}],"urls":[{"start":102,"end":125,"url":"https://t.co/y1FLniUcoT","expanded_url":"http://efpia.eu","display_url":"efpia.eu"}]}},"pinned_tweet_id":"1406907697275060226"},{"id":"243301370","username":"Elena_Tomas","profile_image_url":"https://pbs.twimg.com/profile_images/938674421547507713/EfGMkSq6_normal.jpg","verified":false,"name":"Elena Tomas","description":"","protected":false,"created_at":"2011-01-26T19:08:53.000Z","public_metrics":{"followers_count":94,"following_count":566,"tweet_count":2104,"listed_count":0},"url":"","location":"Vilassar de Mar ","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1425017433052508166"},{"id":"790421354","username":"cureLauncher","profile_image_url":"https://pbs.twimg.com/profile_images/3540121861/8ab5b11edd6de7319baa7c440e451bd3_normal.png","verified":false,"name":"CureLauncher","description":"Personalized Clinical Trial Matching Team \nPatientCentered.SurvivorInspired #clinicaltrials Official LIVESTRONG Partner\nhttp://t.co/0hxQWygyjO","protected":false,"created_at":"2012-08-30T00:10:03.000Z","public_metrics":{"followers_count":1038,"following_count":1836,"tweet_count":3548,"listed_count":36},"url":"http://t.co/34XeZgo0IC","location":"USA","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/34XeZgo0IC","expanded_url":"http://curelauncher.com","display_url":"curelauncher.com"}]},"description":{"mentions":{},"hashtags":[{"start":76,"end":91,"tag":"clinicaltrials"}],"urls":[{"start":120,"end":142,"url":"http://t.co/0hxQWygyjO","expanded_url":"http://www.facebook.com/cureLauncher","display_url":"facebook.com/cureLauncher"}]}}},{"id":"182561601","username":"velascozamora","profile_image_url":"https://pbs.twimg.com/profile_images/543061037004500992/rgbN2h3R_normal.png","verified":false,"name":"Jorge Velasco Zamora","description":"Jorge Velasco Zamora. M√©dico reumat√≥logo. Investigador Principal, MBA.\r\nSite Manager @CERInstitute. Pte Fundaci√≥n Articular\r\nhttp://t.co/okrdF0zaOq","protected":false,"created_at":"2010-08-24T22:03:58.000Z","public_metrics":{"followers_count":7452,"following_count":3729,"tweet_count":21161,"listed_count":123},"url":"http://t.co/BOO2C7eUUn","location":"Buenos Aires - Argentina","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/BOO2C7eUUn","expanded_url":"http://www.jorgevelascozamora.com/","display_url":"jorgevelascozamora.com"}]},"description":{"mentions":[{"start":85,"end":98,"username":"CERInstitute"}],"hashtags":{},"urls":[{"start":125,"end":147,"url":"http://t.co/okrdF0zaOq","expanded_url":"http://cerclinicaltrials.com/","display_url":"cerclinicaltrials.com"}]}}},{"id":"184756856","username":"EPHA_EU","profile_image_url":"https://pbs.twimg.com/profile_images/1470767114294382599/a_d37jhG_normal.jpg","verified":false,"name":"EPHA","description":"The European Public Health Alliance is a change agent ‚Äì Europe‚Äôs leading NGO alliance advocating for better health. Retweets are not endorsements.","protected":false,"created_at":"2010-08-30T12:11:13.000Z","public_metrics":{"followers_count":15302,"following_count":1893,"tweet_count":13499,"listed_count":437},"url":"https://t.co/B7bodgX2W1","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/B7bodgX2W1","expanded_url":"http://www.epha.org","display_url":"epha.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"207897978","username":"lakemedel","profile_image_url":"https://pbs.twimg.com/profile_images/1188766274295402496/pHQMCyTn_normal.jpg","verified":false,"name":"Mikael Hoffmann","description":"\"Droppen urholkar stenen\"\nL√§kare & patient. Privata tweets.\nChef NEPI, ordf L√§kares√§llskapets l√§kemedelsgrupp, medlem L√§kemedelsverkets vetenskapliga r√•d.","protected":false,"created_at":"2010-10-26T07:44:29.000Z","public_metrics":{"followers_count":2143,"following_count":432,"tweet_count":20982,"listed_count":42},"url":"https://t.co/hFy80Jm4NV","location":"Link√∂ping, Sweden","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/hFy80Jm4NV","expanded_url":"http://www.nepi.net","display_url":"nepi.net"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1449616378525360133"},{"id":"183177433","username":"MedtechAmanda","profile_image_url":"https://pbs.twimg.com/profile_images/572720346856308736/pBxeAVob_normal.jpeg","verified":false,"name":"Amanda Maxwell","description":"#medtech regulations expert at @Medtech_Insight. #medicaldevices, #IVDs & #drug/device combinations. Own opinions. @Pharma_Intelligence","protected":false,"created_at":"2010-08-26T10:06:53.000Z","public_metrics":{"followers_count":1781,"following_count":158,"tweet_count":6594,"listed_count":144},"url":"","location":"UK","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":31,"end":47,"username":"Medtech_Insight"},{"start":115,"end":135,"username":"Pharma_Intelligence"}],"hashtags":[{"start":0,"end":8,"tag":"medtech"},{"start":49,"end":64,"tag":"medicaldevices"},{"start":66,"end":71,"tag":"IVDs"},{"start":74,"end":79,"tag":"drug"}],"urls":{}}}},{"id":"1262320285","username":"VaccinesEurope","profile_image_url":"https://pbs.twimg.com/profile_images/1253680106352119809/XMRZTvHq_normal.jpg","verified":false,"name":"VaccinesEurope","description":"VE represents major innovative research-based vaccine companies operating in Europe, including SMEs.\nVE is a specialised group within EFPIA. #WeWontRest","protected":false,"created_at":"2013-03-12T16:08:10.000Z","public_metrics":{"followers_count":6123,"following_count":1008,"tweet_count":4927,"listed_count":102},"url":"https://t.co/TPJJSanMkb","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/TPJJSanMkb","expanded_url":"http://www.vaccineseurope.eu","display_url":"vaccineseurope.eu"}]},"description":{"mentions":{},"hashtags":[{"start":141,"end":152,"tag":"WeWontRest"}],"urls":{}}},"pinned_tweet_id":"1448641886009192450"},{"id":"595127053","username":"MarvinOLicious","profile_image_url":"https://pbs.twimg.com/profile_images/3560527314/f4bc361222d5485f9f30d7081edca248_normal.jpeg","verified":false,"name":"Marvin O'Licious","description":"","protected":true,"created_at":"2012-05-31T03:10:55.000Z","public_metrics":{"followers_count":0,"following_count":123,"tweet_count":138,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"5383942","username":"GSK","profile_image_url":"https://pbs.twimg.com/profile_images/1324755585837993988/Suh2dHvH_normal.png","verified":true,"name":"GSK","description":"Latest news and views from science-led global healthcare company GSK. Run by the global digital comms team. Community guidelines: https://t.co/oOQS7yzSyY","protected":false,"created_at":"2007-04-21T18:19:31.000Z","public_metrics":{"followers_count":234058,"following_count":725,"tweet_count":13025,"listed_count":2279},"url":"https://t.co/W5S4VfZfEG","location":"London, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/W5S4VfZfEG","expanded_url":"http://www.gsk.com","display_url":"gsk.com"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":130,"end":153,"url":"https://t.co/oOQS7yzSyY","expanded_url":"http://gsk.to/1OCpCfJ","display_url":"gsk.to/1OCpCfJ"}]}}},{"id":"51995902","username":"Jesduarte","profile_image_url":"https://pbs.twimg.com/profile_images/1432093139645382658/7dxnVloz_normal.jpg","verified":false,"name":"Jo√£o Duarte","description":"Living the living life. | RT or like ‚â† Endorsement | Tweets and views are personal.","protected":false,"created_at":"2009-06-29T07:54:14.000Z","public_metrics":{"followers_count":359,"following_count":696,"tweet_count":2513,"listed_count":2},"url":"","location":"Paris, France","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1324830324585566208"},{"id":"392623482","username":"GacetaMedicaCom","profile_image_url":"https://pbs.twimg.com/profile_images/1347508599749283840/9o3JJzLH_normal.jpg","verified":false,"name":"Gaceta M√©dica","description":"Diario de informaci√≥n de Sanidad, Profesionales, Pol√≠tica y Opini√≥n.","protected":false,"created_at":"2011-10-17T10:07:17.000Z","public_metrics":{"followers_count":53840,"following_count":2475,"tweet_count":37558,"listed_count":1087},"url":"https://t.co/zYckKrdW1o","location":"Madrid","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/zYckKrdW1o","expanded_url":"http://www.gacetamedica.com","display_url":"gacetamedica.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1496485066838618115"},{"id":"717962540","username":"Asphalion","profile_image_url":"https://pbs.twimg.com/profile_images/1454163191521480712/UwvBT6Lr_normal.jpg","verified":false,"name":"Asphalion","description":"Latest news on the regulatory affairs and pharmaceutical sector! \nInternacional Scientific and Regulatory Affairs Consultancy","protected":false,"created_at":"2012-07-26T11:51:00.000Z","public_metrics":{"followers_count":603,"following_count":854,"tweet_count":2476,"listed_count":12},"url":"https://t.co/YMyNVKdJw5","location":"Barcelona, Espa√±a","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/YMyNVKdJw5","expanded_url":"http://www.asphalion.com","display_url":"asphalion.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1484176236163178501"},{"id":"206819876","username":"K_N_Atuah","profile_image_url":"https://pbs.twimg.com/profile_images/1674926096/image_normal.jpg","verified":false,"name":"Kwame N. Atuah","description":"","protected":false,"created_at":"2010-10-23T20:14:25.000Z","public_metrics":{"followers_count":12,"following_count":121,"tweet_count":19,"listed_count":0},"url":"","location":"UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1725069487","username":"pharmatweat","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"Pharmatweat","description":"","protected":false,"created_at":"2013-09-03T10:10:14.000Z","public_metrics":{"followers_count":1,"following_count":0,"tweet_count":2,"listed_count":0},"url":"","location":"UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"266609916","username":"Mailas1809","profile_image_url":"https://pbs.twimg.com/profile_images/378800000591051403/6e068bdfb3ba4378f98e700273b9eaf0_normal.jpeg","verified":false,"name":"Marina I. Assetta, MRQA","description":"Pharmaceutical Consultant at MIA Clinical Research Services - Global Clinical Trial Management, GCP Auditing, Quality Evaluator Manager","protected":false,"created_at":"2011-03-15T14:21:42.000Z","public_metrics":{"followers_count":144,"following_count":161,"tweet_count":3654,"listed_count":8},"url":"","location":"Clinical Trial Mgt. ex-US","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"247239882","username":"PrescrireMieux","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"PrescrireMieux","description":"","protected":false,"created_at":"2011-02-04T11:36:24.000Z","public_metrics":{"followers_count":165,"following_count":0,"tweet_count":4,"listed_count":1},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"873777758","username":"EUombudsman","profile_image_url":"https://pbs.twimg.com/profile_images/1194630187788300288/bE3Y5tdH_normal.jpg","verified":true,"name":"European Ombudsman","description":"üá™üá∫ Ombudsman O'Reilly promotes good EU administration by investigating complaints and systemic issues. Account managed by the comms team. https://t.co/YbpgtPtsjM","protected":false,"created_at":"2012-10-11T15:02:05.000Z","public_metrics":{"followers_count":32440,"following_count":5806,"tweet_count":7852,"listed_count":793},"url":"https://t.co/uaDmsPxpmt","location":"Strasbourg/Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/uaDmsPxpmt","expanded_url":"https://www.ombudsman.europa.eu/en/home","display_url":"ombudsman.europa.eu/en/home"}]},"description":{"mentions":{},"hashtags":{},"urls":[{"start":138,"end":161,"url":"https://t.co/YbpgtPtsjM","expanded_url":"http://europa.eu/!bc33kQ","display_url":"europa.eu/!bc33kQ"}]}}},{"id":"1675439491","username":"daferlo647","profile_image_url":"https://pbs.twimg.com/profile_images/378800000307059685/a68ab459450a2222801f587761fa9c9d_normal.jpeg","verified":false,"name":"REPARACIONES LOBERA","description":"Reparaciones Lobera ¬°Que no vuelvan a tomarte el pelo!","protected":false,"created_at":"2013-08-16T10:40:04.000Z","public_metrics":{"followers_count":37,"following_count":57,"tweet_count":208,"listed_count":0},"url":"http://t.co/rONvWqKRAv","location":"Madrid y Espa√±a","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/rONvWqKRAv","expanded_url":"http://danielfernandezlober.wix.com/reparaciones","display_url":"danielfernandezlober.wix.com/reparaciones"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1300585957","username":"StopEssure","profile_image_url":"https://pbs.twimg.com/profile_images/3429587261/2532ad842d7e6239957abd68d0bb816c_normal.jpeg","verified":false,"name":"Essure Uncensored","description":"Essure sterilization is destroying women forcing them into hysterectomies at young ages. #Essure #EssureProblems https://t.co/OYobkjNQkD","protected":false,"created_at":"2013-03-25T18:25:41.000Z","public_metrics":{"followers_count":2513,"following_count":2230,"tweet_count":12082,"listed_count":37},"url":"https://t.co/GPArqWcdV1","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/GPArqWcdV1","expanded_url":"https://www.facebook.com/groups/Essureproblems/","display_url":"facebook.com/groups/Essurep‚Ä¶"}]},"description":{"mentions":{},"hashtags":[{"start":89,"end":96,"tag":"Essure"},{"start":97,"end":112,"tag":"EssureProblems"}],"urls":[{"start":113,"end":136,"url":"https://t.co/OYobkjNQkD","expanded_url":"http://essureproblems.webs.com/home","display_url":"essureproblems.webs.com/home"}]}}},{"id":"223692135","username":"cooldoc123","profile_image_url":"https://pbs.twimg.com/profile_images/1430256320/Doctor_Photo_normal.jpg","verified":false,"name":"docnuman","description":"Medical affairs Director ,clinical development ,commercial strategy. Posts/tweets DO NOT reflect the views of the company that i work for","protected":false,"created_at":"2010-12-07T02:23:02.000Z","public_metrics":{"followers_count":302,"following_count":2499,"tweet_count":7234,"listed_count":18},"url":"https://t.co/6ZJWJXGeIg","location":"usa","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/6ZJWJXGeIg","expanded_url":"http://www.linkedin.com/profile/view?id=36238831&trk=tab_pro","display_url":"linkedin.com/profile/view?i‚Ä¶"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"166509226","username":"LindaMcAvanMEP","profile_image_url":"https://pbs.twimg.com/profile_images/755321530394050560/P53-Z2Mi_normal.jpg","verified":true,"name":"Linda McAvan","description":"","protected":false,"created_at":"2010-07-14T09:43:09.000Z","public_metrics":{"followers_count":10873,"following_count":4384,"tweet_count":3732,"listed_count":377},"url":"","location":"sheffield ","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"65877691","username":"iu_st","profile_image_url":"https://pbs.twimg.com/profile_images/1461961014354890756/K9ralWZv_normal.jpg","verified":false,"name":"M.Justyna M.","description":"tu niemedycznie, med info na @iust_med /foto w≈Çasne/","protected":false,"created_at":"2009-08-15T11:08:18.000Z","public_metrics":{"followers_count":3162,"following_count":3865,"tweet_count":53694,"listed_count":31},"url":"","location":"Warszawa","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":29,"end":38,"username":"iust_med"}],"hashtags":{},"urls":{}}}},{"id":"1496947920","username":"StripSafely","profile_image_url":"https://pbs.twimg.com/profile_images/378800000469372933/0534062edbd39f2766a2842e959b466b_normal.png","verified":false,"name":"StripSafely","description":"People with Diabetes Need Safe & Accurate Test Strips. Join the Campaign http://t.co/nNiHOJdnGs","protected":false,"created_at":"2013-06-10T00:34:07.000Z","public_metrics":{"followers_count":745,"following_count":439,"tweet_count":1275,"listed_count":16},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":[{"start":73,"end":95,"url":"http://t.co/nNiHOJdnGs","expanded_url":"http://www.StripSafely.com","display_url":"StripSafely.com"}]}}},{"id":"758619698","username":"webDM1","profile_image_url":"https://pbs.twimg.com/profile_images/1457784920848273409/4zFgja92_normal.png","verified":false,"name":"Dani Royo","description":"Trabajo para las personas en el Serv. Atenci√≥n y Comunicaci√≥n con el Paciente de @GVAsanitat .Pitufo gru√±√≥n. Me interesa la #diabetESP Still to come","protected":false,"created_at":"2012-08-15T05:09:55.000Z","public_metrics":{"followers_count":6718,"following_count":1710,"tweet_count":45837,"listed_count":221},"url":"https://t.co/cpMNFN2DkS","location":"Valencia. Espa√±a","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/cpMNFN2DkS","expanded_url":"http://www.diabetestipo1.es/","display_url":"diabetestipo1.es"}]},"description":{"mentions":[{"start":81,"end":92,"username":"GVAsanitat"}],"hashtags":[{"start":124,"end":134,"tag":"diabetESP"}],"urls":{}}},"pinned_tweet_id":"1472267380764123141"},{"id":"17509073","username":"wombarrapete","profile_image_url":"https://pbs.twimg.com/profile_images/378800000229073961/d9357ca96b2f6472c5eedf5e64a282e2_normal.jpeg","verified":false,"name":"wombarrapete","description":"","protected":false,"created_at":"2008-11-20T10:39:57.000Z","public_metrics":{"followers_count":6,"following_count":24,"tweet_count":41,"listed_count":0},"url":"","location":"Planet Earth","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1367162942","username":"Fiouw","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"Jolanda de Fiouw","description":"","protected":false,"created_at":"2013-04-20T14:24:00.000Z","public_metrics":{"followers_count":15,"following_count":14,"tweet_count":29,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1397042496","username":"EconCancerRes","profile_image_url":"https://pbs.twimg.com/profile_images/3602809183/474f88507873d062e0cec490604744b3_normal.png","verified":false,"name":"Economics of Cancer","description":"Economics of Cancer Research Group Research - Dissemination - Collaboration","protected":false,"created_at":"2013-05-02T12:20:34.000Z","public_metrics":{"followers_count":807,"following_count":943,"tweet_count":1642,"listed_count":23},"url":"http://t.co/wrFawJEmhA","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/wrFawJEmhA","expanded_url":"http://economicsofcancer.com","display_url":"economicsofcancer.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"661819458353274881"},{"id":"296358959","username":"engenerico","profile_image_url":"https://pbs.twimg.com/profile_images/809859064972853248/lBew9Dy2_normal.jpg","verified":false,"name":"en gen√©rico","description":"Queremos aprender contigo sobre los medicamentos gen√©ricos, c√≥mo usar de forma responsable nuestro sistema sanitario y cuidar nuestra salud. ¬°Bienvenid@s!","protected":false,"created_at":"2011-05-10T16:37:49.000Z","public_metrics":{"followers_count":12667,"following_count":11691,"tweet_count":17321,"listed_count":213},"url":"https://t.co/6e7dKHPfoi","location":"Madrid, Spain","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/6e7dKHPfoi","expanded_url":"http://www.engenerico.com","display_url":"engenerico.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"79702114","username":"EASDnews","profile_image_url":"https://pbs.twimg.com/profile_images/1489176521667399684/ph8Y_kOl_normal.jpg","verified":false,"name":"EASD","description":"EASD is a non-profit association for HCP's with an interest in #diabetes and related subjects. Privacy Policy: https://t.co/j4xYeJHX5W‚Ä¶","protected":false,"created_at":"2009-10-04T10:24:49.000Z","public_metrics":{"followers_count":10356,"following_count":91,"tweet_count":6064,"listed_count":184},"url":"https://t.co/S8s8VGA8Nd","location":"D√ºsseldorf, Germany","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/S8s8VGA8Nd","expanded_url":"http://www.easd.org","display_url":"easd.org"}]},"description":{"mentions":{},"hashtags":[{"start":63,"end":72,"tag":"diabetes"}],"urls":[{"start":111,"end":134,"url":"https://t.co/j4xYeJHX5W","expanded_url":"http://easd.org/easd/privacy-p","display_url":"easd.org/easd/privacy-p"}]}}},{"id":"917639060","username":"FarmaOnco","profile_image_url":"https://pbs.twimg.com/profile_images/2930931336/c5ed1efcf9ddf36d4803c1ab88604f4f_normal.jpeg","verified":false,"name":"FarmaOnco","description":"Farmac√©utica hospitalaria que intenta mantenerse al d√≠a en onco, hemato y otras cosas","protected":false,"created_at":"2012-10-31T20:48:41.000Z","public_metrics":{"followers_count":2592,"following_count":1180,"tweet_count":22164,"listed_count":102},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"17437735","username":"Boehringer","profile_image_url":"https://pbs.twimg.com/profile_images/1118140978366492672/aAynk1K9_normal.png","verified":true,"name":"Boehringer Ingelheim","description":"Let‚Äôs connect for better health.","protected":false,"created_at":"2008-11-17T08:55:11.000Z","public_metrics":{"followers_count":103051,"following_count":3611,"tweet_count":15004,"listed_count":1512},"url":"https://t.co/75h3xQFmCt","location":"Ingelheim, Germany","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/75h3xQFmCt","expanded_url":"https://b-i.news/socialtermstw","display_url":"b-i.news/socialtermstw"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1535265686","username":"BarryPharmacist","profile_image_url":"https://pbs.twimg.com/profile_images/1024031630392872960/M2qQUPbZ_normal.jpg","verified":false,"name":"Barry Power üá®üá¶","description":"Pharmacist in primary care and information management; Dad of awesome @kiwaterloo grad; my wife says I'm a music snob","protected":false,"created_at":"2013-06-20T23:20:55.000Z","public_metrics":{"followers_count":769,"following_count":178,"tweet_count":1589,"listed_count":15},"url":"","location":"Ottawa, ON","entities":{"url":{"urls":{}},"description":{"mentions":[{"start":70,"end":81,"username":"kiwaterloo"}],"hashtags":{},"urls":{}}}},{"id":"525779070","username":"LillyPadEU","profile_image_url":"https://pbs.twimg.com/profile_images/1158305851381288961/f1p4NOFE_normal.jpg","verified":true,"name":"LillyPad EU","description":"The Eli Lilly and Company BXL team official Twitter\nprofile - Tweets on EU Health Policy, Innovation, Life at Lilly and\nCorporate Responsibility","protected":false,"created_at":"2012-03-15T21:46:21.000Z","public_metrics":{"followers_count":10276,"following_count":1510,"tweet_count":5341,"listed_count":177},"url":"https://t.co/vLAT3UlTM7","location":"Brussels, Belgium","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/vLAT3UlTM7","expanded_url":"https://lillypad.eu/","display_url":"lillypad.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"216527950","username":"sanoysalvoblog","profile_image_url":"https://pbs.twimg.com/profile_images/967801202942595073/q51FncDd_normal.jpg","verified":false,"name":"Sano y salvo","description":"Seguridad del Paciente en Atenci√≥n Primaria de Salud. Grupo de Trabajo en #SegPac de semFYC. Patient Safety #PtSafety, Primary Health Care.","protected":false,"created_at":"2010-11-16T23:47:03.000Z","public_metrics":{"followers_count":10960,"following_count":299,"tweet_count":22888,"listed_count":307},"url":"https://t.co/E7DzsUb00a","location":"Espa√±a - Spain","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/E7DzsUb00a","expanded_url":"http://sanoysalvo.es","display_url":"sanoysalvo.es"}]},"description":{"mentions":{},"hashtags":[{"start":74,"end":81,"tag":"SegPac"},{"start":108,"end":117,"tag":"PtSafety"}],"urls":{}}},"pinned_tweet_id":"1474813000536182785"},{"id":"31437646","username":"Margaritus","profile_image_url":"https://pbs.twimg.com/profile_images/762107553304248320/52sDPouc_normal.jpg","verified":false,"name":"I am Margaritus","description":"","protected":false,"created_at":"2009-04-15T15:47:02.000Z","public_metrics":{"followers_count":802,"following_count":916,"tweet_count":69325,"listed_count":22},"url":"","location":"Santiago, Chile","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"897191683028385793"},{"id":"158105629","username":"Sergiplata","profile_image_url":"https://pbs.twimg.com/profile_images/1344012499528658946/GXAo4pGC_normal.jpg","verified":false,"name":"Sergio Plata","description":"Especialista en #FarmaciaHospitalaria en @SanidadAlbacete. CoAutor de @StopErroresMed","protected":false,"created_at":"2010-06-21T20:06:53.000Z","public_metrics":{"followers_count":2059,"following_count":1052,"tweet_count":5942,"listed_count":72},"url":"https://t.co/S7hqUApYLE","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/S7hqUApYLE","expanded_url":"http://www.stoperroresdemedicacion.org","display_url":"stoperroresdemedicacion.org"}]},"description":{"mentions":[{"start":41,"end":57,"username":"SanidadAlbacete"},{"start":70,"end":85,"username":"StopErroresMed"}],"hashtags":[{"start":16,"end":37,"tag":"FarmaciaHospitalaria"}],"urls":{}}}},{"id":"378478769","username":"SIOPEurope","profile_image_url":"https://pbs.twimg.com/profile_images/1035522356213469187/0eTtdio__normal.jpg","verified":false,"name":"SIOPE üéóÔ∏è","description":"SIOP Europe, the European Society of Paediatric Oncology (SIOPE), promotes optimal standards of care for children and adolescents with cancer.","protected":false,"created_at":"2011-09-23T08:27:32.000Z","public_metrics":{"followers_count":5306,"following_count":1696,"tweet_count":8980,"listed_count":102},"url":"https://t.co/75A1bKVAgG","location":"Brussels","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/75A1bKVAgG","expanded_url":"http://www.siope.eu","display_url":"siope.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"14499829","username":"WHO","profile_image_url":"https://pbs.twimg.com/profile_images/875476478988886016/_l61qZdR_normal.jpg","verified":true,"name":"World Health Organization (WHO)","description":"We are the #UnitedNations‚Äô health agency - #HealthForAll.\n‚ñ∂Ô∏è Always check our latest tweets on #COVID19 for updated advice/information.","protected":false,"created_at":"2008-04-23T19:56:27.000Z","public_metrics":{"followers_count":10726535,"following_count":1746,"tweet_count":68017,"listed_count":34883},"url":"https://t.co/wVulKuROWG","location":"Geneva, Switzerland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/wVulKuROWG","expanded_url":"http://www.who.int","display_url":"who.int"}]},"description":{"mentions":{},"hashtags":[{"start":11,"end":25,"tag":"UnitedNations"},{"start":43,"end":56,"tag":"HealthForAll"},{"start":95,"end":103,"tag":"COVID19"}],"urls":{}}},"pinned_tweet_id":"1497281701847961612"},{"id":"13636102","username":"rqgb","profile_image_url":"https://pbs.twimg.com/profile_images/3780735805/829660781d3103c3bc37d64aa6d30b4e_normal.jpeg","verified":false,"name":"rqgb","description":"General Practitioner. Interested in communication, human beings, #ehealth, IT, social media and all the interactions...","protected":false,"created_at":"2008-02-18T18:45:12.000Z","public_metrics":{"followers_count":2027,"following_count":2037,"tweet_count":15515,"listed_count":178},"url":"http://t.co/bvbVz6trxD","location":"Worldwide","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/bvbVz6trxD","expanded_url":"http://rqgb.eu","display_url":"rqgb.eu"}]},"description":{"mentions":{},"hashtags":[{"start":65,"end":73,"tag":"ehealth"}],"urls":{}}},"pinned_tweet_id":"1463853472982446080"},{"id":"349775607","username":"vdgmeu","profile_image_url":"https://pbs.twimg.com/profile_images/672280152399847425/VFYgnF9c_normal.jpg","verified":false,"name":"Vasco da Gama Movement","description":"Welcome to the Vasco da Gama Movement, the WONCA Europe Network for New and Future General Practitioners.","protected":false,"created_at":"2011-08-06T17:36:42.000Z","public_metrics":{"followers_count":2827,"following_count":209,"tweet_count":3642,"listed_count":45},"url":"http://t.co/khtWi2oSGF","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/khtWi2oSGF","expanded_url":"http://www.vdgm.eu","display_url":"vdgm.eu"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1497849191980146690"},{"id":"1238217276","username":"rengerwitkamp","profile_image_url":"https://pbs.twimg.com/profile_images/650212857473142785/Kc1sIqub_normal.jpg","verified":false,"name":"Food&Pharma","description":"Professor in Nutritional Biology | Nutrition and Medicines during Ageing; Lifestyle as Medicine; (endo-)Cannabinoids; Food Supplements","protected":false,"created_at":"2013-03-03T07:36:54.000Z","public_metrics":{"followers_count":2198,"following_count":1152,"tweet_count":13296,"listed_count":70},"url":"http://t.co/SKOrZJQclp","location":"Wageningen, Netherlands","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/SKOrZJQclp","expanded_url":"http://nl.linkedin.com/pub/renger-witkamp/6/70/693","display_url":"nl.linkedin.com/pub/renger-wit‚Ä¶"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"305434870","username":"ICH_news","profile_image_url":"https://pbs.twimg.com/profile_images/1562052762/logo_only_transparent_normal.png","verified":false,"name":"ICH","description":"International Council for Harmonisation of Technical Requirements for \nPharmaceuticals for Human Use","protected":false,"created_at":"2011-05-26T06:29:14.000Z","public_metrics":{"followers_count":2590,"following_count":31,"tweet_count":153,"listed_count":57},"url":"http://t.co/tLbkcqnfEA","location":"Geneva","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/tLbkcqnfEA","expanded_url":"http://www.ich.org","display_url":"ich.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"43617900","username":"elazzouzim","profile_image_url":"https://pbs.twimg.com/profile_images/378800000399321490/22c77bf73ee1c991102aeecb81f65aef_normal.jpeg","verified":false,"name":"Monir El Azzouzi","description":"Med Dev & Pharma, QA/RA. Favorite question : Would I give this product to a member of my family? #meddevice #medtech #leadership #management #medicaldevices","protected":false,"created_at":"2009-05-30T23:47:55.000Z","public_metrics":{"followers_count":2145,"following_count":838,"tweet_count":73652,"listed_count":214},"url":"https://t.co/bbMmsphOoe","location":"Solothurn - Switzerland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/bbMmsphOoe","expanded_url":"https://easymedicaldevice.com","display_url":"easymedicaldevice.com"}]},"description":{"mentions":{},"hashtags":[{"start":97,"end":107,"tag":"meddevice"},{"start":108,"end":116,"tag":"medtech"},{"start":117,"end":128,"tag":"leadership"},{"start":129,"end":140,"tag":"management"},{"start":141,"end":156,"tag":"medicaldevices"}],"urls":{}}},"pinned_tweet_id":"1440225651580039178"},{"id":"498073573","username":"t_swam","profile_image_url":"https://pbs.twimg.com/profile_images/1338873336625950721/yL2GrSvW_normal.jpg","verified":false,"name":"Tara Swami","description":"Rheumatology Fellow a UOttawa, Former Internal Medicine Resident at USask and Lifelong Learner","protected":false,"created_at":"2012-02-20T17:22:31.000Z","public_metrics":{"followers_count":148,"following_count":286,"tweet_count":552,"listed_count":0},"url":"","location":"Saskatoon, Saskatchewan","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"115898830","username":"DIJs_pistol","profile_image_url":"https://pbs.twimg.com/profile_images/1379772113234501635/OHU8tHkf_normal.jpg","verified":false,"name":"„Å¥„Åô","description":"„É°„É≠„É≥„ÇΩ„Éº„ÉÄ„Å®„ÉÅ„É™„Éâ„ÉÉ„ÇØ„Åå„ÅÇ„Çå„Å∞Áîü„Åç„Å¶„ÅÑ„Åë„Çã„Å®ÊÄù„Å£„Å¶„ÅÑ„ÇãÊúÄÊñ∞Âûã„ÅÆ„ÅÇ„Çå„Åß„Åô„ÄÇ„Åü„Åæ„Å´Ê†™„Å®„ÅãFX„Å®„ÅãÂºÑ„Å£„Å¶„Åæ„Åô„ÄÇÂÜÜÂÆöÊúü„Çà„Çä„Çà„ÅèÂõû„Å£„Å¶„Åè„Çå„Çå„Å∞„Åù„Çå„Åß„ÅÑ„ÅÑ„Åß„Åô„ÄÇ‰Ωï„ÇÇ„Çè„Åã„Çä„Åæ„Åõ„Çì„ÄÇ„ÄÇ6Âπ¥ÊåÅ„Å°Á∂ö„Åë„Åü„Åù„Éº„Åõ„ÅÑ„Çí„ÅÇ„ÅÆÂ§ßÁõ∏Â†¥Áõ¥Ââç„Å´ÊâãÊîæ„Åó1Âπ¥ÂçäÊ∞ó„ÇíÂ§±„Å£„Å¶„ÅÑ„Åæ„Åó„Åü„ÄÇ2017ËæõÂãù2018Âø´Âãù2019ÂñÑÊà¶2020ÊÉ®Êïó„ÄÇ‰ªäÂπ¥„ÅØÁ®º„Åê„ÇàÔºÅÔºÅ","protected":false,"created_at":"2010-02-20T10:44:20.000Z","public_metrics":{"followers_count":117,"following_count":35,"tweet_count":5088,"listed_count":0},"url":"","location":"„Å≤„Åü„Å°„Åó","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"26791880","username":"apotekare","profile_image_url":"https://pbs.twimg.com/profile_images/1490228956217417728/A5VS12R4_normal.jpg","verified":false,"name":"Jon Haraldsson","description":"Apotekare och Rotarian som jobbar f√∂r Allas b√§sta. I hela Lerum. Styrelseledamot Lerums kommun. √Ñven hematologiansvarig p√• GSK Sverige","protected":false,"created_at":"2009-03-26T16:55:22.000Z","public_metrics":{"followers_count":326,"following_count":499,"tweet_count":3879,"listed_count":16},"url":"https://t.co/r5QwW9S22o","location":"Lerum, Sweden","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/r5QwW9S22o","expanded_url":"http://www.socialdemokraternailerum.se","display_url":"socialdemokraternailerum.se"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1545818551","username":"stevekshwang","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"Î≤†Î•ºÎ¶∞Ï≤úÏÇ¨","description":"","protected":false,"created_at":"2013-06-25T13:55:02.000Z","public_metrics":{"followers_count":0,"following_count":1,"tweet_count":3,"listed_count":0},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"325032216","username":"paulinemacco","profile_image_url":"https://pbs.twimg.com/profile_images/1445875890026475524/EdNFbXZP_normal.jpg","verified":false,"name":"dr pauline mccormack","description":"@NCLSociology health and illness, bioethics, patient experiences of health technologies, the patient voice","protected":false,"created_at":"2011-06-27T16:39:46.000Z","public_metrics":{"followers_count":534,"following_count":205,"tweet_count":2192,"listed_count":21},"url":"https://t.co/yevrSKMG7O","location":"UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/yevrSKMG7O","expanded_url":"https://www.ncl.ac.uk/gps/staff/profile/paulinemccormack.html","display_url":"ncl.ac.uk/gps/staff/prof‚Ä¶"}]},"description":{"mentions":[{"start":0,"end":13,"username":"NCLSociology"}],"hashtags":{},"urls":{}}}},{"id":"1216228962","username":"BushbyKate","profile_image_url":"https://pbs.twimg.com/profile_images/664909171930869760/db0plyta_normal.jpg","verified":false,"name":"Katie Bushby","description":"Professor Emerita in Neuromuscular Genetics Newcastle University JWMDRC. Fan of Northumberland seaside & good food.","protected":false,"created_at":"2013-02-24T18:37:13.000Z","public_metrics":{"followers_count":3091,"following_count":1168,"tweet_count":5768,"listed_count":67},"url":"https://t.co/4W08QAXO8t","location":"Newcastle upon Tyne","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/4W08QAXO8t","expanded_url":"http://www.ncl.ac.uk/igm/services/muscle","display_url":"ncl.ac.uk/igm/services/m‚Ä¶"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1460651427827785743"},{"id":"1299022237","username":"asociacionamife","profile_image_url":"https://pbs.twimg.com/profile_images/1433473878584614913/3gI6cb9V_normal.jpg","verified":false,"name":"AMIFE","description":"Asociaci√≥n de Medicina de la Industria Farmac√©utica en Espa√±a","protected":false,"created_at":"2013-03-25T11:26:07.000Z","public_metrics":{"followers_count":1321,"following_count":594,"tweet_count":4385,"listed_count":48},"url":"https://t.co/KPAsOsA2gu","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/KPAsOsA2gu","expanded_url":"http://www.amife.net","display_url":"amife.net"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"16579894","username":"pauldixey","profile_image_url":"https://pbs.twimg.com/profile_images/1040258710516510723/KK1R8WHb_normal.jpg","verified":false,"name":"Paul Dixey","description":"Healthcare Customer Engagement Consultant","protected":false,"created_at":"2008-10-03T16:26:09.000Z","public_metrics":{"followers_count":1167,"following_count":1052,"tweet_count":2308,"listed_count":77},"url":"https://t.co/Xw1UF3MTrH","location":"Kinoulton, Nottinghamshire","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Xw1UF3MTrH","expanded_url":"http://uk.linkedin.com/in/pauldixey","display_url":"uk.linkedin.com/in/pauldixey"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"23783432","username":"PMLIVE","profile_image_url":"https://pbs.twimg.com/profile_images/633898284/PMTWITTERLOGO_normal.jpg","verified":false,"name":"PM LIVE Team","description":"A Think Forward Music Magazine . Exposing  Quality Music Through An Original Lens.","protected":false,"created_at":"2009-03-11T16:08:20.000Z","public_metrics":{"followers_count":1082,"following_count":1484,"tweet_count":1216,"listed_count":15},"url":"http://t.co/clSU1r42fo","location":"Everywhere","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/clSU1r42fo","expanded_url":"http://www.pm-live.com","display_url":"pm-live.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1497946333","username":"Pharmaforkids","profile_image_url":"https://pbs.twimg.com/profile_images/3781533827/4edf2b66cd95a7f7233a359e1e2a0843_normal.png","verified":false,"name":"Paeds Pharmacologist (Dan)","description":"Dan Hawcutt, senior lecturer/consultant in paediatric pharmacology at University of Liverpool & Alder Hey Children's hospital. My opinions.","protected":false,"created_at":"2013-06-10T10:21:48.000Z","public_metrics":{"followers_count":1424,"following_count":722,"tweet_count":2102,"listed_count":18},"url":"","location":"Liverpool, UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"137349917","username":"FondazioneE35","profile_image_url":"https://pbs.twimg.com/profile_images/964066062474989568/TWtSaKPn_normal.jpg","verified":false,"name":"Fondazione E35","description":"Fondazione per la Progettazione europea e la Cooperazione Internazionale del territorio di Reggio Emilia e Provincia","protected":false,"created_at":"2010-04-26T14:11:23.000Z","public_metrics":{"followers_count":1759,"following_count":1211,"tweet_count":5957,"listed_count":76},"url":"https://t.co/NOxCx9FkqE","location":"Reggio Emilia","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/NOxCx9FkqE","expanded_url":"http://www.e-35.it","display_url":"e-35.it"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"482482613","username":"Wyattheinforma","profile_image_url":"https://pbs.twimg.com/profile_images/643308466807963648/76WhEN79_normal.jpg","verified":false,"name":"James Wyatt","description":"In transition...","protected":false,"created_at":"2012-02-03T23:40:49.000Z","public_metrics":{"followers_count":59,"following_count":121,"tweet_count":484,"listed_count":3},"url":"","location":"London, UK","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"63136204","username":"Informa_LS","profile_image_url":"https://pbs.twimg.com/profile_images/504927436530647040/GM045l_d_normal.png","verified":false,"name":"Informa LifeSciences","description":"Providing quality, expert-led conferences; delivering the knowledge our clients need to excel, guaranteeing a competitive advantage for their organisations.","protected":false,"created_at":"2009-08-05T13:46:27.000Z","public_metrics":{"followers_count":1826,"following_count":1818,"tweet_count":4852,"listed_count":35},"url":"http://t.co/712HIOKYGY","location":"London","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/712HIOKYGY","expanded_url":"http://www.informa-ls.com","display_url":"informa-ls.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"1114124408","username":"JnlAnaesthesia","profile_image_url":"https://pbs.twimg.com/profile_images/558270610069934081/QvsSWr99_normal.jpeg","verified":false,"name":"JournalAnaesthesia","description":"Journal of #Anaesthesia Practice, ideal for the #anesthetists & #anesthesiologist. Sign up to receive our newletter - https://t.co/e4Zw7M0AC1","protected":false,"created_at":"2013-01-23T11:11:20.000Z","public_metrics":{"followers_count":2225,"following_count":933,"tweet_count":993,"listed_count":27},"url":"http://t.co/iI3lat9m9M","location":"Harrogate, UK","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/iI3lat9m9M","expanded_url":"http://www.japractice.com","display_url":"japractice.com"}]},"description":{"mentions":{},"hashtags":[{"start":11,"end":23,"tag":"Anaesthesia"},{"start":48,"end":61,"tag":"anesthetists"},{"start":64,"end":81,"tag":"anesthesiologist"}],"urls":[{"start":118,"end":141,"url":"https://t.co/e4Zw7M0AC1","expanded_url":"http://eepurl.com/bqNDuf","display_url":"eepurl.com/bqNDuf"}]}}},{"id":"956329627","username":"Docjedy","profile_image_url":"https://pbs.twimg.com/profile_images/443733090784256000/zeYlggvp_normal.jpeg","verified":false,"name":"Jedi","description":"MG - Running - Papa de 4","protected":false,"created_at":"2012-11-18T22:15:06.000Z","public_metrics":{"followers_count":2176,"following_count":703,"tweet_count":19747,"listed_count":29},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"292158149","username":"docdu16","profile_image_url":"https://pbs.twimg.com/profile_images/963442295952506880/xCZ0_ue3_normal.jpg","verified":false,"name":"Grange JC","description":"Ex M√©decin G√©n√©raliste. Selon le d√©cret 2012-745 du 9/5/12 : pas de liens d‚Äôint√©r√™ts avec les industriels de la sant√©.","protected":false,"created_at":"2011-05-03T06:03:07.000Z","public_metrics":{"followers_count":5135,"following_count":168,"tweet_count":86372,"listed_count":151},"url":"https://t.co/Qb2NaTx96M","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Qb2NaTx96M","expanded_url":"http://docteurdu16.blogspot.com/","display_url":"docteurdu16.blogspot.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1040349271277621248"},{"id":"292400876","username":"doctorhelgi","profile_image_url":"https://pbs.twimg.com/profile_images/1447854028226957312/nNXwMioa_normal.jpg","verified":false,"name":"Dr Helgi üá∫üá¶","description":"Dr Helgi Johannsson - doctor specialising in anaesthesia at Imperial. Runner, singer. RCOA council member. Many opinions, all mine. üáÆüá∏üá¨üáßüá™üá∫üè≥Ô∏è‚Äçüåà","protected":false,"created_at":"2011-05-03T15:55:52.000Z","public_metrics":{"followers_count":30064,"following_count":2942,"tweet_count":45393,"listed_count":258},"url":"https://t.co/nXAcMIyvs6","location":"London, UK","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/nXAcMIyvs6","expanded_url":"https://www.drhelgi.com","display_url":"drhelgi.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1487334471594651649"},{"id":"232124120","username":"sanidadgob","profile_image_url":"https://pbs.twimg.com/profile_images/1495890330020896769/eA3ridxS_normal.jpg","verified":true,"name":"Ministerio de Sanidad","description":"Ministerio de Sanidad #YoMeVacunoSeguro","protected":false,"created_at":"2010-12-30T09:00:21.000Z","public_metrics":{"followers_count":687348,"following_count":699,"tweet_count":21725,"listed_count":4139},"url":"https://t.co/Uz115LXvLp","location":"Madrid, Espa√±a","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/Uz115LXvLp","expanded_url":"https://www.sanidad.gob.es/","display_url":"sanidad.gob.es"}]},"description":{"mentions":{},"hashtags":[{"start":22,"end":39,"tag":"YoMeVacunoSeguro"}],"urls":{}}}},{"id":"317401291","username":"BIOcomuniCAT","profile_image_url":"https://pbs.twimg.com/profile_images/1513015956/Biocomunicat_LOGO_normal.jpg","verified":false,"name":"BIOcomuniCA'T","description":"Som un equip de joves investigadors internacionals i organitzem activitats cient√≠fiques, jornades de divulgaci√≥ i tallers! Si hi est√†s interessat contacta'ns!","protected":false,"created_at":"2011-06-14T21:48:51.000Z","public_metrics":{"followers_count":1018,"following_count":169,"tweet_count":1607,"listed_count":47},"url":"http://t.co/DgW5eQOb3y","location":"barcelona","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/DgW5eQOb3y","expanded_url":"http://www.biocomunicat.cat","display_url":"biocomunicat.cat"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"123864717","username":"the_prbb","profile_image_url":"https://pbs.twimg.com/profile_images/1328459121637683208/op7uOSfo_normal.png","verified":false,"name":"Biomedicina BCN","description":"Biomedical research with a view | La millor recerca biom√®dica amb vistes\ncc @IMIM_research @CRGenomica @UPFbiomed @EMBLBarcelona @IBE_Barcelona @ISGlobalorg","protected":false,"created_at":"2010-03-17T13:05:36.000Z","public_metrics":{"followers_count":19238,"following_count":1616,"tweet_count":26160,"listed_count":406},"url":"https://t.co/HGFHt5QV7y","location":"Barcelona","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/HGFHt5QV7y","expanded_url":"http://www.prbb.org","display_url":"prbb.org"}]},"description":{"mentions":[{"start":76,"end":90,"username":"IMIM_research"},{"start":91,"end":102,"username":"CRGenomica"},{"start":103,"end":113,"username":"UPFbiomed"},{"start":114,"end":128,"username":"EMBLBarcelona"},{"start":129,"end":143,"username":"IBE_Barcelona"},{"start":144,"end":156,"username":"ISGlobalorg"}],"hashtags":{},"urls":{}}},"pinned_tweet_id":"1496788271183056896"},{"id":"756505452515512324","username":"HSJDBCN","profile_image_url":"https://abs.twimg.com/sticky/default_profile_images/default_profile_normal.png","verified":false,"name":"Adrian Cook","description":"","protected":false,"created_at":"2016-07-22T15:05:29.000Z","public_metrics":{"followers_count":8,"following_count":0,"tweet_count":0,"listed_count":1},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"122015101","username":"SIETES7","profile_image_url":"https://pbs.twimg.com/profile_images/586093630030512128/mUToIj5w_normal.jpg","verified":false,"name":"Sietes.org","description":"SIETES, Sistema de Informaci√≥n Esencial en Terap√©utica y Salud | Electronic information system on medicines & therapeutics | @FundacioICF | RT‚â†Endorsements","protected":false,"created_at":"2010-03-11T09:29:42.000Z","public_metrics":{"followers_count":3549,"following_count":363,"tweet_count":9009,"listed_count":202},"url":"http://t.co/dmfCfQexne","location":"Vall d'Hebron, Barcelona","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/dmfCfQexne","expanded_url":"http://www.sietes.org","display_url":"sietes.org"}]},"description":{"mentions":[{"start":125,"end":137,"username":"FundacioICF"}],"hashtags":{},"urls":{}}}},{"id":"228845995","username":"3NT","profile_image_url":"https://pbs.twimg.com/profile_images/1496939277896278017/v7HqoU5L_normal.jpg","verified":false,"name":"Pieter Droppert","description":"","protected":false,"created_at":"2010-12-20T20:58:41.000Z","public_metrics":{"followers_count":799,"following_count":228,"tweet_count":16594,"listed_count":140},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"44614314","username":"Annals_Oncology","profile_image_url":"https://pbs.twimg.com/profile_images/1212658619667365889/FXP-OFGP_normal.png","verified":false,"name":"Annals of Oncology","description":"Medical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.","protected":false,"created_at":"2009-06-04T13:26:20.000Z","public_metrics":{"followers_count":38109,"following_count":507,"tweet_count":3437,"listed_count":664},"url":"https://t.co/VTawI7ghHV","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/VTawI7ghHV","expanded_url":"https://www.annalsofoncology.org/","display_url":"annalsofoncology.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1255835557516763138"},{"id":"912929083","username":"BairdAM","profile_image_url":"https://pbs.twimg.com/profile_images/1345095746480197635/linNbKeb_normal.jpg","verified":false,"name":"Dr Anne-Marie Baird","description":"Cancer Researcher @tcddublin; Advocate; President @LungCancerEU; @EuropeanCancer PAC; @Donegal_SAL @LungCommunity Views are my own #NoStigma #LCSM","protected":false,"created_at":"2012-10-29T17:53:43.000Z","public_metrics":{"followers_count":3494,"following_count":1608,"tweet_count":16557,"listed_count":114},"url":"https://t.co/sH2hQXyxSD","location":"Dublin, Ireland","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/sH2hQXyxSD","expanded_url":"https://ie.linkedin.com/in/bairdam","display_url":"ie.linkedin.com/in/bairdam"}]},"description":{"mentions":[{"start":18,"end":28,"username":"tcddublin"},{"start":50,"end":63,"username":"LungCancerEU"},{"start":65,"end":80,"username":"EuropeanCancer"},{"start":86,"end":98,"username":"Donegal_SAL"},{"start":99,"end":113,"username":"LungCommunity"}],"hashtags":[{"start":131,"end":140,"tag":"NoStigma"},{"start":141,"end":146,"tag":"LCSM"}],"urls":{}}}},{"id":"125456212","username":"oncology23","profile_image_url":"https://pbs.twimg.com/profile_images/1905719124/Poza_Cluj_2_normal.jpg","verified":false,"name":"Banu Eugeniu","description":"Senior board-certified medical oncologist (France and Romania), Saint-Constantin Hospital. Focus on personalised treatment, clinical research, networking.","protected":false,"created_at":"2010-03-22T21:57:21.000Z","public_metrics":{"followers_count":1197,"following_count":1828,"tweet_count":5633,"listed_count":37},"url":"http://t.co/wRQq8ZxQy4","location":"Brasov, Romania","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/wRQq8ZxQy4","expanded_url":"http://wefollow.com/oncology23","display_url":"wefollow.com/oncology23"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"330036521","username":"jrgralow","profile_image_url":"https://pbs.twimg.com/profile_images/1320709251711463424/ZbKnmp5J_normal.jpg","verified":false,"name":"Julie Gralow","description":"Chief Medical Officer, American Society of Clinical Oncology (ASCO). Tweets are my own.","protected":false,"created_at":"2011-07-06T00:37:16.000Z","public_metrics":{"followers_count":8775,"following_count":700,"tweet_count":12718,"listed_count":260},"url":"https://t.co/PxgRGvpoOr","location":"Seattle WA & Alexandria VA USA","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/PxgRGvpoOr","expanded_url":"https://www.asco.org/about-asco/asco-overview/leadership/senior-leadership","display_url":"asco.org/about-asco/asc‚Ä¶"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"170039453","username":"drseisenberg","profile_image_url":"https://pbs.twimg.com/profile_images/829486029438492672/NAbK6KKh_normal.jpg","verified":true,"name":"Dr. Steven Eisenberg","description":"Text me +1 (310) 564-8857 #Oncologist | #Host, The @drstevenshow | #Songwriter 4 people living w/ #cancer | New Book: Love Is the Strongest Medicine @hayhouse","protected":false,"created_at":"2010-07-23T20:04:31.000Z","public_metrics":{"followers_count":36866,"following_count":11953,"tweet_count":62886,"listed_count":1373},"url":"https://t.co/UQ5ZYkk7MB","location":"San Diego, CA","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/UQ5ZYkk7MB","expanded_url":"http://bit.ly/loveisthestrongestmedicine","display_url":"bit.ly/loveisthestron‚Ä¶"}]},"description":{"mentions":[{"start":51,"end":64,"username":"drstevenshow"},{"start":149,"end":158,"username":"hayhouse"}],"hashtags":[{"start":26,"end":37,"tag":"Oncologist"},{"start":40,"end":45,"tag":"Host"},{"start":67,"end":78,"tag":"Songwriter"},{"start":98,"end":105,"tag":"cancer"}],"urls":{}}},"pinned_tweet_id":"1369080785106440193"},{"id":"177176270","username":"aftimosp","profile_image_url":"https://pbs.twimg.com/profile_images/1476472143038795777/M9ygX33Q_normal.jpg","verified":false,"name":"Philippe Aftimos, MD","description":"Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Views are mine https://t.co/PeEXATwb02","protected":false,"created_at":"2010-08-11T13:04:08.000Z","public_metrics":{"followers_count":5258,"following_count":3929,"tweet_count":16521,"listed_count":185},"url":"https://t.co/sMMkyHZPzt","location":"Brussels, BELGIUM","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/sMMkyHZPzt","expanded_url":"http://be.linkedin.com/pub/philippe-aftimos-md/25/a76/664","display_url":"be.linkedin.com/pub/philippe-a‚Ä¶"}]},"description":{"mentions":[{"start":44,"end":56,"username":"JulesBordet"}],"hashtags":[{"start":57,"end":70,"tag":"BreastCancer"},{"start":71,"end":89,"tag":"PrecisionMedicine"}],"urls":[{"start":106,"end":129,"url":"https://t.co/PeEXATwb02","expanded_url":"https://coi.asco.org/share/SJ5-FFQQ/Philippe%20Aftimos","display_url":"coi.asco.org/share/SJ5-FFQQ‚Ä¶"}]}},"pinned_tweet_id":"1357354116343816195"},{"id":"196132848","username":"mlazqui","profile_image_url":"https://pbs.twimg.com/profile_images/1262490438130376704/BGRHGts2_normal.jpg","verified":false,"name":"Mart√≠n L√°zaro","description":"Medical oncologist. Lung and genitourinary cancer.\n#lcsm #pcsm #kcsm","protected":false,"created_at":"2010-09-28T12:19:20.000Z","public_metrics":{"followers_count":3885,"following_count":3312,"tweet_count":20947,"listed_count":0},"url":"https://t.co/3yh0L7qfN9","location":"Vigo","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/3yh0L7qfN9","expanded_url":"http://www.novedadesenoncologia.blogspot.com","display_url":"novedadesenoncologia.blogspot.com"}]},"description":{"mentions":{},"hashtags":[{"start":51,"end":56,"tag":"lcsm"},{"start":57,"end":62,"tag":"pcsm"},{"start":63,"end":68,"tag":"kcsm"}],"urls":{}}}},{"id":"1180456747","username":"FlBontemps","profile_image_url":"https://pbs.twimg.com/profile_images/1081116738572431360/wCSLdNcJ_normal.jpg","verified":false,"name":"Florence Bontemps","description":"#TeamPharma. J‚Äôai cr√©√© l‚Äôapplication mobile de formation sur les m√©dicaments @defimedoc. ExDirectrice scientifique du Moniteur des Pharmacies.","protected":false,"created_at":"2013-02-14T22:12:00.000Z","public_metrics":{"followers_count":1716,"following_count":1181,"tweet_count":4219,"listed_count":53},"url":"https://t.co/JdO3D5SJy6","location":"Paris, France","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/JdO3D5SJy6","expanded_url":"http://www.defimedoc.fr","display_url":"defimedoc.fr"}]},"description":{"mentions":[{"start":77,"end":87,"username":"defimedoc"}],"hashtags":[{"start":0,"end":11,"tag":"TeamPharma"}],"urls":{}}},"pinned_tweet_id":"1173901655705817088"},{"id":"142310101","username":"cesareserono","profile_image_url":"https://pbs.twimg.com/profile_images/888956353/logo_serono2_normal.jpg","verified":false,"name":"Fondazione Serono","description":"La Fondazione Serono si occupa di sclerosi multipla, oncologia, endocrinologia, fertilit√† e malattie rare, guidata dal principio della centralit√† della persona","protected":false,"created_at":"2010-05-10T14:50:15.000Z","public_metrics":{"followers_count":1270,"following_count":140,"tweet_count":6950,"listed_count":29},"url":"http://t.co/O2IbGgMgTj","location":"Italy","entities":{"url":{"urls":[{"start":0,"end":22,"url":"http://t.co/O2IbGgMgTj","expanded_url":"http://www.fondazioneserono.org","display_url":"fondazioneserono.org"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"120702168","username":"goursaho","profile_image_url":"https://pbs.twimg.com/profile_images/561964853003583488/m34_KtY8_normal.jpeg","verified":false,"name":"Goursaho","description":"Beaucoup de sant√©, un peu de droit et des embruns bretons. Les propos tenus dans mes tweets n'engagent que moi.","protected":false,"created_at":"2010-03-07T08:10:25.000Z","public_metrics":{"followers_count":494,"following_count":1307,"tweet_count":15272,"listed_count":119},"url":"","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"117459814","username":"jdflaysakier","profile_image_url":"https://pbs.twimg.com/profile_images/446015525718470657/GED4_rOw_normal.jpeg","verified":false,"name":"j.daniel Flaysakier","description":"J‚Äôutilise  mes neurones restants √† essayer d‚Äôam√©liorer la qualit√© de vie des femmes ( et des hommes) trait√©es pour un cancer du sein.","protected":false,"created_at":"2010-02-25T16:45:58.000Z","public_metrics":{"followers_count":39392,"following_count":359,"tweet_count":120266,"listed_count":0},"url":"https://t.co/lfqJTCWCLT","location":"France","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/lfqJTCWCLT","expanded_url":"http://www.docteurjd.com","display_url":"docteurjd.com"}]},"description":{"mentions":{},"hashtags":{},"urls":{}}}},{"id":"264291314","username":"lucaspueyo","profile_image_url":"https://pbs.twimg.com/profile_images/441719701023252480/tj6zccTF_normal.jpeg","verified":false,"name":"Lucas Pueyo","description":"Industria farmace√∫tica. Interesado en todo lo referente a la salud. Es mi opini√≥n. Ojal√° se curen las enfermedades m√°s graves. Siempre se puede aprender.","protected":false,"created_at":"2011-03-11T17:17:32.000Z","public_metrics":{"followers_count":3520,"following_count":3319,"tweet_count":42340,"listed_count":163},"url":"","location":"Pamplona, Spain","entities":{"url":{"urls":{}},"description":{"mentions":{},"hashtags":{},"urls":{}}},"pinned_tweet_id":"1431508154613895168"},{"id":"109792171","username":"iWomanish","profile_image_url":"https://pbs.twimg.com/profile_images/645973652199092224/GHftVkAC_normal.jpg","verified":false,"name":"Mar√≠a Zabala","description":"Periodista. Cuento cosas sobre tecnolog√≠a y personas. #NoEsLaTecla ‚Äî Autora de  üìï #SerPadresEnLaEraDigital","protected":false,"created_at":"2010-01-30T08:07:12.000Z","public_metrics":{"followers_count":4423,"following_count":1727,"tweet_count":18761,"listed_count":333},"url":"https://t.co/k2E7XvwliP","location":"Madrid, Spain","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/k2E7XvwliP","expanded_url":"http://www.iwomanish.com","display_url":"iwomanish.com"}]},"description":{"mentions":{},"hashtags":[{"start":54,"end":66,"tag":"NoEsLaTecla"},{"start":82,"end":106,"tag":"SerPadresEnLaEraDigital"}],"urls":{}}},"pinned_tweet_id":"1433066046634827785"},{"id":"769373400","username":"FrancoisMaignen","profile_image_url":"https://pbs.twimg.com/profile_images/1425134116727574535/KUVXns8c_normal.jpg","verified":false,"name":"Francois Maignen","description":"I am the oomny chelloveck who will get you skorry horrorshow well with some bezoomny drencrom if you feel real bolnoy. üá™üá∫üá´üá∑üá¨üáß #NoFakeMed #BlackLivesMatter","protected":false,"created_at":"2012-08-20T11:47:47.000Z","public_metrics":{"followers_count":214,"following_count":154,"tweet_count":9655,"listed_count":72},"url":"https://t.co/pIwuVYbJUL","location":"Londinium","entities":{"url":{"urls":[{"start":0,"end":23,"url":"https://t.co/pIwuVYbJUL","expanded_url":"http://www.francoismaignen.eu","display_url":"francoismaignen.eu"}]},"description":{"mentions":{},"hashtags":[{"start":126,"end":136,"tag":"NoFakeMed"},{"start":137,"end":154,"tag":"BlackLivesMatter"}],"urls":{}}},"pinned_tweet_id":"1022232786042855424"}],"tweets":[{"source":"TweetDeck","text":"We've published a draft concept paper on a user safety guideline for topically administered #veterinary products: http://t.co/DMb3rzKtAp","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/DMb3rzKtAp","expanded_url":"http://bit.ly/1jmvhK2","display_url":"bit.ly/1jmvhK2"}],"hashtags":[{"start":92,"end":103,"tag":"veterinary"}],"mentions":{},"annotations":{}},"created_at":"2014-03-25T10:07:49.000Z","conversation_id":"448400855700873216","possibly_sensitive":false,"lang":"en","id":"448400855700873216","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"CMDh endorsed recommendations to restrict the use of #diacerein-containing medicines: http://t.co/lqlvQF8pmj","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/lqlvQF8pmj","expanded_url":"http://bit.ly/1r4R2iz","display_url":"bit.ly/1r4R2iz"}],"hashtags":[{"start":53,"end":63,"tag":"diacerein"}],"mentions":{},"annotations":{}},"created_at":"2014-03-21T12:45:01.000Z","conversation_id":"446990865974968321","possibly_sensitive":false,"lang":"en","id":"446990865974968321","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've issued recommendations for the composition of #flu vaccines for the coming season: http://t.co/YybwSTfTky","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/YybwSTfTky","expanded_url":"http://bit.ly/1g7Z5qu","display_url":"bit.ly/1g7Z5qu"}],"hashtags":[{"start":52,"end":56,"tag":"flu"}],"mentions":{},"annotations":{}},"created_at":"2014-03-21T12:31:42.000Z","conversation_id":"446987512662466560","possibly_sensitive":false,"lang":"en","id":"446987512662466560","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @LV_MPA: 2014 Pharmacovigilance Day http://t.co/I6I3OUFfKg","entities":{"urls":[{"start":39,"end":61,"url":"http://t.co/I6I3OUFfKg","expanded_url":"http://bit.ly/OzQHWj","display_url":"bit.ly/OzQHWj"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"created_at":"2014-03-20T10:31:40.000Z","conversation_id":"446594917490769920","possibly_sensitive":false,"lang":"en","id":"446594917490769920","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We're inviting companies to take part in a pilot project on #adaptivelicensing: http://t.co/1Xwzb9QxYp","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/1Xwzb9QxYp","expanded_url":"http://bit.ly/1fHHbWC","display_url":"bit.ly/1fHHbWC"}],"hashtags":[{"start":60,"end":78,"tag":"adaptivelicensing"}],"mentions":{},"annotations":{}},"created_at":"2014-03-19T16:51:02.000Z","conversation_id":"446328001979248641","possibly_sensitive":false,"lang":"en","id":"446328001979248641","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":2,"like_count":6,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @Aifa_ufficiale: Avastin - Lucentis: Position of the Italian Society of Pharmacology | Italian Medicines Agency http://t.co/8Px7Jd4RGB","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/8Px7Jd4RGB","expanded_url":"http://bit.ly/1nAp6nj","display_url":"bit.ly/1nAp6nj"}],"hashtags":{},"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":[{"start":90,"end":113,"probability":0.5453,"type":"Organization","normalized_text":"Italian Medicines Agency"}]},"created_at":"2014-03-18T10:38:21.000Z","conversation_id":"445871824807940096","possibly_sensitive":false,"lang":"en","id":"445871824807940096","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @INFARMED_IP: Prior assessment of medicinal products for human use for use in a hospital environment. http://t.co/GwLqGk67ap","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/GwLqGk67ap","expanded_url":"http://bit.ly/1fVPins","display_url":"bit.ly/1fVPins"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2014-03-18T12:49:53.000Z","conversation_id":"445904925856636929","possibly_sensitive":false,"lang":"en","id":"445904925856636929","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Two weeks to comment on a paediatric addendum to guidance on clinical investigation of medicines for #hypertension: http://t.co/Gza4hT522i","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/Gza4hT522i","expanded_url":"http://bit.ly/1kBnbdH","display_url":"bit.ly/1kBnbdH"}],"hashtags":[{"start":101,"end":114,"tag":"hypertension"}],"mentions":{},"annotations":{}},"created_at":"2014-03-17T10:38:52.000Z","conversation_id":"445509567720747008","possibly_sensitive":false,"lang":"en","id":"445509567720747008","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Two weeks left to comment on our draft guideline on clinical development of medicines for treating #HIV infection: http://t.co/9jX4i4VlnA","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/9jX4i4VlnA","expanded_url":"http://bit.ly/1gEHx16","display_url":"bit.ly/1gEHx16"}],"hashtags":[{"start":99,"end":103,"tag":"HIV"}],"mentions":{},"annotations":{}},"created_at":"2014-03-17T10:35:50.000Z","conversation_id":"445508802352525312","possibly_sensitive":false,"lang":"en","id":"445508802352525312","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@kerfors We're finalising a policy on access to trial data: http://t.co/5zznJo3X2a. Our board will discuss this week: http://t.co/dvLFzsUwhW","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/5zznJo3X2a","expanded_url":"http://bit.ly/Ywugka","display_url":"bit.ly/Ywugka"},{"start":118,"end":140,"url":"http://t.co/dvLFzsUwhW","expanded_url":"http://bit.ly/1dZDjE7","display_url":"bit.ly/1dZDjE7"}],"hashtags":{},"mentions":[{"start":0,"end":8,"username":"kerfors","id":"144624330"}],"annotations":{}},"created_at":"2014-03-17T10:05:10.000Z","conversation_id":"444583515603365888","possibly_sensitive":false,"lang":"en","id":"445501083923021824","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"444583515603365888"}],"in_reply_to_user_id":"144624330","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Our Committee for Medicinal Products for Veterinary Use (#CVMP) has recommended authorisation of 2 #dog #vaccines: http://t.co/4plvQm9POY","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/4plvQm9POY","expanded_url":"http://bit.ly/1ilCSFM","display_url":"bit.ly/1ilCSFM"}],"hashtags":[{"start":57,"end":62,"tag":"CVMP"},{"start":99,"end":103,"tag":"dog"},{"start":104,"end":113,"tag":"vaccines"}],"mentions":{},"annotations":{}},"created_at":"2014-03-14T16:12:55.000Z","conversation_id":"444506469728522240","possibly_sensitive":false,"lang":"en","id":"444506469728522240","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: Information on the new headquarters of the Polish medicines agency http://t.co/K8al9iibcL","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/K8al9iibcL","expanded_url":"http://bit.ly/1eAeLhC","display_url":"bit.ly/1eAeLhC"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2014-03-14T15:27:11.000Z","conversation_id":"444494960516403200","possibly_sensitive":false,"lang":"en","id":"444494960516403200","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @GCessak: Communication on the content of Supplement 8.1 to the eighth edition of the European Pharmacopoeia http://t.co/td3IcMflqI","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/td3IcMflqI","expanded_url":"http://bit.ly/1eAcqDv","display_url":"bit.ly/1eAcqDv"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"created_at":"2014-03-14T15:19:50.000Z","conversation_id":"444493110996115456","possibly_sensitive":false,"lang":"en","id":"444493110996115456","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@EAHPtweet @GCessak We'll be publishing the agenda on this page shortly: http://t.co/dvLFzsUwhW","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/dvLFzsUwhW","expanded_url":"http://bit.ly/1dZDjE7","display_url":"bit.ly/1dZDjE7"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"EAHPtweet","id":"203357203"},{"start":11,"end":19,"username":"GCessak","id":"556859372"}],"annotations":{}},"created_at":"2014-03-14T15:15:20.000Z","conversation_id":"444445442563383296","possibly_sensitive":false,"lang":"en","id":"444491978269810688","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"444468155050901504"}],"in_reply_to_user_id":"203357203","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @LV_MPA: The use of ADHD medicines in 2013 identified http://t.co/bk3ICLnbV2","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/bk3ICLnbV2","expanded_url":"http://bit.ly/1njrlLQ","display_url":"bit.ly/1njrlLQ"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"created_at":"2014-03-12T11:53:28.000Z","conversation_id":"443716401317314561","possibly_sensitive":false,"lang":"en","id":"443716401317314561","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Yesterday we started publishing summaries of risk-management plans for authorised human medicines: http://t.co/h8Hybr2YTs #transparency","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/h8Hybr2YTs","expanded_url":"http://bit.ly/1cR952c","display_url":"bit.ly/1cR952c"}],"hashtags":[{"start":122,"end":135,"tag":"transparency"}],"mentions":{},"annotations":{}},"created_at":"2014-03-12T09:53:01.000Z","conversation_id":"443686090189570048","possibly_sensitive":false,"lang":"en","id":"443686090189570048","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@GeoMurariu However please note that we don't approve medicines. The @EU_Commission approves after we've given an opinion.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":11,"username":"GeoMurariu","id":"1125798749727539202"},{"start":69,"end":83,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2014-03-10T14:41:23.000Z","conversation_id":"443022598331719680","possibly_sensitive":false,"lang":"en","id":"443033884650135552","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"443033688855834624"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@GeoMurariu You can search human medicines at http://t.co/HKFvTyBOp8. We also have searches for veterinary and herbal medicines.","entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/HKFvTyBOp8","expanded_url":"http://bit.ly/1oFjhQT","display_url":"bit.ly/1oFjhQT"}],"hashtags":{},"mentions":[{"start":0,"end":11,"username":"GeoMurariu","id":"1125798749727539202"}],"annotations":{}},"created_at":"2014-03-10T14:40:37.000Z","conversation_id":"443022598331719680","possibly_sensitive":false,"lang":"en","id":"443033688855834624","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"443022598331719680"}],"in_reply_to_user_id":"329999446","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Please help us improve our Twitter feed by completing this five-minute survey: http://t.co/q987RFusP6","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/q987RFusP6","expanded_url":"http://svy.mk/OcE6HP","display_url":"svy.mk/OcE6HP"}],"hashtags":{},"mentions":{},"annotations":[{"start":27,"end":33,"probability":0.7008,"type":"Product","normalized_text":"Twitter"}]},"created_at":"2014-03-10T10:57:15.000Z","conversation_id":"442977479574429696","possibly_sensitive":false,"lang":"en","id":"442977479574429696","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC has re-examined #diacerein and recommended that it remain available with restrictions: http://t.co/BdfMVR4bOa","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/BdfMVR4bOa","expanded_url":"http://bit.ly/P843cU","display_url":"bit.ly/P843cU"}],"hashtags":[{"start":21,"end":31,"tag":"diacerein"}],"mentions":{},"annotations":{}},"created_at":"2014-03-07T12:23:50.000Z","conversation_id":"441912105214943232","possibly_sensitive":false,"lang":"en","id":"441912105214943232","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"The EPAR for #Brintellix (#vortioxetine), a recently authorised medicine to treat major #depression, is available: http://t.co/Q2MrQmopwo","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/Q2MrQmopwo","expanded_url":"http://bit.ly/1aZeKCi","display_url":"bit.ly/1aZeKCi"}],"hashtags":[{"start":13,"end":24,"tag":"Brintellix"},{"start":26,"end":39,"tag":"vortioxetine"},{"start":88,"end":99,"tag":"depression"}],"mentions":{},"annotations":{}},"created_at":"2014-01-16T15:20:22.000Z","conversation_id":"423837136668741632","possibly_sensitive":false,"lang":"en","id":"423837136668741632","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We're extending by 2 years our programme for parallel assessment of #qualitybydesign applications with @US_FDA: http://t.co/CJXrp8mBj6","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/CJXrp8mBj6","expanded_url":"http://bit.ly/1g2QmFt","display_url":"bit.ly/1g2QmFt"}],"hashtags":[{"start":68,"end":84,"tag":"qualitybydesign"}],"mentions":[{"start":103,"end":110,"username":"US_FDA","id":"208120290"}],"annotations":{}},"created_at":"2014-03-07T10:47:19.000Z","conversation_id":"441887814486339584","possibly_sensitive":false,"lang":"en","id":"441887814486339584","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: If you notice side effects, contact your doctor, pharmacist, or national medicines agency directly http://t.co/G0lwJMcz0t","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/G0lwJMcz0t","expanded_url":"http://bit.ly/1gc0Y19","display_url":"bit.ly/1gc0Y19"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2014-03-06T09:53:04.000Z","conversation_id":"441511772135387136","possibly_sensitive":false,"lang":"en","id":"441511772135387136","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @igznl: Save the date: 19 June Dutch Healthcare Inspectorate patient safety conference. #IGZ #patientsafety http://t.co/DXIyedne0o","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/DXIyedne0o","expanded_url":"http://bit.ly/1c53daJ","display_url":"bit.ly/1c53daJ"}],"hashtags":[{"start":91,"end":95,"tag":"IGZ"},{"start":96,"end":110,"tag":"patientsafety"}],"mentions":[{"start":3,"end":9,"username":"Igznl","id":"1601603352"}],"annotations":{}},"created_at":"2014-03-04T15:46:45.000Z","conversation_id":"440876007118348288","possibly_sensitive":false,"lang":"en","id":"440876007118348288","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Find out about our work in medicines for the treatment of rare diseases: http://t.co/jT9MpwkY7D #RareDiseaseDay","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/jT9MpwkY7D","expanded_url":"http://bit.ly/1cjFONF","display_url":"bit.ly/1cjFONF"}],"hashtags":[{"start":96,"end":111,"tag":"RareDiseaseDay"}],"mentions":{},"annotations":{}},"created_at":"2014-02-26T10:46:13.000Z","conversation_id":"438626046074953728","possibly_sensitive":false,"lang":"en","id":"438626046074953728","author_id":"116716199","public_metrics":{"retweet_count":11,"reply_count":3,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our #pharmacovigilance committee's (#PRAC) next meeting is next week. We're publishing the highlights on Friday: http://t.co/Uep4ZHWccW","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/Uep4ZHWccW","expanded_url":"http://bit.ly/1fvANas","display_url":"bit.ly/1fvANas"}],"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":36,"end":41,"tag":"PRAC"}],"mentions":{},"annotations":{}},"created_at":"2014-02-28T12:02:10.000Z","conversation_id":"439369935668936704","possibly_sensitive":false,"lang":"en","id":"439369935668936704","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've recommended 12 medicines for the treatment of rare diseases over the past year: http://t.co/jT9MpwkY7D #RareDiseaseDay","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/jT9MpwkY7D","expanded_url":"http://bit.ly/1cjFONF","display_url":"bit.ly/1cjFONF"}],"hashtags":[{"start":109,"end":124,"tag":"RareDiseaseDay"}],"mentions":{},"annotations":{}},"created_at":"2014-02-25T14:58:38.000Z","conversation_id":"438327181207691264","possibly_sensitive":false,"lang":"en","id":"438327181207691264","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @LV_MPA: Treatment with paracetamol during pregnancy http://t.co/ag1o9Tz7Qi","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/ag1o9Tz7Qi","expanded_url":"http://bit.ly/1ljehnN","display_url":"bit.ly/1ljehnN"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"created_at":"2014-02-25T17:26:28.000Z","conversation_id":"438364385091010560","possibly_sensitive":false,"lang":"en","id":"438364385091010560","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@CDeRede No we don't because it falls outside of our remit. We suggest you contact @EU_enterprise or @EU_Health  for more information.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":8,"username":"CDeRede","id":"2254792730"},{"start":83,"end":97,"username":"EU_enterprise","id":"2562735307"},{"start":101,"end":111,"username":"EU_Health","id":"606325697"}],"annotations":{}},"created_at":"2014-02-25T16:05:34.000Z","conversation_id":"438341840572776448","possibly_sensitive":false,"lang":"en","id":"438344026258149377","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"438341840572776448"}],"in_reply_to_user_id":"2254792730","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One week left to comment on draft product-specific bioequivalence guidance for sunitinib: http://t.co/wxBKopxh3g","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/wxBKopxh3g","expanded_url":"http://bit.ly/1bcBnsu","display_url":"bit.ly/1bcBnsu"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2014-02-24T18:04:14.000Z","conversation_id":"438011501840855040","possibly_sensitive":false,"lang":"en","id":"438011501840855040","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We recommend that #Protelos / Osseor remain available but with further restrictions: http://t.co/lhgjSU3Dc7","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/lhgjSU3Dc7","expanded_url":"http://bit.ly/1edkwkm","display_url":"bit.ly/1edkwkm"}],"hashtags":[{"start":18,"end":27,"tag":"Protelos"}],"mentions":{},"annotations":{}},"created_at":"2014-02-21T13:08:49.000Z","conversation_id":"436849994252181504","possibly_sensitive":false,"lang":"en","id":"436849994252181504","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter for iPad","text":"RT @INFARMED_IP: Protelos and Osseor - New recommendation to restrict use http://t.co/nnSeCwiYgP","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/nnSeCwiYgP","expanded_url":"http://www.infarmed.pt/portal/page/portal/INFARMED/MAIS_ALERTAS/DETALHE_ALERTA?itemid=9681873","display_url":"infarmed.pt/portal/page/po‚Ä¶"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2014-02-21T18:30:41.000Z","conversation_id":"436920210600112128","possibly_sensitive":false,"lang":"en","id":"436930995577962496","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"436920210600112128"}],"in_reply_to_user_id":"1392501529","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @GCessak: Information on the 75th meeting of the heads of EU medicines agencies (HMA): http://t.co/gJXw5vA2v5","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/gJXw5vA2v5","expanded_url":"http://bit.ly/1hv65jw","display_url":"bit.ly/1hv65jw"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":61,"end":62,"probability":0.5651,"type":"Organization","normalized_text":"EU"}]},"created_at":"2014-02-19T14:19:48.000Z","conversation_id":"436143081889730560","possibly_sensitive":false,"lang":"en","id":"436143081889730560","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Last chance to comment on draft public statement on herbal medicines containing pyrrolizidine alkaloids: http://t.co/vlikiAtv9y","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/vlikiAtv9y","expanded_url":"http://bit.ly/1crVrCP","display_url":"bit.ly/1crVrCP"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2014-02-14T09:55:48.000Z","conversation_id":"434264704291450880","possibly_sensitive":false,"lang":"en","id":"434264704291450880","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @GCessak: What does the #blacktriangle mean? http://t.co/qybC42RFtb http://t.co/K2ImcFfQoz","entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/qybC42RFtb","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/09/WC500150608.pdf","display_url":"ema.europa.eu/docs/en_GB/doc‚Ä¶"},{"start":71,"end":93,"url":"http://t.co/K2ImcFfQoz","expanded_url":"https://twitter.com/GCessak/status/385031341013618689/photo/1","display_url":"pic.twitter.com/K2ImcFfQoz"}],"hashtags":[{"start":27,"end":41,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"created_at":"2013-10-01T13:21:46.000Z","conversation_id":"385031787141148672","possibly_sensitive":false,"lang":"en","id":"385031787141148672","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":4,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":["3_385031341022007296"]}},{"source":"bitly bitlink","text":"Public consultation now open on review and update of our guidelines to implement best practice with regard to #3Rs: http://t.co/jM1xEGu7fI","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/jM1xEGu7fI","expanded_url":"http://bit.ly/1caQb5O","display_url":"bit.ly/1caQb5O"}],"hashtags":[{"start":110,"end":114,"tag":"3Rs"}],"mentions":{},"annotations":{}},"created_at":"2014-02-07T16:21:45.000Z","conversation_id":"431825118810365952","possibly_sensitive":false,"lang":"en","id":"431825118810365952","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the #PRAC meeting highlights:  http://t.co/FmUJubL2Ns","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/FmUJubL2Ns","expanded_url":"http://bit.ly/Mxa6FR","display_url":"bit.ly/Mxa6FR"}],"hashtags":[{"start":25,"end":30,"tag":"PRAC"}],"mentions":{},"annotations":{}},"created_at":"2014-02-07T12:09:33.000Z","conversation_id":"431761648748347392","possibly_sensitive":false,"lang":"en","id":"431761648748347392","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"There's just one week left to comment on our 16 product-specific guidelines on the demonstration of #bioequivalence: http://t.co/BZ9TH8Tn8U","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/BZ9TH8Tn8U","expanded_url":"http://bit.ly/1a63PMi","display_url":"bit.ly/1a63PMi"}],"hashtags":[{"start":100,"end":115,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"created_at":"2014-02-07T12:27:03.000Z","conversation_id":"431766052519677952","possibly_sensitive":false,"lang":"en","id":"431766052519677952","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @GCessak: Vitamin C divides the oncologists: http://t.co/Yiynun3W75","entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/Yiynun3W75","expanded_url":"http://bit.ly/1kjO5ZB","display_url":"bit.ly/1kjO5ZB"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":{}},"created_at":"2014-02-07T10:02:37.000Z","conversation_id":"431729705080086529","possibly_sensitive":false,"lang":"en","id":"431729705080086529","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"11 out of the 81 human #medicines we recommended for marketing authorisation in 2013 were for #rarediseases: http://t.co/0dNkvkxcPc #orphan","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/0dNkvkxcPc","expanded_url":"http://bit.ly/1foANVR","display_url":"bit.ly/1foANVR"}],"hashtags":[{"start":23,"end":33,"tag":"medicines"},{"start":94,"end":107,"tag":"rarediseases"},{"start":132,"end":139,"tag":"orphan"}],"mentions":{},"annotations":{}},"created_at":"2014-02-03T15:08:57.000Z","conversation_id":"430357244220567552","possibly_sensitive":false,"lang":"en","id":"430357244220567552","author_id":"116716199","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":5,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We've published the EPAR for #Sovaldi (#sofosbuvir), a new medicine to treat #hepatitisC in adults: http://t.co/PRCemaYFgo","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/PRCemaYFgo","expanded_url":"http://bit.ly/1lAybf1","display_url":"bit.ly/1lAybf1"}],"hashtags":[{"start":29,"end":37,"tag":"Sovaldi"},{"start":39,"end":50,"tag":"sofosbuvir"},{"start":77,"end":88,"tag":"hepatitisC"}],"mentions":{},"annotations":{}},"created_at":"2014-02-06T10:38:05.000Z","conversation_id":"431376241577324544","possibly_sensitive":false,"lang":"en","id":"431376241577324544","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We've published a roundup of the activities of our committee on medicines for rare diseases: http://t.co/NlxscaNCnR  #orphan","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/NlxscaNCnR","expanded_url":"http://bit.ly/1foANVR","display_url":"bit.ly/1foANVR"}],"hashtags":[{"start":117,"end":124,"tag":"orphan"}],"mentions":{},"annotations":{}},"created_at":"2014-02-04T11:36:05.000Z","conversation_id":"430666062338600960","possibly_sensitive":false,"lang":"en","id":"430666062338600960","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@VanessaVanHalen The longest CHMP reviews: Natalizumab Elan Pharma (1,123 days, negative opinion); Zeftera (1,073 days, negative opinion)...","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":[{"start":43,"end":65,"probability":0.2582,"type":"Organization","normalized_text":"Natalizumab Elan Pharma"}]},"created_at":"2014-02-05T15:47:35.000Z","conversation_id":"430926683273986048","possibly_sensitive":false,"lang":"en","id":"431091742293884929","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"430926683273986048"}],"in_reply_to_user_id":"2305187534","attachments":{"media_keys":{}}},{"source":"Twitter for iPhone","text":"‚Äú@INFARMED_IP: Hydergine (dihydroergotoxin) - suspension of marketing authorisation http://t.co/lazd4seh2M‚Äù","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/lazd4seh2M","expanded_url":"http://www.infarmed.pt/portal/page/portal/INFARMED/MAIS_ALERTAS/DETALHE_ALERTA?itemid=9661314","display_url":"infarmed.pt/portal/page/po‚Ä¶"}],"hashtags":{},"mentions":[{"start":1,"end":13,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2014-02-03T19:55:57.000Z","conversation_id":"430395236133511168","possibly_sensitive":false,"lang":"en","id":"430429471888658433","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"430395236133511168"}],"in_reply_to_user_id":"1392501529","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@VanessaVanHalen Our committee, CHMP, is evaluating the application for Scenesse. We will release full details at the end of the evaluation.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":[{"start":72,"end":79,"probability":0.5067,"type":"Organization","normalized_text":"Scenesse"}]},"created_at":"2014-02-03T09:35:35.000Z","conversation_id":"429388398470889472","possibly_sensitive":false,"lang":"en","id":"430273350838263808","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"429388398470889472"}],"in_reply_to_user_id":"2305187534","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Read about the originators of innovative medicines in the EU in a new article by EMA staff: http://t.co/7jSb2sfTWY  #innovation","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/7jSb2sfTWY","expanded_url":"http://bit.ly/1gwFKBf","display_url":"bit.ly/1gwFKBf"}],"hashtags":[{"start":116,"end":127,"tag":"innovation"}],"mentions":{},"annotations":[{"start":81,"end":89,"probability":0.3522,"type":"Organization","normalized_text":"EMA staff"}]},"created_at":"2014-02-03T09:11:55.000Z","conversation_id":"430267392581570560","possibly_sensitive":false,"lang":"en","id":"430267392581570560","author_id":"116716199","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've released guidance on the use of #pharmacogenomics to improve the safety monitoring of medicines: http://t.co/kCeMEramUW","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/kCeMEramUW","expanded_url":"http://bit.ly/1gtHM59","display_url":"bit.ly/1gtHM59"}],"hashtags":[{"start":38,"end":55,"tag":"pharmacogenomics"}],"mentions":{},"annotations":{}},"created_at":"2014-01-30T14:40:49.000Z","conversation_id":"428900615251845120","possibly_sensitive":false,"lang":"en","id":"428900615251845120","author_id":"116716199","public_metrics":{"retweet_count":23,"reply_count":1,"like_count":7,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@sTuDiO54x We're assessing a marketing-authorisation application and have issued an opinion on compassionate use: http://t.co/3tn1iLL9sg","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/3tn1iLL9sg","expanded_url":"http://bit.ly/17yT6q0","display_url":"bit.ly/17yT6q0"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"sTuDiO54x","id":"22255878"}],"annotations":{}},"created_at":"2014-01-31T09:52:59.000Z","conversation_id":"428925100986212354","possibly_sensitive":false,"lang":"en","id":"429190564509388800","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"429022076343554048"}],"in_reply_to_user_id":"22255878","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @INFARMED_IP: Notification and validation of the treatment of chronic hepatitis C http://t.co/lw98tM2oyf","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/lw98tM2oyf","expanded_url":"http://bit.ly/LsNWV2","display_url":"bit.ly/LsNWV2"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2014-01-30T16:18:07.000Z","conversation_id":"428925100986212354","possibly_sensitive":false,"lang":"en","id":"428925100986212354","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We've published the meeting minutes from all our scientific committees, including #CHMP, for the first time: http://t.co/2Dsjgi2xhH","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/2Dsjgi2xhH","expanded_url":"http://bit.ly/L5U0SH","display_url":"bit.ly/L5U0SH"}],"hashtags":[{"start":82,"end":87,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2014-01-29T10:54:38.000Z","conversation_id":"428481304682700800","possibly_sensitive":false,"lang":"en","id":"428481304682700800","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"@louis_ide We're awaiting responses to our outstanding issues now; recommendation to the CMDh expected in March: http://t.co/fbKo4AMP7U","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/fbKo4AMP7U","expanded_url":"http://bit.ly/15sIeYB","display_url":"bit.ly/15sIeYB"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":[{"start":89,"end":92,"probability":0.2901,"type":"Person","normalized_text":"CMDh"}]},"created_at":"2014-01-28T09:22:57.000Z","conversation_id":"428095843179065344","possibly_sensitive":false,"lang":"en","id":"428095843179065344","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Last Friday we published the CHMP meeting highlights: http://t.co/BzN9YLSAAu","entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/BzN9YLSAAu","expanded_url":"http://bit.ly/KPtsVt","display_url":"bit.ly/KPtsVt"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2014-01-28T08:55:30.000Z","conversation_id":"428088936766771200","possibly_sensitive":false,"lang":"en","id":"428088936766771200","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've started a review of emergency #contraceptives: http://t.co/6FJ0akVFp1","entities":{"urls":[{"start":53,"end":75,"url":"http://t.co/6FJ0akVFp1","expanded_url":"http://bit.ly/LPQqN8","display_url":"bit.ly/LPQqN8"}],"hashtags":[{"start":36,"end":51,"tag":"contraceptives"}],"mentions":{},"annotations":{}},"created_at":"2014-01-24T12:22:11.000Z","conversation_id":"426691399715946497","possibly_sensitive":false,"lang":"en","id":"426691399715946497","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @igznl: The Netherlands refuses Ranbaxy raw materials for medicinal products #IGZ\nhttp://t.co/2JCCWkzxRy","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/2JCCWkzxRy","expanded_url":"http://bit.ly/1itiRP8","display_url":"bit.ly/1itiRP8"}],"hashtags":[{"start":80,"end":84,"tag":"IGZ"}],"mentions":[{"start":3,"end":9,"username":"Igznl","id":"1601603352"}],"annotations":[{"start":15,"end":25,"probability":0.8397,"type":"Place","normalized_text":"Netherlands"}]},"created_at":"2014-01-24T11:43:51.000Z","conversation_id":"426681749369024512","possibly_sensitive":false,"lang":"en","id":"426681749369024512","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@thedanalyst We were referring to the December minutes. Minutes are adopted during the following month's meeting and published afterwards.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"annotations":{}},"created_at":"2014-01-22T17:46:55.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","id":"426048345074049024","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"426046517380513794"}],"in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@thedanalyst We will be publishing the minutes after this week's meeting where they are being adopted, on this page: http://t.co/tgGL9p4r9N","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/tgGL9p4r9N","expanded_url":"http://bit.ly/1eSRmZC","display_url":"bit.ly/1eSRmZC"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"annotations":{}},"created_at":"2014-01-22T17:37:01.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","id":"426045852231426048","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"426044437924298752"}],"in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@thedanalyst It will be included in the minutes from the meeting.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"annotations":{}},"created_at":"2014-01-22T09:43:49.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","id":"425926768411697152","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425691010442596352"}],"in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @GCessak: Presentation from press conference - Safe Drugs \"Dissemination of information from the Safety Committee\" http://t.co/jfJGXOltgy","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/jfJGXOltgy","expanded_url":"http://bit.ly/1f5FYMs","display_url":"bit.ly/1f5FYMs"}],"hashtags":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"annotations":[{"start":100,"end":115,"probability":0.5131,"type":"Organization","normalized_text":"Safety Committee"}]},"created_at":"2014-01-22T10:05:32.000Z","conversation_id":"425932234604814337","possibly_sensitive":false,"lang":"en","id":"425932234604814337","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@thedanalyst Not necessarily, it depends on whether CHMP has more questions that the company needs to answer.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"thedanalyst","id":"614450788"}],"annotations":{}},"created_at":"2014-01-21T17:43:59.000Z","conversation_id":"425673392335773697","possibly_sensitive":false,"lang":"en","id":"425685220067921920","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425673392335773697"}],"in_reply_to_user_id":"614450788","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@KaiGriebenow @dsobek @Masdeutaff 17-20 Feb 2014. See our calendar for all forthcoming dates: http://t.co/11nNPPeBxP","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/11nNPPeBxP","expanded_url":"http://bit.ly/LO8I1U","display_url":"bit.ly/LO8I1U"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"KaiGriebenow","id":"423776545"},{"start":14,"end":21,"username":"dsobek","id":"243801041"},{"start":22,"end":33,"username":"Masdeutaff","id":"597154294"}],"annotations":{}},"created_at":"2014-01-21T16:41:09.000Z","conversation_id":"425666668686090240","possibly_sensitive":false,"lang":"en","id":"425669403863433216","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425668560501751808"}],"in_reply_to_user_id":"423776545","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Masdeutaff It will be discussed, with an oral explanation by the applicant, but it is not expected to go for opinion this week.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":11,"username":"Masdeutaff","id":"597154294"}],"annotations":{}},"created_at":"2014-01-21T15:58:07.000Z","conversation_id":"425655211177574400","possibly_sensitive":false,"lang":"en","id":"425658574606729216","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425655211177574400"}],"in_reply_to_user_id":"597154294","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"This year's @EMA_News / @IFAHEurope info day is on 13-14 March 2014 in London. Register now: http://t.co/PCGafNo5sr","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/PCGafNo5sr","expanded_url":"http://bit.ly/1mkyhm1","display_url":"bit.ly/1mkyhm1"}],"hashtags":{},"mentions":[{"start":12,"end":21,"username":"EMA_News","id":"116716199"}],"annotations":[{"start":71,"end":76,"probability":0.9945,"type":"Place","normalized_text":"London"}]},"created_at":"2014-01-21T09:53:11.000Z","conversation_id":"425566738093076480","possibly_sensitive":false,"lang":"en","id":"425566738093076480","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Wolf_S_Punk We have not published an EPAR on Lariam because it is authorised at national level, and not centrally at European Union level.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"annotations":[{"start":46,"end":51,"probability":0.3707,"type":"Organization","normalized_text":"Lariam"}]},"created_at":"2014-01-20T15:40:00.000Z","conversation_id":"425287357923721216","possibly_sensitive":false,"lang":"en","id":"425291626890539008","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425287357923721216"}],"in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Wolf_S_Punk All documents mentioning mefloquine are listed in the search results here: http://t.co/tSRpVODW4a","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/tSRpVODW4a","expanded_url":"http://bit.ly/1e5UEKk","display_url":"bit.ly/1e5UEKk"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"annotations":{}},"created_at":"2014-01-20T16:26:45.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","id":"425303392982798336","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":4,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425302255202340865"}],"in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Wolf_S_Punk Please forward your precise request to us at http://t.co/rMxJXKOpHn so that we can investigate and reply to you in full.","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"annotations":{}},"created_at":"2014-01-20T16:09:05.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","id":"425298945850347520","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425298339249135616"}],"in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Wolf_S_Punk To get a more detailed answer, please send your questions and requests for documents to us at http://t.co/rMxJXKOpHn.","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"annotations":{}},"created_at":"2014-01-20T15:49:31.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","id":"425294022588895232","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425293604198686720"}],"in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Wolf_S_Punk Mefloquine has not been referred to us, but our #pharmacovigilance committee is looking into a signal: http://t.co/vwyRLJn4cW","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/vwyRLJn4cW","expanded_url":"http://bit.ly/1aE7m2w","display_url":"bit.ly/1aE7m2w"}],"hashtags":[{"start":61,"end":79,"tag":"pharmacovigilance"}],"mentions":[{"start":0,"end":12,"username":"Wolf_S_Punk","id":"1171771501"}],"annotations":[{"start":13,"end":22,"probability":0.5122,"type":"Person","normalized_text":"Mefloquine"}]},"created_at":"2014-01-20T15:38:41.000Z","conversation_id":"425288995694592001","possibly_sensitive":false,"lang":"en","id":"425291295620206592","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"425288995694592001"}],"in_reply_to_user_id":"1171771501","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Levetiracetam Hospira, a #generic of #Keppra to treat #epilepsy: http://t.co/SI2Os2FXlp","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/SI2Os2FXlp","expanded_url":"http://bit.ly/1e4EosY","display_url":"bit.ly/1e4EosY"}],"hashtags":[{"start":42,"end":56,"tag":"Levetiracetam"},{"start":68,"end":76,"tag":"generic"},{"start":80,"end":87,"tag":"Keppra"},{"start":97,"end":106,"tag":"epilepsy"}],"mentions":{},"annotations":{}},"created_at":"2014-01-20T14:37:29.000Z","conversation_id":"425275897512755200","possibly_sensitive":false,"lang":"en","id":"425275897512755200","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":3,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Last year we recommended 81 human #medicines for marketing authorisation, including 38 with new active substances: http://t.co/lxsIdWInwa","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/lxsIdWInwa","expanded_url":"http://bit.ly/1jhnSKI","display_url":"bit.ly/1jhnSKI"}],"hashtags":[{"start":34,"end":44,"tag":"medicines"}],"mentions":{},"annotations":{}},"created_at":"2014-01-20T11:33:31.000Z","conversation_id":"425229600256696320","possibly_sensitive":false,"lang":"en","id":"425229600256696320","author_id":"116716199","public_metrics":{"retweet_count":18,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Our human medicines committee, #CHMP, is meeting next week. Highlights out next Friday: http://t.co/WKYQ9BIxPn","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/WKYQ9BIxPn","expanded_url":"http://bit.ly/1dAXr0q","display_url":"bit.ly/1dAXr0q"}],"hashtags":[{"start":31,"end":36,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2014-01-17T09:31:13.000Z","conversation_id":"424111658752278528","possibly_sensitive":false,"lang":"en","id":"424111658752278528","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@tomayates We will publish full details about the authorisation and its conditions after the @EU_Commission grants marketing authorisation.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":10,"username":"tomayates","id":"261643662"},{"start":93,"end":107,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2014-01-16T17:12:31.000Z","conversation_id":"420439570862206976","possibly_sensitive":false,"lang":"en","id":"423865361906143232","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"420439570862206976"}],"in_reply_to_user_id":"261643662","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Apply for our 2014 traineeship programme. Details and application form on our website: http://t.co/hEODiqQZxd","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/hEODiqQZxd","expanded_url":"http://bit.ly/Uc0JfN","display_url":"bit.ly/Uc0JfN"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2014-01-10T14:25:03.000Z","conversation_id":"421648886475005953","possibly_sensitive":false,"lang":"en","id":"421648886475005953","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":2,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@RK_PassingCloud Please discuss in detail with the treating doctor who may refer you to a suitable trial: http://t.co/Bg628FXr4V","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/Bg628FXr4V","expanded_url":"http://bit.ly/1bKgEpO","display_url":"bit.ly/1bKgEpO"}],"hashtags":{},"mentions":[{"start":0,"end":16,"username":"RK_PassingCloud","id":"16842175"}],"annotations":{}},"created_at":"2014-01-06T10:42:05.000Z","conversation_id":"419170307492954112","possibly_sensitive":false,"lang":"en","id":"420143226566098944","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"420135742090657793"}],"in_reply_to_user_id":"16842175","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@RK_PassingCloud Please contact the sponsor for information. Check our site re. our role: http://t.co/c21zUA82wL http://t.co/Z7GrvbXFM6","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/c21zUA82wL","expanded_url":"http://bit.ly/1g6iA01","display_url":"bit.ly/1g6iA01"},{"start":113,"end":135,"url":"http://t.co/Z7GrvbXFM6","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"hashtags":{},"mentions":[{"start":0,"end":16,"username":"RK_PassingCloud","id":"16842175"}],"annotations":{}},"created_at":"2014-01-06T09:32:01.000Z","conversation_id":"419170307492954112","possibly_sensitive":false,"lang":"en","id":"420125593150042112","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"419170307492954112"}],"in_reply_to_user_id":"16842175","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Kadcyla (#trastuzumab emtansine) for #breastcancer: http://t.co/eQKvCsvRtV","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/eQKvCsvRtV","expanded_url":"http://bit.ly/1jpyZCo","display_url":"bit.ly/1jpyZCo"}],"hashtags":[{"start":42,"end":50,"tag":"Kadcyla"},{"start":52,"end":64,"tag":"trastuzumab"},{"start":80,"end":93,"tag":"breastcancer"}],"mentions":{},"annotations":{}},"created_at":"2013-12-20T15:32:57.000Z","conversation_id":"414055830460583936","possibly_sensitive":false,"lang":"en","id":"414055830460583936","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"A few days left to comment on our draft concept paper on revising guidance on manufacture of finished dosage form: http://t.co/5lXkR8yTgH","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/5lXkR8yTgH","expanded_url":"http://bit.ly/18Wdi2W","display_url":"bit.ly/18Wdi2W"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-12-20T12:07:01.000Z","conversation_id":"414004005950353408","possibly_sensitive":false,"lang":"en","id":"414004005950353408","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We launched a generic medicines application inspections initiative with the @US_FDA: http://t.co/dbZaxm220P","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/dbZaxm220P","expanded_url":"http://bit.ly/19cEIqS","display_url":"bit.ly/19cEIqS"}],"hashtags":{},"mentions":[{"start":76,"end":83,"username":"US_FDA","id":"208120290"}],"annotations":{}},"created_at":"2013-12-19T11:04:33.000Z","conversation_id":"413625897808179200","possibly_sensitive":false,"lang":"en","id":"413625897808179200","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Statements of non-compliance with good manufacturing practice (#GMP) are now publicly available on #EudraGMDP: http://t.co/DMg2SNPdNc","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/DMg2SNPdNc","expanded_url":"http://bit.ly/1fmIjB1","display_url":"bit.ly/1fmIjB1"}],"hashtags":[{"start":63,"end":67,"tag":"GMP"},{"start":99,"end":109,"tag":"EudraGMDP"}],"mentions":{},"annotations":{}},"created_at":"2013-12-18T14:52:38.000Z","conversation_id":"413320907516805121","possibly_sensitive":false,"lang":"en","id":"413320907516805121","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're looking to recruit a Head of #Communication Department. Apply by 29 January 2014: http://t.co/zxqfSWRmuj #vacancy #recruitment","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/zxqfSWRmuj","expanded_url":"http://bit.ly/1dmcW8j","display_url":"bit.ly/1dmcW8j"}],"hashtags":[{"start":35,"end":49,"tag":"Communication"},{"start":111,"end":119,"tag":"vacancy"},{"start":120,"end":132,"tag":"recruitment"}],"mentions":{},"annotations":{}},"created_at":"2013-12-18T11:15:49.000Z","conversation_id":"413266343551827968","possibly_sensitive":false,"lang":"en","id":"413266343551827968","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @INFARMED_IP: Voluntary recall of batches of the drug sodium chloride 0.9% Viaflo 9 mg/ml, solution for infusion\nhttp://t.co/lWifgHUnAO","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/lWifgHUnAO","expanded_url":"http://bit.ly/18yrMev","display_url":"bit.ly/18yrMev"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2013-12-18T11:37:43.000Z","conversation_id":"413271855496060928","possibly_sensitive":false,"lang":"en","id":"413271855496060928","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@FinansciCenk However, we do not include the outcomes in our 'highlights' press release on the Friday after the CHMP meeting.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"annotations":{}},"created_at":"2013-12-18T11:23:39.000Z","conversation_id":"413248888129081344","possibly_sensitive":false,"lang":"en","id":"413268315616718848","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"413268133458087936"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@FinansciCenk New routes of administration (= line extensions) to be discussed at the meeting are in the agenda, yes:http://t.co/vvjHnoel2U","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/vvjHnoel2U","expanded_url":"http://bit.ly/1bckwQ9","display_url":"bit.ly/1bckwQ9"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"FinansciCenk","id":"362772214"}],"annotations":{}},"created_at":"2013-12-18T11:22:55.000Z","conversation_id":"413248888129081344","possibly_sensitive":false,"lang":"en","id":"413268133458087936","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"413248888129081344"}],"in_reply_to_user_id":"362772214","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@louis_ide We are reviewing the benefits and the risks thoroughly. Any concerns in the meantime, please speak to your doctor or pharmacist.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":{}},"created_at":"2013-12-16T17:47:04.000Z","conversation_id":"412615439596781568","possibly_sensitive":false,"lang":"en","id":"412640030633385984","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"412621529583599616"}],"in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@louis_ide Some issues remain outstanding; recommendation from #pharmacovigilance committee now expected in March: http://t.co/fbKo4AMP7U","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/fbKo4AMP7U","expanded_url":"http://bit.ly/15sIeYB","display_url":"bit.ly/15sIeYB"}],"hashtags":[{"start":63,"end":81,"tag":"pharmacovigilance"}],"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":{}},"created_at":"2013-12-16T16:28:14.000Z","conversation_id":"412615439596781568","possibly_sensitive":false,"lang":"en","id":"412620192955383808","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"412618955539238913"}],"in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: Message to healthcare professionals on severe skin reactions after using the medicine Xeloda¬Æ \nhttp://t.co/zF2VjtG0Jt","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/zF2VjtG0Jt","expanded_url":"http://bit.ly/1bKIN31","display_url":"bit.ly/1bKIN31"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2013-12-16T16:09:21.000Z","conversation_id":"412615439596781568","possibly_sensitive":false,"lang":"en","id":"412615439596781568","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Our human medicine committee, #CHMP is meeting next week. We're publishing the highlights on Friday: http://t.co/GE7mdAWXzz","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/GE7mdAWXzz","expanded_url":"http://bit.ly/19lLTel","display_url":"bit.ly/19lLTel"}],"hashtags":[{"start":30,"end":35,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2013-12-13T09:12:24.000Z","conversation_id":"411423347470524416","possibly_sensitive":false,"lang":"en","id":"411423347470524416","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @LV_MPA: Monthly report from the CHMP (November 2013) http://t.co/IoR8EMKrwB","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/IoR8EMKrwB","expanded_url":"http://bit.ly/1ffBKkg","display_url":"bit.ly/1ffBKkg"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"created_at":"2013-12-10T09:37:59.000Z","conversation_id":"410342623254024192","possibly_sensitive":false,"lang":"en","id":"410342623254024192","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @INFARMED_IP: New requirements for notification of withdrawal of medicines http://t.co/Hv5TSJXgGS","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/Hv5TSJXgGS","expanded_url":"http://bit.ly/Iwj1pr","display_url":"bit.ly/Iwj1pr"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2013-12-06T16:53:47.000Z","conversation_id":"409002743143997440","possibly_sensitive":false,"lang":"en","id":"409002743143997440","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're providing enhanced fee-reduction rates for companies developing #orphan medicines in 2014: http://t.co/noAje7cQxJ","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/noAje7cQxJ","expanded_url":"http://bit.ly/1hv98H5","display_url":"bit.ly/1hv98H5"}],"hashtags":[{"start":70,"end":77,"tag":"orphan"}],"mentions":{},"annotations":{}},"created_at":"2013-12-03T10:44:14.000Z","conversation_id":"407822577571491840","possibly_sensitive":false,"lang":"en","id":"407822577571491840","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"It's World #AIDS Day on 1 December. Read about our activities in the area of medicines for #HIV: http://t.co/zUUzoLZvRr","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/zUUzoLZvRr","expanded_url":"http://bit.ly/1iWdAhb","display_url":"bit.ly/1iWdAhb"}],"hashtags":[{"start":11,"end":16,"tag":"AIDS"},{"start":91,"end":95,"tag":"HIV"}],"mentions":{},"annotations":{}},"created_at":"2013-11-28T17:01:21.000Z","conversation_id":"406105545859284992","possibly_sensitive":false,"lang":"en","id":"406105545859284992","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: How to report side effects #sideeffects http://t.co/L7qkUzN0RO","entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/L7qkUzN0RO","expanded_url":"http://bit.ly/17TisiL","display_url":"bit.ly/17TisiL"}],"hashtags":[{"start":42,"end":54,"tag":"sideeffects"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2013-11-27T09:32:48.000Z","conversation_id":"405630274286780416","possibly_sensitive":false,"lang":"en","id":"405630274286780416","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We recommended approval of #sofosbuvir for the treatment of chronic #hepatitis C: http://t.co/D8cMLabt1c","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/D8cMLabt1c","expanded_url":"http://bit.ly/1bIip72","display_url":"bit.ly/1bIip72"}],"hashtags":[{"start":27,"end":38,"tag":"sofosbuvir"},{"start":68,"end":78,"tag":"hepatitis"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T11:00:17.000Z","conversation_id":"404927514843152384","possibly_sensitive":false,"lang":"en","id":"404927514843152384","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We advised on compassionate use of #daclatasvir: http://t.co/1Lqp35yNgG","entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/1Lqp35yNgG","expanded_url":"http://bit.ly/17yT6q0","display_url":"bit.ly/17yT6q0"}],"hashtags":[{"start":35,"end":47,"tag":"daclatasvir"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T11:00:52.000Z","conversation_id":"404927660783988736","possibly_sensitive":false,"lang":"en","id":"404927660783988736","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We recommended two new treatment options for #tuberculosis: http://t.co/6GdMNc4PWF","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/6GdMNc4PWF","expanded_url":"http://bit.ly/1i1ALJf","display_url":"bit.ly/1i1ALJf"}],"hashtags":[{"start":45,"end":58,"tag":"tuberculosis"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T11:02:07.000Z","conversation_id":"404927978422800384","possibly_sensitive":false,"lang":"en","id":"404927978422800384","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We recommended approval of new #HIV medicine: http://t.co/SdNvISL7B7","entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/SdNvISL7B7","expanded_url":"http://bit.ly/1emapMW","display_url":"bit.ly/1emapMW"}],"hashtags":[{"start":31,"end":35,"tag":"HIV"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T11:03:21.000Z","conversation_id":"404928286175674368","possibly_sensitive":false,"lang":"en","id":"404928286175674368","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We recommended extending use of #Abraxane to include treatment of #pancreatic #cancer: http://t.co/ouON7w6FJn","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/ouON7w6FJn","expanded_url":"http://bit.ly/1i1AYfp","display_url":"bit.ly/1i1AYfp"}],"hashtags":[{"start":32,"end":41,"tag":"Abraxane"},{"start":66,"end":77,"tag":"pancreatic"},{"start":78,"end":85,"tag":"cancer"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T11:04:08.000Z","conversation_id":"404928483668668416","possibly_sensitive":false,"lang":"en","id":"404928483668668416","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Benefits of combined hormonal #contraceptives continue to outweigh risks: http://t.co/7tcQRaJck3","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/7tcQRaJck3","expanded_url":"http://bit.ly/17THqeA","display_url":"bit.ly/17THqeA"}],"hashtags":[{"start":30,"end":45,"tag":"contraceptives"}],"mentions":{},"annotations":{}},"created_at":"2013-11-25T10:54:55.000Z","conversation_id":"404926163421630464","possibly_sensitive":false,"lang":"en","id":"404926163421630464","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the CHMP meeting highlights: http://t.co/GjnqCdtG7k","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/GjnqCdtG7k","expanded_url":"http://bit.ly/1fqSKGT","display_url":"bit.ly/1fqSKGT"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-11-22T13:49:23.000Z","conversation_id":"403882908366417920","possibly_sensitive":false,"lang":"en","id":"403882908366417920","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Benefits of combined hormonal #contraceptives continue to outweigh risks: http://t.co/n3K4MBRpnC","entities":{"urls":[{"start":74,"end":96,"url":"http://t.co/n3K4MBRpnC","expanded_url":"http://bit.ly/17THqeA","display_url":"bit.ly/17THqeA"}],"hashtags":[{"start":30,"end":45,"tag":"contraceptives"}],"mentions":{},"annotations":{}},"created_at":"2013-11-22T12:20:17.000Z","conversation_id":"403860484606418944","possibly_sensitive":false,"lang":"en","id":"403860484606418944","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One more week to comment on our draft guideline for #veterinary medicines containing #antimicrobial substances: http://t.co/0TNrxR4BIK","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/0TNrxR4BIK","expanded_url":"http://bit.ly/1hRrYJO","display_url":"bit.ly/1hRrYJO"}],"hashtags":[{"start":52,"end":63,"tag":"veterinary"},{"start":85,"end":99,"tag":"antimicrobial"}],"mentions":{},"annotations":{}},"created_at":"2013-11-22T09:13:44.000Z","conversation_id":"403813536201068544","possibly_sensitive":false,"lang":"en","id":"403813536201068544","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We finalised review of medicines concerned by Roche pharmacovigilance inspection: http://t.co/af5AuucTZq","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/af5AuucTZq","expanded_url":"http://bit.ly/1aOLRHy","display_url":"bit.ly/1aOLRHy"}],"hashtags":{},"mentions":{},"annotations":[{"start":46,"end":50,"probability":0.4128,"type":"Person","normalized_text":"Roche"}]},"created_at":"2013-11-20T10:40:59.000Z","conversation_id":"403110718049771521","possibly_sensitive":false,"lang":"en","id":"403110718049771521","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've agreed a joint work plan with @EUnetHTA: http://t.co/pA9fAlJQTx","entities":{"urls":[{"start":47,"end":69,"url":"http://t.co/pA9fAlJQTx","expanded_url":"http://bit.ly/1aOAM9m","display_url":"bit.ly/1aOAM9m"}],"hashtags":{},"mentions":[{"start":36,"end":45,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"created_at":"2013-11-19T10:04:55.000Z","conversation_id":"402739254440513536","possibly_sensitive":false,"lang":"en","id":"402739254440513536","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Article co-authored by senior EMA staff states that excessive risk aversion not in best interest of public health: http://t.co/BteCcdG2L4","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/BteCcdG2L4","expanded_url":"http://bit.ly/1atRfTM","display_url":"bit.ly/1atRfTM"}],"hashtags":{},"mentions":{},"annotations":[{"start":30,"end":32,"probability":0.6403,"type":"Organization","normalized_text":"EMA"}]},"created_at":"2013-11-18T10:53:06.000Z","conversation_id":"402388994295472128","possibly_sensitive":false,"lang":"en","id":"402388994295472128","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"New article on the risks of risk aversion in drug #regulation, co-authored by senior EMA staff and committee members: http://t.co/9bqYDKK8r9","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/9bqYDKK8r9","expanded_url":"http://bit.ly/1atRfTM","display_url":"bit.ly/1atRfTM"}],"hashtags":[{"start":50,"end":61,"tag":"regulation"}],"mentions":{},"annotations":[{"start":85,"end":87,"probability":0.6983,"type":"Organization","normalized_text":"EMA"}]},"created_at":"2013-11-15T11:44:15.000Z","conversation_id":"401314703114522624","possibly_sensitive":false,"lang":"en","id":"401314703114522624","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":3,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published 16 product-specific guidance documents on demonstrating #bioequivalence, open for consultation: http://t.co/LFE1dwRYqR","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/LFE1dwRYqR","expanded_url":"http://bit.ly/1ifPXQq","display_url":"bit.ly/1ifPXQq"}],"hashtags":[{"start":72,"end":87,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"created_at":"2013-11-15T14:21:38.000Z","conversation_id":"401354309168013312","possibly_sensitive":false,"lang":"en","id":"401354309168013312","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Registration is open for the annual EMA review of the year and outlook for 2014, on 28-29 November in London: http://t.co/WjECFTKOn2","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/WjECFTKOn2","expanded_url":"http://bit.ly/1e5fCbX","display_url":"bit.ly/1e5fCbX"}],"hashtags":{},"mentions":{},"annotations":[{"start":102,"end":107,"probability":0.9926,"type":"Place","normalized_text":"London"}]},"created_at":"2013-11-14T16:40:35.000Z","conversation_id":"401026888480460800","possibly_sensitive":false,"lang":"en","id":"401026888480460800","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"The annual EMA review of the year and outlook for 2014 takes place on 28-29 November in London: http://t.co/FToe2jiGg2","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/FToe2jiGg2","expanded_url":"http://bit.ly/1e5fCbX","display_url":"bit.ly/1e5fCbX"}],"hashtags":{},"mentions":{},"annotations":[{"start":88,"end":93,"probability":0.9918,"type":"Place","normalized_text":"London"}]},"created_at":"2013-11-14T11:21:00.000Z","conversation_id":"400946463574069248","possibly_sensitive":false,"lang":"en","id":"400946463574069248","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We've provided an update on our policy on the publication of clinical-trial data http://t.co/pVZWUx4ubB #ctdata","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/pVZWUx4ubB","expanded_url":"http://bit.ly/18ra6LY","display_url":"bit.ly/18ra6LY"}],"hashtags":[{"start":104,"end":111,"tag":"ctdata"}],"mentions":{},"annotations":{}},"created_at":"2013-11-13T10:22:46.000Z","conversation_id":"400569418544971776","possibly_sensitive":false,"lang":"en","id":"400569418544971776","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @Aifa_ufficiale: All information on #medicines just a click away. We present the Medicines Databank #AIFA http://t.co/TaIIxlHZo1","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/TaIIxlHZo1","expanded_url":"http://bit.ly/1gJghTN","display_url":"bit.ly/1gJghTN"}],"hashtags":[{"start":39,"end":49,"tag":"medicines"},{"start":103,"end":108,"tag":"AIFA"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"annotations":{}},"created_at":"2013-11-13T12:21:59.000Z","conversation_id":"400599420137259008","possibly_sensitive":false,"lang":"en","id":"400599420137259008","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@ScripRegMaureen We will provide an update following our next Management Board meeting on 11-12 December at the latest.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":16,"username":"ScripRegMaureen","id":"552617924"}],"annotations":{}},"created_at":"2013-11-13T10:41:03.000Z","conversation_id":"400572507893161984","possibly_sensitive":false,"lang":"en","id":"400574018836656128","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"400572507893161984"}],"in_reply_to_user_id":"552617924","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC recommends suspension of #diacerein-containing medicines: http://t.co/vLptpM8Fnu","entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/vLptpM8Fnu","expanded_url":"http://bit.ly/HCA0Wn","display_url":"bit.ly/HCA0Wn"}],"hashtags":[{"start":30,"end":40,"tag":"diacerein"}],"mentions":{},"annotations":{}},"created_at":"2013-11-08T12:26:33.000Z","conversation_id":"398788629373661184","possibly_sensitive":false,"lang":"en","id":"398788629373661184","author_id":"116716199","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Remember the EMA website will be unavailable from 09:00 to 18:00 tomorrow Sat 9 Nov due to maintenance: http://t.co/b0a7p9EaWx","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/b0a7p9EaWx","expanded_url":"http://bit.ly/17RiKXB","display_url":"bit.ly/17RiKXB"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-11-08T15:59:51.000Z","conversation_id":"398842309665517568","possibly_sensitive":false,"lang":"en","id":"398842309665517568","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @FDA_Drug_Info: #FDA asks the manufacturer #Iclusig (ponatinib) for leukaemia to suspend marketing and sale http://t.co/ffwgAvC14t","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/ffwgAvC14t","expanded_url":"http://bit.ly/HqEgYP","display_url":"bit.ly/HqEgYP"}],"hashtags":[{"start":19,"end":23,"tag":"FDA"},{"start":46,"end":54,"tag":"Iclusig"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"annotations":{}},"created_at":"2013-11-04T13:18:06.000Z","conversation_id":"397352051811692545","possibly_sensitive":false,"lang":"en","id":"397352051811692545","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One day left to comment on need to revise condition‚Äìspecific guidance on the evaluation of anti-#cancer medicines: http://t.co/5dbmJU4yMi","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/5dbmJU4yMi","expanded_url":"http://bit.ly/1etgd7d","display_url":"bit.ly/1etgd7d"}],"hashtags":[{"start":96,"end":103,"tag":"cancer"}],"mentions":{},"annotations":{}},"created_at":"2013-10-30T12:06:20.000Z","conversation_id":"395522053295443968","possibly_sensitive":false,"lang":"en","id":"395522053295443968","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @HAIEurope: Policy Paper: 'Protecting Citizens' Health: Transparency of #ClinicalTrials Data in the EU' http://t.co/pNKBNLcjAi #ctdata","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/pNKBNLcjAi","expanded_url":"http://bit.ly/1a9Xrga","display_url":"bit.ly/1a9Xrga"}],"hashtags":[{"start":75,"end":90,"tag":"ClinicalTrials"},{"start":130,"end":137,"tag":"ctdata"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"created_at":"2013-10-30T10:04:03.000Z","conversation_id":"395491279347261440","possibly_sensitive":false,"lang":"en","id":"395491279347261440","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published a report of our workshop on further involving patients in the benefit-risk assessment of #medicines: http://t.co/QuNgugyuVY","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/QuNgugyuVY","expanded_url":"http://bit.ly/18yrVaY","display_url":"bit.ly/18yrVaY"}],"hashtags":[{"start":105,"end":115,"tag":"medicines"}],"mentions":{},"annotations":{}},"created_at":"2013-10-29T14:39:40.000Z","conversation_id":"395198251882008577","possibly_sensitive":false,"lang":"en","id":"395198251882008577","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Batches of the #insulin medicine #NovoMix 30 #FlexPen and #Penfill to be recalled: http://t.co/yorxjZ6UK6","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/yorxjZ6UK6","expanded_url":"http://bit.ly/1a4G3cK","display_url":"bit.ly/1a4G3cK"}],"hashtags":[{"start":15,"end":23,"tag":"insulin"},{"start":33,"end":41,"tag":"NovoMix"},{"start":45,"end":53,"tag":"FlexPen"},{"start":58,"end":66,"tag":"Penfill"}],"mentions":{},"annotations":{}},"created_at":"2013-10-28T11:31:51.000Z","conversation_id":"394788597666029568","possibly_sensitive":false,"lang":"en","id":"394788597666029568","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the CHMP meeting highlights: October 2013 http://t.co/PJfiwMbFCe","entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/PJfiwMbFCe","expanded_url":"http://bit.ly/168zqJ5","display_url":"bit.ly/168zqJ5"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-25T12:24:44.000Z","conversation_id":"393714745758732289","possibly_sensitive":false,"lang":"en","id":"393714745758732289","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Batches of the #insulin medicine #NovoMix 30 #FlexPen and #Penfill to be recalled: http://t.co/bs9xeVastf","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/bs9xeVastf","expanded_url":"http://bit.ly/1a4G3cK","display_url":"bit.ly/1a4G3cK"}],"hashtags":[{"start":15,"end":23,"tag":"insulin"},{"start":33,"end":41,"tag":"NovoMix"},{"start":45,"end":53,"tag":"FlexPen"},{"start":58,"end":66,"tag":"Penfill"}],"mentions":{},"annotations":{}},"created_at":"2013-10-25T11:32:33.000Z","conversation_id":"393701613736833024","possibly_sensitive":false,"lang":"en","id":"393701613736833024","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One week left to comment on our guideline on the use of #phthalates as excipients in human medicines: http://t.co/slqCKReqR4","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/slqCKReqR4","expanded_url":"http://bit.ly/174dVvR","display_url":"bit.ly/174dVvR"}],"hashtags":[{"start":56,"end":67,"tag":"phthalates"}],"mentions":{},"annotations":{}},"created_at":"2013-10-24T11:25:17.000Z","conversation_id":"393337393517821953","possibly_sensitive":false,"lang":"en","id":"393337393517821953","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One week left to comment on our reflection paper on the use of #parabens as excipients in oral human medicines: http://t.co/X7nXdWRWMD","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/X7nXdWRWMD","expanded_url":"http://bit.ly/15KxJkS","display_url":"bit.ly/15KxJkS"}],"hashtags":[{"start":63,"end":72,"tag":"parabens"}],"mentions":{},"annotations":{}},"created_at":"2013-10-24T11:25:44.000Z","conversation_id":"393337506659176449","possibly_sensitive":false,"lang":"en","id":"393337506659176449","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One week left to comment on our guideline on similar biological medicinal products (#biosimilars): http://t.co/eP6eLuld9g","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/eP6eLuld9g","expanded_url":"http://bit.ly/1etg4k0","display_url":"bit.ly/1etg4k0"}],"hashtags":[{"start":84,"end":96,"tag":"biosimilars"}],"mentions":{},"annotations":{}},"created_at":"2013-10-24T11:26:19.000Z","conversation_id":"393337653833134080","possibly_sensitive":false,"lang":"en","id":"393337653833134080","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"What does the #blacktriangle mean? Find out about additional monitoring of medicines by watching our video: http://t.co/ZzDNIqm0Nk","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":14,"end":28,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-22T08:21:32.000Z","conversation_id":"392566375182368768","possibly_sensitive":false,"lang":"en","id":"392566375182368768","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @HAIEurope: Paper supports #clinicaltrials data disclosure benefits for R&amp;D, efficiency &amp; #transparency  http://t.co/WwlcnrDgxQ #ctdata","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/WwlcnrDgxQ","expanded_url":"http://bit.ly/18FtKak","display_url":"bit.ly/18FtKak"}],"hashtags":[{"start":30,"end":45,"tag":"clinicaltrials"},{"start":101,"end":114,"tag":"transparency"},{"start":139,"end":146,"tag":"ctdata"}],"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"}],"annotations":{}},"created_at":"2013-10-22T09:12:11.000Z","conversation_id":"392579123450638336","possibly_sensitive":false,"lang":"en","id":"392579123450638336","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @INFARMED_IP: Voluntary recall of batches of the medicine Captopril Zentiva http://t.co/sZZXn84JjE","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/sZZXn84JjE","expanded_url":"http://bit.ly/1i1qnvC","display_url":"bit.ly/1i1qnvC"}],"hashtags":{},"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"annotations":{}},"created_at":"2013-10-18T10:47:18.000Z","conversation_id":"391153508210049024","possibly_sensitive":false,"lang":"en","id":"391153508210049024","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @AEMPSGOB: Intravenous hydroxyethyl starch: use restrictions http://t.co/QBzIFavx4w","entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/QBzIFavx4w","expanded_url":"http://bit.ly/17tO1Mu","display_url":"bit.ly/17tO1Mu"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"created_at":"2013-10-16T15:37:01.000Z","conversation_id":"390501644112101376","possibly_sensitive":false,"lang":"en","id":"390501644112101376","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Giotrif (#afatinib) for non-small-cell #lung #cancer: http://t.co/fjqifNmn4W","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/fjqifNmn4W","expanded_url":"http://bit.ly/1fCB0bA","display_url":"bit.ly/1fCB0bA"}],"hashtags":[{"start":42,"end":50,"tag":"Giotrif"},{"start":52,"end":61,"tag":"afatinib"},{"start":82,"end":87,"tag":"lung"},{"start":88,"end":95,"tag":"cancer"}],"mentions":{},"annotations":{}},"created_at":"2013-10-16T14:16:04.000Z","conversation_id":"390481272726102017","possibly_sensitive":false,"lang":"en","id":"390481272726102017","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our latest report on sales of veterinary antimicrobials is now available, covering 25 EU/EEA countries in 2011: http://t.co/BKkWEkwCOM","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/BKkWEkwCOM","expanded_url":"http://bit.ly/GPunDM","display_url":"bit.ly/GPunDM"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-16T08:42:03.000Z","conversation_id":"390397214305972226","possibly_sensitive":false,"lang":"en","id":"390397214305972226","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@cancereu We'll pass the message on.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":9,"username":"cancereu","id":"140344419"}],"annotations":{}},"created_at":"2013-10-14T14:31:51.000Z","conversation_id":"389759765196189696","possibly_sensitive":false,"lang":"en","id":"389760468337696770","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"389759765196189696"}],"in_reply_to_user_id":"140344419","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@cancereu We haven't suggested one for this workshop. Please feel free to use a hashtag of your choice.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":9,"username":"cancereu","id":"140344419"}],"annotations":{}},"created_at":"2013-10-14T14:28:32.000Z","conversation_id":"389742290832334848","possibly_sensitive":false,"lang":"en","id":"389759633230798848","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"389758309231640576"}],"in_reply_to_user_id":"140344419","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Follow the workshop on preventing product shortages due to manufacturing and quality problems, live on our website: http://t.co/fm5KVrMvK0","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/fm5KVrMvK0","expanded_url":"http://bit.ly/1akvPpd","display_url":"bit.ly/1akvPpd"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-14T13:19:37.000Z","conversation_id":"389742290832334848","possibly_sensitive":false,"lang":"en","id":"389742290832334848","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Watch the live broadcast of our workshop on preventing product shortages due to manufacturing and quality problems: http://t.co/GDR1CXpHVQ","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/GDR1CXpHVQ","expanded_url":"http://bit.ly/1akvPpd","display_url":"bit.ly/1akvPpd"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-14T09:04:55.000Z","conversation_id":"389678190886924288","possibly_sensitive":false,"lang":"en","id":"389678190886924288","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the PRAC meeting highlights: http://t.co/K0BGqXJFGJ","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/K0BGqXJFGJ","expanded_url":"http://bit.ly/15YE1Q3","display_url":"bit.ly/15YE1Q3"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-11T11:13:20.000Z","conversation_id":"388623345287450624","possibly_sensitive":false,"lang":"en","id":"388623345287450624","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":2,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're hosting a workshop on prevention of product shortages due to manufacturing and quality problems on 14 October: http://t.co/2L38IQmcoP","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/2L38IQmcoP","expanded_url":"http://bit.ly/1acjgwa","display_url":"bit.ly/1acjgwa"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-10T11:02:17.000Z","conversation_id":"388258176665399296","possibly_sensitive":false,"lang":"en","id":"388258176665399296","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"What does the #blacktriangle on medicines mean? Watch our video: http://t.co/ZzDNIqm0Nk","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":14,"end":28,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-07T08:20:27.000Z","conversation_id":"387130284593803264","possibly_sensitive":false,"lang":"en","id":"387130284593803264","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Watch our video on the #blacktriangle and additional monitoring of medicines: http://t.co/ZzDNIqm0Nk","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":23,"end":37,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-07T11:10:00.000Z","conversation_id":"387172956381528064","possibly_sensitive":false,"lang":"en","id":"387172956381528064","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann Thanks for your message. Please send your query to us at http://t.co/rMxJXKOpHn so that we can reply to you directly.","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/rMxJXKOpHn","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-10-07T10:00:29.000Z","conversation_id":"387130470867017728","possibly_sensitive":false,"lang":"en","id":"387155461805309952","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"387134868431179776"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We're now publishing our recommendations based on the assessment of #safety #signals: http://t.co/4TcedOgAR9  #pharmacovigilance","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/4TcedOgAR9","expanded_url":"http://bit.ly/1ga3wzL","display_url":"bit.ly/1ga3wzL"}],"hashtags":[{"start":68,"end":75,"tag":"safety"},{"start":76,"end":84,"tag":"signals"},{"start":110,"end":128,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-10-07T08:21:11.000Z","conversation_id":"387130470867017728","possibly_sensitive":false,"lang":"en","id":"387130470867017728","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Find out what the #blacktriangle means and how additional monitoring works: http://t.co/ZzDNIqm0Nk","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":18,"end":32,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-04T11:23:05.000Z","conversation_id":"386089083480457216","possibly_sensitive":false,"lang":"en","id":"386089083480457216","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our website is down at the moment due to technical problems. We're working on getting it back up as soon as possible. Apologies.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-10-04T11:40:13.000Z","conversation_id":"386093396764262400","possibly_sensitive":false,"lang":"en","id":"386093396764262400","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"The #blacktriangle is an invitation for patients and healthcare professionals to report suspected side effects: http://t.co/ZzDNIqm0Nk","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/ZzDNIqm0Nk","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":4,"end":18,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-04T08:25:38.000Z","conversation_id":"386044426146959360","possibly_sensitive":false,"lang":"en","id":"386044426146959360","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":2,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Yesterday we published the report and video from our workshop on #conflictsofinterests: http://t.co/yAXSlcN27o  #coiworkshop","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/yAXSlcN27o","expanded_url":"http://bit.ly/1730C94","display_url":"bit.ly/1730C94"}],"hashtags":[{"start":65,"end":86,"tag":"conflictsofinterests"},{"start":112,"end":124,"tag":"coiworkshop"}],"mentions":{},"annotations":{}},"created_at":"2013-10-03T08:34:35.000Z","conversation_id":"385684292044476416","possibly_sensitive":false,"lang":"en","id":"385684292044476416","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our video and factsheet explaining the #blacktriangle &amp; additional monitoring in all EU languages are now available: http://t.co/WeoH36QuED","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/WeoH36QuED","expanded_url":"http://bit.ly/19SceN0","display_url":"bit.ly/19SceN0"}],"hashtags":[{"start":39,"end":53,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-01T11:01:16.000Z","conversation_id":"384996429652963328","possibly_sensitive":false,"lang":"en","id":"384996429652963328","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@EPHA_EU The #blacktriangle is not a warning, but an invitation to report suspected side effects.","entities":{"urls":{},"hashtags":[{"start":13,"end":27,"tag":"blacktriangle"}],"mentions":[{"start":0,"end":8,"username":"EPHA_EU","id":"184756856"}],"annotations":{}},"created_at":"2013-10-01T10:13:46.000Z","conversation_id":"384971025286307840","possibly_sensitive":false,"lang":"en","id":"384984474796457984","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"384971025286307840"}],"in_reply_to_user_id":"184756856","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@ClinicaAmanda The #blacktriangle is only for medicines; a deliverable of the 2010 pharmacovigilance legislation: http://t.co/Mq1KF9kPri","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Mq1KF9kPri","expanded_url":"http://bit.ly/10EQUGI","display_url":"bit.ly/10EQUGI"}],"hashtags":[{"start":19,"end":33,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-01T10:32:11.000Z","conversation_id":"384963559614316544","possibly_sensitive":false,"lang":"en","id":"384989111255572480","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"384980031728279552"}],"in_reply_to_user_id":"183177433","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published a video and factsheet in all EU languages explaining the #blacktriangle and additional monitoring: http://t.co/YWsuLDhWrE","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/YWsuLDhWrE","expanded_url":"http://bit.ly/19SceN0","display_url":"bit.ly/19SceN0"}],"hashtags":[{"start":73,"end":87,"tag":"blacktriangle"}],"mentions":{},"annotations":{}},"created_at":"2013-10-01T08:50:39.000Z","conversation_id":"384963559614316544","possibly_sensitive":false,"lang":"en","id":"384963559614316544","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our #advancedtherapies committee has issued its first recommendation for certification of non-clinical data: http://t.co/6NTwU4WFiR","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/6NTwU4WFiR","expanded_url":"http://bit.ly/1fqLhIw","display_url":"bit.ly/1fqLhIw"}],"hashtags":[{"start":4,"end":22,"tag":"advancedtherapies"}],"mentions":{},"annotations":{}},"created_at":"2013-09-27T08:18:57.000Z","conversation_id":"383506032338563072","possibly_sensitive":false,"lang":"en","id":"383506032338563072","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We're holding a workshop on #biosimilars on 31 October. A few places are available: http://t.co/Wb5YqNPTTs","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/Wb5YqNPTTs","expanded_url":"http://bit.ly/15TYTpE","display_url":"bit.ly/15TYTpE"}],"hashtags":[{"start":28,"end":40,"tag":"biosimilars"}],"mentions":{},"annotations":{}},"created_at":"2013-09-26T08:11:40.000Z","conversation_id":"383141810156998656","possibly_sensitive":false,"lang":"en","id":"383141810156998656","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Lemtrada (#alemtuzumab) for the treatment of #multiplesclerosis: http://t.co/ZbfHnyT0F9","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/ZbfHnyT0F9","expanded_url":"http://bit.ly/1be3fwf","display_url":"bit.ly/1be3fwf"}],"hashtags":[{"start":42,"end":51,"tag":"Lemtrada"},{"start":53,"end":65,"tag":"alemtuzumab"},{"start":88,"end":106,"tag":"multiplesclerosis"}],"mentions":{},"annotations":{}},"created_at":"2013-09-26T08:40:10.000Z","conversation_id":"383148983629398016","possibly_sensitive":false,"lang":"en","id":"383148983629398016","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're organising a workshop on #biosimilars on 31 October: http://t.co/sTwbmf855w","entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/sTwbmf855w","expanded_url":"http://bit.ly/15TYTpE","display_url":"bit.ly/15TYTpE"}],"hashtags":[{"start":31,"end":43,"tag":"biosimilars"}],"mentions":{},"annotations":{}},"created_at":"2013-09-25T16:20:36.000Z","conversation_id":"382902466805006336","possibly_sensitive":false,"lang":"en","id":"382902466805006336","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One more week to comment on our concept paper on the development of product-specific guidance on #bioequivalence: http://t.co/2lqZfQ5tzI","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/2lqZfQ5tzI","expanded_url":"http://bit.ly/1687kt7","display_url":"bit.ly/1687kt7"}],"hashtags":[{"start":97,"end":112,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"created_at":"2013-09-23T08:59:52.000Z","conversation_id":"382066775531065344","possibly_sensitive":false,"lang":"en","id":"382066775531065344","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the CHMP meeting highlights: http://t.co/NVZGPQitu1","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/NVZGPQitu1","expanded_url":"http://bit.ly/18fpSwm","display_url":"bit.ly/18fpSwm"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-09-20T11:21:17.000Z","conversation_id":"381015199429689345","possibly_sensitive":false,"lang":"en","id":"381015199429689345","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@MarvinOLicious @fezziwig2008 We don't include new routes of administration in highlights. Please keep an eye on http://t.co/8mSUDahGIt.","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/8mSUDahGIt","expanded_url":"http://bit.ly/16dRdRD","display_url":"bit.ly/16dRdRD"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"MarvinOLicious","id":"595127053"},{"start":16,"end":29,"username":"fezziwig2008","id":"376154503"}],"annotations":{}},"created_at":"2013-09-20T11:50:26.000Z","conversation_id":"381022536055934976","possibly_sensitive":false,"lang":"en","id":"381022536055934976","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"in_reply_to_user_id":"595127053","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our websites and other online tools will be unavailable from 5.30pm tomorrow London time until Monday morning: http://t.co/WyC0u6Gyxb","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/WyC0u6Gyxb","expanded_url":"http://bit.ly/155UOjL","display_url":"bit.ly/155UOjL"}],"hashtags":{},"mentions":{},"annotations":[{"start":77,"end":82,"probability":0.9413,"type":"Place","normalized_text":"London"}]},"created_at":"2013-09-19T11:02:15.000Z","conversation_id":"380648022536753152","possibly_sensitive":false,"lang":"en","id":"380648022536753152","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Tafinlar (#dabrafenib) for the treatment of #melanoma: http://t.co/yfpgCi1C39","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/yfpgCi1C39","expanded_url":"http://bit.ly/19glED1","display_url":"bit.ly/19glED1"}],"hashtags":[{"start":42,"end":51,"tag":"Tafinlar"},{"start":53,"end":64,"tag":"dabrafenib"},{"start":87,"end":96,"tag":"melanoma"}],"mentions":{},"annotations":{}},"created_at":"2013-09-19T08:57:30.000Z","conversation_id":"380616630759600128","possibly_sensitive":false,"lang":"en","id":"380616630759600128","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Yesterday we published details on our new organisational structure: http://t.co/MIS1VfUoTd","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/MIS1VfUoTd","expanded_url":"http://bit.ly/17CRM4l","display_url":"bit.ly/17CRM4l"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-09-17T10:18:50.000Z","conversation_id":"379912320048037889","possibly_sensitive":false,"lang":"en","id":"379912320048037889","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just announced details of our new organisational structure: http://t.co/e3qjALiuwK","entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/e3qjALiuwK","expanded_url":"http://bit.ly/17CRM4l","display_url":"bit.ly/17CRM4l"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-09-16T09:12:07.000Z","conversation_id":"379533142170017792","possibly_sensitive":false,"lang":"en","id":"379533142170017792","author_id":"116716199","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@pharmatweat Please forward details of the problems to us at http://t.co/81mvfkEvbJ and we will look into it.","entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/81mvfkEvbJ","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"pharmatweat","id":"1725069487"}],"annotations":{}},"created_at":"2013-09-03T10:53:44.000Z","conversation_id":"374840221033975808","possibly_sensitive":false,"lang":"en","id":"374847673691803649","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374840221033975808"}],"in_reply_to_user_id":"1725069487","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Registration is open for a workshop on designation of #orphan medicines and grants: http://t.co/IJpoMiKcuZ","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/IJpoMiKcuZ","expanded_url":"http://bit.ly/19pHuoj","display_url":"bit.ly/19pHuoj"}],"hashtags":[{"start":54,"end":61,"tag":"orphan"}],"mentions":{},"annotations":{}},"created_at":"2013-09-06T16:43:47.000Z","conversation_id":"376022929274077184","possibly_sensitive":false,"lang":"en","id":"376022929274077184","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Aubagio (#teriflunomide) for the treatment of #multiplesclerosis: http://t.co/bX84oiq936","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/bX84oiq936","expanded_url":"http://bit.ly/18HYvaY","display_url":"bit.ly/18HYvaY"}],"hashtags":[{"start":42,"end":50,"tag":"Aubagio"},{"start":52,"end":66,"tag":"teriflunomide"},{"start":89,"end":107,"tag":"multiplesclerosis"}],"mentions":{},"annotations":{}},"created_at":"2013-09-06T14:58:04.000Z","conversation_id":"375996325349040128","possibly_sensitive":false,"lang":"en","id":"375996325349040128","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Pierre Chirac from @PrescrireMieux calls for EMA to only use experts with no links to industry: http://t.co/FlQL32MWTh #coiworkshop","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"hashtags":[{"start":119,"end":131,"tag":"coiworkshop"}],"mentions":[{"start":19,"end":34,"username":"PrescrireMieux","id":"247239882"}],"annotations":[{"start":0,"end":12,"probability":0.9867,"type":"Person","normalized_text":"Pierre Chirac"}]},"created_at":"2013-09-06T11:32:35.000Z","conversation_id":"375944616584830976","possibly_sensitive":false,"lang":"en","id":"375944616584830976","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":3,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@EUombudsman Go to http://t.co/IO7nFwBCvs and click on 'multimedia' for broadcast and instructions for what to do if you're having problems.","entities":{"urls":[{"start":19,"end":41,"url":"http://t.co/IO7nFwBCvs","expanded_url":"http://bit.ly/1f6tUr9","display_url":"bit.ly/1f6tUr9"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"EUombudsman","id":"873777758"}],"annotations":{}},"created_at":"2013-09-06T12:28:43.000Z","conversation_id":"375954872983490560","possibly_sensitive":false,"lang":"en","id":"375958739796623360","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"375955342217056256"}],"in_reply_to_user_id":"873777758","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Lunch break now - workshop starting again at 2.00pm London time: http://t.co/FlQL32MWTh #coiworkshop","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/FlQL32MWTh","expanded_url":"http://bit.ly/17cDDL5","display_url":"bit.ly/17cDDL5"}],"hashtags":[{"start":88,"end":100,"tag":"coiworkshop"}],"mentions":{},"annotations":[{"start":52,"end":57,"probability":0.7654,"type":"Place","normalized_text":"London"}]},"created_at":"2013-09-06T12:13:21.000Z","conversation_id":"375954872983490560","possibly_sensitive":false,"lang":"en","id":"375954872983490560","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the PRAC meeting highlights: 2013 http://t.co/8sHEWfcmhS","entities":{"urls":[{"start":55,"end":77,"url":"http://t.co/8sHEWfcmhS","expanded_url":"http://bit.ly/18z2J5R","display_url":"bit.ly/18z2J5R"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-09-06T11:06:44.000Z","conversation_id":"375938107369332736","possibly_sensitive":false,"lang":"en","id":"375938107369332736","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@HJF29088181 We're looking into it. Please bear with us.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":12,"username":"HJF29088181","id":"1007144522"}],"annotations":{}},"created_at":"2013-09-04T09:42:07.000Z","conversation_id":"375157376451489793","possibly_sensitive":false,"lang":"en","id":"375192039677509632","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"375190558186041344"}],"in_reply_to_user_id":"1007144522","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"The EPAR for #Lonquex (#lipegfilgrastim) for #neutropenia in adult #cancer patients is available on our website: http://t.co/55guqCvLOW","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/55guqCvLOW","expanded_url":"http://bit.ly/14fKBkv","display_url":"bit.ly/14fKBkv"}],"hashtags":[{"start":13,"end":21,"tag":"Lonquex"},{"start":23,"end":39,"tag":"lipegfilgrastim"},{"start":45,"end":57,"tag":"neutropenia"},{"start":67,"end":74,"tag":"cancer"}],"mentions":{},"annotations":{}},"created_at":"2013-09-04T08:54:50.000Z","conversation_id":"375180140411498496","possibly_sensitive":false,"lang":"en","id":"375180140411498496","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: The #blacktriangle symbol does not mean that the use of these medicines is subject to greater risk.","entities":{"urls":{},"hashtags":[{"start":19,"end":33,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2013-09-02T09:42:20.000Z","conversation_id":"374467317188796417","possibly_sensitive":false,"lang":"en","id":"374467317188796417","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@fezziwig2008 We will update our information on Herceptin after the Commission decision is granted. Keep an eye on http://t.co/VPOTJIMp13.","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/VPOTJIMp13","expanded_url":"http://bit.ly/1bofovI","display_url":"bit.ly/1bofovI"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"}],"annotations":{}},"created_at":"2013-09-02T15:57:48.000Z","conversation_id":"374560385853956097","possibly_sensitive":false,"lang":"en","id":"374561807119425536","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374561391140962304"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@fezziwig2008 Please refer to the @EU_Commission for information on the marketing authorisation: http://t.co/VOX6tkW6Bm","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/VOX6tkW6Bm","expanded_url":"http://bit.ly/1dWC2wD","display_url":"bit.ly/1dWC2wD"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":34,"end":48,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2013-09-02T15:56:09.000Z","conversation_id":"374560385853956097","possibly_sensitive":false,"lang":"en","id":"374561391140962304","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"374560385853956097"}],"in_reply_to_user_id":"376154503","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @EP_Environment: New medicines to display #blacktriangle from September http://t.co/Cm9aZ8147t lead MEP @LindaMcAvanMEP","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/Cm9aZ8147t","expanded_url":"http://bit.ly/15aEYPg","display_url":"bit.ly/15aEYPg"}],"hashtags":[{"start":45,"end":59,"tag":"blacktriangle"}],"mentions":[{"start":3,"end":18,"username":"EP_Environment","id":"951333319"},{"start":107,"end":122,"username":"LindaMcAvanMEP","id":"166509226"}],"annotations":{}},"created_at":"2013-08-30T11:30:22.000Z","conversation_id":"373407343670992896","possibly_sensitive":false,"lang":"en","id":"373407343670992896","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@fezziwig2008 Once the @eu_commission has granted a positive opinion, the marketing-authorisation holder can start to market.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":23,"end":37,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2013-08-30T12:22:40.000Z","conversation_id":"373414548604481536","possibly_sensitive":false,"lang":"en","id":"373420505099161601","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"373419694512148480"}],"in_reply_to_user_id":"376154503","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@fezziwig2008 We aim to publish updates within 15 days of the decision from the @EU_Commission: http://t.co/MaxNF3ugp7","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/MaxNF3ugp7","expanded_url":"http://bit.ly/17r9vdH","display_url":"bit.ly/17r9vdH"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"fezziwig2008","id":"376154503"},{"start":80,"end":94,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2013-08-30T12:15:12.000Z","conversation_id":"373414548604481536","possibly_sensitive":false,"lang":"en","id":"373418626113888256","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"373414548604481536"}],"in_reply_to_user_id":"376154503","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @LV_MPA: Monthly report from the Committee for Medicinal Products for Human Use (July 2013): http://t.co/QIYj0YEKjH","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/QIYj0YEKjH","expanded_url":"http://bit.ly/1bW1T5J","display_url":"bit.ly/1bW1T5J"}],"hashtags":{},"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"annotations":{}},"created_at":"2013-08-22T11:34:13.000Z","conversation_id":"370509205620654080","possibly_sensitive":false,"lang":"en","id":"370509205620654080","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"A public consultation is open on our draft Community #herbal monograph on #Arnica montana (Arnica flower): http://t.co/FfVL2gvB4r","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/FfVL2gvB4r","expanded_url":"http://bit.ly/16gs5T8","display_url":"bit.ly/16gs5T8"}],"hashtags":[{"start":53,"end":60,"tag":"herbal"},{"start":74,"end":81,"tag":"Arnica"}],"mentions":{},"annotations":{}},"created_at":"2013-08-22T09:54:02.000Z","conversation_id":"370483995076984832","possibly_sensitive":false,"lang":"en","id":"370483995076984832","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Register now for our information day on using #MedDRA, including #medicationerrors, on 22 October: http://t.co/aVsafoAHRx","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/aVsafoAHRx","expanded_url":"http://bit.ly/14iub92","display_url":"bit.ly/14iub92"}],"hashtags":[{"start":46,"end":53,"tag":"MedDRA"},{"start":65,"end":82,"tag":"medicationerrors"}],"mentions":{},"annotations":{}},"created_at":"2013-08-21T11:01:18.000Z","conversation_id":"370138537544261632","possibly_sensitive":false,"lang":"en","id":"370138537544261632","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the first conclusions of parallel assessment of quality-by-design applications with @US_FDA: http://t.co/H21J68dRfK","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/H21J68dRfK","expanded_url":"http://bit.ly/13CzwJR","display_url":"bit.ly/13CzwJR"}],"hashtags":{},"mentions":[{"start":100,"end":107,"username":"US_FDA","id":"208120290"}],"annotations":{}},"created_at":"2013-08-20T14:10:52.000Z","conversation_id":"369823852404436994","possibly_sensitive":false,"lang":"en","id":"369823852404436994","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@StripSafely @webDM1 We do not deal with medical devices such as test strips: these are regulated at national level.http://t.co/v1ddkkIgB6","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/v1ddkkIgB6","expanded_url":"http://bit.ly/17XsIT4","display_url":"bit.ly/17XsIT4"}],"hashtags":{},"mentions":[{"start":0,"end":12,"username":"StripSafely","id":"1496947920"},{"start":13,"end":20,"username":"webDM1","id":"758619698"}],"annotations":{}},"created_at":"2013-08-19T08:24:53.000Z","conversation_id":"368421127447539713","possibly_sensitive":false,"lang":"en","id":"369374395505995776","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"368436912203497472"}],"in_reply_to_user_id":"1496947920","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@wombarrapete @fiouw Yes, orphan designations are only for medicines for diseases that are life-threatening or chronically debilitating.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"},{"start":14,"end":20,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"created_at":"2013-08-19T11:07:22.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","id":"369415289110155264","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"369414395077488640"}],"in_reply_to_user_id":"17509073","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@wombarrapete @fiouw Apologies, the correct link for the orphan designation is http://t.co/ybv9RSBgHs","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/ybv9RSBgHs","expanded_url":"http://bit.ly/1ajS6bP","display_url":"bit.ly/1ajS6bP"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"},{"start":14,"end":20,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"created_at":"2013-08-19T10:56:18.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","id":"369412501634416640","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"369411157016076288"}],"in_reply_to_user_id":"17509073","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Imvanex, a vaccine to protect against #smallpox in adults: http://t.co/foVwlCYYSA","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/foVwlCYYSA","expanded_url":"http://bit.ly/1dcYfpJ","display_url":"bit.ly/1dcYfpJ"}],"hashtags":[{"start":42,"end":50,"tag":"Imvanex"},{"start":81,"end":90,"tag":"smallpox"}],"mentions":{},"annotations":{}},"created_at":"2013-08-16T12:32:11.000Z","conversation_id":"368349468036694016","possibly_sensitive":false,"lang":"en","id":"368349468036694016","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"New dossier-submission requirements for active-substance master files (ASMFs) come into force on 1 September:  http://t.co/ckX3kxvOKY","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/ckX3kxvOKY","expanded_url":"http://bit.ly/13ztmF3","display_url":"bit.ly/13ztmF3"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-08-14T08:54:36.000Z","conversation_id":"367569934844694528","possibly_sensitive":false,"lang":"en","id":"367569934844694528","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":4,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"The EPAR for #Pomalidomide Celgene for the treatment of #multiplemyeloma is now available on our website: http://t.co/rI8Zbj9xq3","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/rI8Zbj9xq3","expanded_url":"http://bit.ly/19qaWyn","display_url":"bit.ly/19qaWyn"}],"hashtags":[{"start":13,"end":26,"tag":"Pomalidomide"},{"start":56,"end":72,"tag":"multiplemyeloma"}],"mentions":{},"annotations":{}},"created_at":"2013-08-14T08:14:05.000Z","conversation_id":"367559740010016768","possibly_sensitive":false,"lang":"en","id":"367559740010016768","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published the assessment report for #Pomalidomide Celgene for the treatment of #multiplemyeloma http://t.co/rI8Zbj9xq3","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/rI8Zbj9xq3","expanded_url":"http://bit.ly/19qaWyn","display_url":"bit.ly/19qaWyn"}],"hashtags":[{"start":42,"end":55,"tag":"Pomalidomide"},{"start":85,"end":101,"tag":"multiplemyeloma"}],"mentions":{},"annotations":{}},"created_at":"2013-08-13T13:34:44.000Z","conversation_id":"367278045172080641","possibly_sensitive":false,"lang":"en","id":"367278045172080641","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Send us your comments on our inventory of #paediatric needs in #nephrourology: consultation open until 14 November: http://t.co/YR2ts17Q2P","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/YR2ts17Q2P","expanded_url":"http://bit.ly/19Ytoxl","display_url":"bit.ly/19Ytoxl"}],"hashtags":[{"start":42,"end":53,"tag":"paediatric"},{"start":63,"end":77,"tag":"nephrourology"}],"mentions":{},"annotations":{}},"created_at":"2013-08-13T08:36:12.000Z","conversation_id":"367202918207733761","possibly_sensitive":false,"lang":"en","id":"367202918207733761","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Two weeks to comment on our opinion on a new model of disease progression &amp; trial evaluation in #Alzheimer's disease: http://t.co/Izrc2TPeTV","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/Izrc2TPeTV","expanded_url":"http://bit.ly/16I4Ljl","display_url":"bit.ly/16I4Ljl"}],"hashtags":[{"start":100,"end":110,"tag":"Alzheimer"}],"mentions":{},"annotations":{}},"created_at":"2013-08-13T08:33:24.000Z","conversation_id":"367202214659358720","possibly_sensitive":false,"lang":"en","id":"367202214659358720","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Our guideline on the pharmaceutical development of medicines for #paediatric use is available:http://t.co/rJ15XFJH72","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/rJ15XFJH72","expanded_url":"http://bit.ly/11OPlKp","display_url":"bit.ly/11OPlKp"}],"hashtags":[{"start":65,"end":76,"tag":"paediatric"}],"mentions":{},"annotations":{}},"created_at":"2013-08-08T14:28:56.000Z","conversation_id":"365479746554961921","possibly_sensitive":false,"lang":"en","id":"365479746554961921","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published guidance on the #validation process for initial marketing authorisations: http://t.co/sv8R6JkPA5","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/sv8R6JkPA5","expanded_url":"http://bit.ly/13eIszI","display_url":"bit.ly/13eIszI"}],"hashtags":[{"start":32,"end":43,"tag":"validation"}],"mentions":{},"annotations":{}},"created_at":"2013-08-05T10:19:00.000Z","conversation_id":"364329684139778048","possibly_sensitive":false,"lang":"en","id":"364329684139778048","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Send us your comments on our concept paper on development of product-specific guidance on #bioequivalence: http://t.co/eISk9bSd8U","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/eISk9bSd8U","expanded_url":"http://bit.ly/16me5LD","display_url":"bit.ly/16me5LD"}],"hashtags":[{"start":90,"end":105,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"created_at":"2013-08-02T08:11:11.000Z","conversation_id":"363210354668474368","possibly_sensitive":false,"lang":"en","id":"363210354668474368","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Our concept paper on development of product-specific guidance on #bioequivalence is open for consultation: http://t.co/eISk9bSd8U","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/eISk9bSd8U","expanded_url":"http://bit.ly/16me5LD","display_url":"bit.ly/16me5LD"}],"hashtags":[{"start":65,"end":80,"tag":"bioequivalence"}],"mentions":{},"annotations":{}},"created_at":"2013-08-01T14:59:30.000Z","conversation_id":"362950721869590528","possibly_sensitive":false,"lang":"en","id":"362950721869590528","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published a guideline on using starting materials and intermediates from different sources for biologicals: http://t.co/QphlXLE5el","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/QphlXLE5el","expanded_url":"http://bit.ly/18Rdqpp","display_url":"bit.ly/18Rdqpp"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-31T10:21:01.000Z","conversation_id":"362518252104073216","possibly_sensitive":false,"lang":"en","id":"362518252104073216","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@wombarrapete The longest in the link we supplied was NexoBrid - 210 active days + 463 clock stop = 673 days or about 22 months.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":13,"username":"wombarrapete","id":"17509073"}],"annotations":{}},"created_at":"2013-07-30T11:11:53.000Z","conversation_id":"360726350052605952","possibly_sensitive":false,"lang":"en","id":"362168665245892608","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"362167070118526976"}],"in_reply_to_user_id":"17509073","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@louis_ide We expect to issue a recommendation on domperidone in December at the earliest: http://t.co/fbKo4AMP7U","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/fbKo4AMP7U","expanded_url":"http://bit.ly/15sIeYB","display_url":"bit.ly/15sIeYB"}],"hashtags":{},"mentions":[{"start":0,"end":10,"username":"louis_ide","id":"1548804618"}],"annotations":{}},"created_at":"2013-07-30T08:47:13.000Z","conversation_id":"360690347334057984","possibly_sensitive":false,"lang":"en","id":"362132260981440512","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":1,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"360700049375772672"}],"in_reply_to_user_id":"1548804618","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One week left to comment on our draft good #pharmacovigilance practice module on risk-minimisation measures: http://t.co/0rFfpOTVCc","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":43,"end":61,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-07-29T10:49:34.000Z","conversation_id":"361800660603248640","possibly_sensitive":false,"lang":"en","id":"361800660603248640","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We recommend suspension of marketing authorisations for oral #ketoconazole: http://t.co/qdFoA4IN6O","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/qdFoA4IN6O","expanded_url":"http://bit.ly/13gJEkI","display_url":"bit.ly/13gJEkI"}],"hashtags":[{"start":61,"end":74,"tag":"ketoconazole"}],"mentions":{},"annotations":{}},"created_at":"2013-07-29T09:29:41.000Z","conversation_id":"361780557295783937","possibly_sensitive":false,"lang":"en","id":"361780557295783937","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We published the CHMP meeting highlights on Friday: http://t.co/0yt85BB8Ef","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/0yt85BB8Ef","expanded_url":"http://bit.ly/1bUzNuf","display_url":"bit.ly/1bUzNuf"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-29T09:29:01.000Z","conversation_id":"361780390639312896","possibly_sensitive":false,"lang":"en","id":"361780390639312896","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We recommend changes to the use of #metoclopramide: http://t.co/mBUtjSDI6S","entities":{"urls":[{"start":52,"end":74,"url":"http://t.co/mBUtjSDI6S","expanded_url":"http://bit.ly/1dZrdXF","display_url":"bit.ly/1dZrdXF"}],"hashtags":[{"start":35,"end":50,"tag":"metoclopramide"}],"mentions":{},"annotations":{}},"created_at":"2013-07-26T09:17:34.000Z","conversation_id":"360690347334057984","possibly_sensitive":false,"lang":"en","id":"360690347334057984","author_id":"116716199","public_metrics":{"retweet_count":11,"reply_count":4,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"No new concerns for #GLP-1 therapies identified on the basis of available evidence: http://t.co/iNybk9S0Vd","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/iNybk9S0Vd","expanded_url":"http://bit.ly/15PIQqa","display_url":"bit.ly/15PIQqa"}],"hashtags":[{"start":20,"end":24,"tag":"GLP"}],"mentions":{},"annotations":{}},"created_at":"2013-07-26T09:14:46.000Z","conversation_id":"360689641986338816","possibly_sensitive":false,"lang":"en","id":"360689641986338816","author_id":"116716199","public_metrics":{"retweet_count":12,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Two more weeks to comment on our draft good #pharmacovigilance practice module on risk-minimisation measures: http://t.co/0rFfpOTVCc","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/0rFfpOTVCc","expanded_url":"http://bit.ly/15RB1kE","display_url":"bit.ly/15RB1kE"}],"hashtags":[{"start":44,"end":62,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-07-22T08:11:15.000Z","conversation_id":"359224104353660931","possibly_sensitive":false,"lang":"en","id":"359224104353660931","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC: one year of public health promotion and protection: http://t.co/80foENOv00","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/80foENOv00","expanded_url":"http://bit.ly/14mS686","display_url":"bit.ly/14mS686"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-19T15:59:36.000Z","conversation_id":"358254805031981057","possibly_sensitive":false,"lang":"en","id":"358254805031981057","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published our guideline on medicines for the treatment of urinary #incontinence: http://t.co/6xGm78C5Tx","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/6xGm78C5Tx","expanded_url":"http://bit.ly/15saNnQ","display_url":"bit.ly/15saNnQ"}],"hashtags":[{"start":77,"end":90,"tag":"incontinence"}],"mentions":{},"annotations":{}},"created_at":"2013-07-19T10:31:29.000Z","conversation_id":"358172232842887170","possibly_sensitive":false,"lang":"en","id":"358172232842887170","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We've extended the public consultation on our inventory of #paediatric needs to 26 July - one week left to comment: http://t.co/DI2O8H4btl","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/DI2O8H4btl","expanded_url":"http://bit.ly/11Sged6","display_url":"bit.ly/11Sged6"}],"hashtags":[{"start":59,"end":70,"tag":"paediatric"}],"mentions":{},"annotations":{}},"created_at":"2013-07-19T08:09:21.000Z","conversation_id":"358136462316806144","possibly_sensitive":false,"lang":"en","id":"358136462316806144","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Next week is the July #CHMP meeting. We're publishing the main outcomes on Friday: http://t.co/BVe20M2eXv","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/BVe20M2eXv","expanded_url":"http://bit.ly/1bNmfiH","display_url":"bit.ly/1bNmfiH"}],"hashtags":[{"start":22,"end":27,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2013-07-19T08:12:38.000Z","conversation_id":"358137291010609152","possibly_sensitive":false,"lang":"en","id":"358137291010609152","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"From 4 August, marketing-authorisation holders will need to use the updated application forms for variations: http://t.co/7eMVGXSiZi","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/7eMVGXSiZi","expanded_url":"http://bit.ly/18obr8n","display_url":"bit.ly/18obr8n"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-19T08:07:22.000Z","conversation_id":"358135964813635586","possibly_sensitive":false,"lang":"en","id":"358135964813635586","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"The website is live again now. Please bear with us while we continue to work on our technical problems.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-17T14:26:38.000Z","conversation_id":"357502255412428802","possibly_sensitive":false,"lang":"en","id":"357506635725406208","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"357502255412428802"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our website is down again due to ongoing technical problems. We apologise for the inconvenience.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-17T14:09:14.000Z","conversation_id":"357502255412428802","possibly_sensitive":false,"lang":"en","id":"357502255412428802","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"Our website is now back up and running. Apologies for the inconvenience.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-16T10:56:56.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","id":"357091472404774912","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"356805472726163457"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our website will be down until at least tomorrow morning because of ongoing technical problems. We apologise for the inconvenience.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-15T16:00:28.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","id":"356805472726163457","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"356766910630735872"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"We've had to take our website down temporarily while we try to resolve the problems we're having. Apologies for the inconvenience.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-15T13:27:14.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","id":"356766910630735872","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"356739492599701504"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We're having some problems with documents published on our website. Please bear with us while we try to resolve the issue.","entities":{"urls":{},"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-15T11:38:17.000Z","conversation_id":"356739492599701504","possibly_sensitive":false,"lang":"en","id":"356739492599701504","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're organising webinars to train applicants on electronic submission of single-assessment #PSURs: http://t.co/CfzhJtroNL","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/CfzhJtroNL","expanded_url":"http://bit.ly/12ojoct","display_url":"bit.ly/12ojoct"}],"hashtags":[{"start":92,"end":98,"tag":"PSURs"}],"mentions":{},"annotations":{}},"created_at":"2013-07-11T10:24:11.000Z","conversation_id":"355271290992607232","possibly_sensitive":false,"lang":"en","id":"355271290992607232","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann Information on safety monitoring of medicines is here: http://t.co/MpdmGvj0Ui.","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/MpdmGvj0Ui","expanded_url":"http://bit.ly/16tC1te","display_url":"bit.ly/16tC1te"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-11T10:15:58.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355269226325479426","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355267503389286400"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann If Stamaril is marketed in Greece, it will have a Greek marketing authorisation; not regulated centrally at EU level.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":19,"end":26,"probability":0.395,"type":"Person","normalized_text":"Stamaril"},{"start":43,"end":48,"probability":0.995,"type":"Place","normalized_text":"Greece"}]},"created_at":"2013-07-11T10:03:02.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355265970102738944","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355265419902320643"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann Referrals are one-off. This one ended in July 2006.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-11T09:45:22.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355261524983549952","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355261359857991680"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann No, we do not deal with nationally authorised medicines unless referred to us. Please contact relation@eof.gr.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-11T09:33:59.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355258657795084288","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355258184644050945"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann No Greek authorisations for Stamaril were included in this referral in 2006.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":44,"end":51,"probability":0.3868,"type":"Person","normalized_text":"Stamaril"}]},"created_at":"2013-07-11T09:33:13.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355258468476788736","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355256131406405632"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann To get detailed information on the marketing authorisation granted in Greece, you will need to contact relation@eof.gr.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":86,"end":91,"probability":0.9942,"type":"Place","normalized_text":"Greece"}]},"created_at":"2013-07-11T09:27:30.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355257027993411584","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355252926798766080"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann We only deal with centrally authorised medicines and referrals: http://t.co/U6hy4UKtZD.","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/U6hy4UKtZD","expanded_url":"http://bit.ly/18P5cgv","display_url":"bit.ly/18P5cgv"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-11T09:17:47.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355254581632049154","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355252926798766080"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann We only deal with centrally authorised meds unless referred to us. Contact the Greek agency for info on Greek authorisation.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-11T09:02:17.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355250683731128321","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355249962784784385"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann The referral was in 2006; no authorisations in Greece to include. Contact the Greek agency for more info: relation@eof.gr.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":63,"end":68,"probability":0.9951,"type":"Place","normalized_text":"Greece"}]},"created_at":"2013-07-11T08:35:09.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355243854540177408","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355015922769068032"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann Otherwise, try contacting the Greek medicines agency directly at relation@eof.gr for more info on the Greek authorisation.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-07-10T16:30:02.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355000975758606340","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"355000370117869568"}],"in_reply_to_user_id":"116716199","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@xOneStepBehind @WHO Try contacting your national regulator. If you're in Norway, email post@legemiddelverket.no http://t.co/gaXR2yqWLp","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/gaXR2yqWLp","expanded_url":"http://bit.ly/1531o5P","display_url":"bit.ly/1531o5P"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"xOneStepBehind","id":"40722651"},{"start":16,"end":20,"username":"WHO","id":"14499829"}],"annotations":[{"start":74,"end":79,"probability":0.9931,"type":"Place","normalized_text":"Norway"}]},"created_at":"2013-07-10T16:40:46.000Z","conversation_id":"354573717747142657","possibly_sensitive":false,"lang":"en","id":"355003675850190850","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"354573717747142657"}],"in_reply_to_user_id":"40722651","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann Stamaril is not centrally authorised in the EU but we did recommend harmonised information in 2006: http://t.co/0NW5KHaluK","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/0NW5KHaluK","expanded_url":"http://bit.ly/15wqYlM","display_url":"bit.ly/15wqYlM"}],"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":[{"start":60,"end":61,"probability":0.3822,"type":"Organization","normalized_text":"EU"}]},"created_at":"2013-07-10T16:27:38.000Z","conversation_id":"351645431878520835","possibly_sensitive":false,"lang":"en","id":"355000370117869568","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"351645431878520835"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"European Medicines Agency creates Healthcare Professionals‚Äô Working Party: http://t.co/y2H0FJKx6H","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/y2H0FJKx6H","expanded_url":"http://bit.ly/13IQndb","display_url":"bit.ly/13IQndb"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-09T14:24:35.000Z","conversation_id":"354607016880246785","possibly_sensitive":false,"lang":"en","id":"354607016880246785","author_id":"116716199","public_metrics":{"retweet_count":9,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"One more week to apply for our #vacancy for a #scientist to work in #quality of medicines. Deadline: 12 July 2013: http://t.co/smbCJX2nuX","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":31,"end":39,"tag":"vacancy"},{"start":46,"end":56,"tag":"scientist"},{"start":68,"end":76,"tag":"quality"}],"mentions":{},"annotations":{}},"created_at":"2013-07-05T14:49:27.000Z","conversation_id":"353163724019859457","possibly_sensitive":false,"lang":"en","id":"353163724019859457","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our draft concept paper on manufacture of the finished dosage form is open for consultation until 31 Dec 2013: http://t.co/NkVFxTBYin","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/NkVFxTBYin","expanded_url":"http://bit.ly/16QiPI8","display_url":"bit.ly/16QiPI8"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-04T14:50:28.000Z","conversation_id":"352801590698188800","possibly_sensitive":false,"lang":"en","id":"352801590698188800","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Concept paper on manufacture of the finished dosage form open for consultation: http://t.co/NkVFxTBYin","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/NkVFxTBYin","expanded_url":"http://bit.ly/16QiPI8","display_url":"bit.ly/16QiPI8"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-07-04T09:27:28.000Z","conversation_id":"352720304407187456","possibly_sensitive":false,"lang":"en","id":"352720304407187456","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"#Falsified medicines directive requires written confirmation for importation of active substances http://t.co/WRGW3Va8JC","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/WRGW3Va8JC","expanded_url":"http://bit.ly/1cM8jTx","display_url":"bit.ly/1cM8jTx"}],"hashtags":[{"start":0,"end":10,"tag":"Falsified"}],"mentions":{},"annotations":{}},"created_at":"2013-07-02T13:14:57.000Z","conversation_id":"352052775942762496","possibly_sensitive":false,"lang":"en","id":"352052775942762496","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We welcome #croatia to the European medicines network http://t.co/fw6EbbQd3a","entities":{"urls":[{"start":54,"end":76,"url":"http://t.co/fw6EbbQd3a","expanded_url":"http://bit.ly/11XW7KA","display_url":"bit.ly/11XW7KA"}],"hashtags":[{"start":11,"end":19,"tag":"croatia"}],"mentions":{},"annotations":{}},"created_at":"2013-07-01T10:31:01.000Z","conversation_id":"351649135897751554","possibly_sensitive":false,"lang":"en","id":"351649135897751554","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Two more weeks to comment on the draft herbal monograph on #Sambucus niger (elderberry): http://t.co/WPhroYicf2","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/WPhroYicf2","expanded_url":"http://bit.ly/17HyVbx","display_url":"bit.ly/17HyVbx"}],"hashtags":[{"start":59,"end":68,"tag":"Sambucus"}],"mentions":{},"annotations":{}},"created_at":"2013-07-01T10:33:40.000Z","conversation_id":"351649801722531841","possibly_sensitive":false,"lang":"en","id":"351649801722531841","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've just published the CHMP highlights: http://t.co/8yFvm3eCLG","entities":{"urls":[{"start":42,"end":64,"url":"http://t.co/8yFvm3eCLG","expanded_url":"http://bit.ly/14BLwar","display_url":"bit.ly/14BLwar"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-06-28T11:47:47.000Z","conversation_id":"350581290778624000","possibly_sensitive":false,"lang":"en","id":"350581290778624000","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":2,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Two days left to comment on the @ICH_news guideline on #mutagenic impurities in medicines and #carcinogenic risk: http://t.co/Nh3n9fwpm9","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/Nh3n9fwpm9","expanded_url":"http://bit.ly/12KKk8z","display_url":"bit.ly/12KKk8z"}],"hashtags":[{"start":55,"end":65,"tag":"mutagenic"},{"start":94,"end":107,"tag":"carcinogenic"}],"mentions":[{"start":32,"end":41,"username":"ICH_news","id":"305434870"}],"annotations":{}},"created_at":"2013-06-28T11:13:58.000Z","conversation_id":"350572777423634432","possibly_sensitive":false,"lang":"en","id":"350572777423634432","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Concept paper on statistical methodology for the comparative assessment of quality attributes open for consultation:  http://t.co/cPzrMeq9Ln","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/cPzrMeq9Ln","expanded_url":"http://bit.ly/17HuhKI","display_url":"bit.ly/17HuhKI"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-06-28T14:06:22.000Z","conversation_id":"350616162826059777","possibly_sensitive":false,"lang":"en","id":"350616162826059777","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've recommended approval of the first two #monoclonalantibody #biosimilars - #Remsima and #Inflectra: http://t.co/HqLWfluEcI","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/HqLWfluEcI","expanded_url":"http://bit.ly/10p8uBN","display_url":"bit.ly/10p8uBN"}],"hashtags":[{"start":44,"end":63,"tag":"monoclonalantibody"},{"start":64,"end":76,"tag":"biosimilars"},{"start":79,"end":87,"tag":"Remsima"},{"start":92,"end":102,"tag":"Inflectra"}],"mentions":{},"annotations":{}},"created_at":"2013-06-28T11:49:44.000Z","conversation_id":"350581781545762817","possibly_sensitive":false,"lang":"en","id":"350581781545762817","author_id":"116716199","public_metrics":{"retweet_count":11,"reply_count":2,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Tomorrow some of our IT systems will be unavailable due to maintenance. We apologise for any inconvenience: http://t.co/zqcRWqsUAL","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/zqcRWqsUAL","expanded_url":"http://bit.ly/13d10Vh","display_url":"bit.ly/13d10Vh"}],"hashtags":{},"mentions":{},"annotations":{}},"created_at":"2013-06-28T11:10:24.000Z","conversation_id":"350571882807959554","possibly_sensitive":false,"lang":"en","id":"350571882807959554","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've recommended new restrictions on use of medicines containing #ergot derivatives: http://t.co/1kU9OsO0Fq","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/1kU9OsO0Fq","expanded_url":"http://bit.ly/10oWW1x","display_url":"bit.ly/10oWW1x"}],"hashtags":[{"start":66,"end":72,"tag":"ergot"}],"mentions":{},"annotations":{}},"created_at":"2013-06-28T09:29:34.000Z","conversation_id":"350546504722812928","possibly_sensitive":false,"lang":"en","id":"350546504722812928","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@BushbyKate @paulinemacco We're working together with @EUnetHTA on this. More info here: http://t.co/LQnKlrypm5","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/LQnKlrypm5","expanded_url":"http://bit.ly/1226jAB","display_url":"bit.ly/1226jAB"}],"hashtags":{},"mentions":[{"start":0,"end":11,"username":"BushbyKate","id":"1216228962"},{"start":12,"end":25,"username":"paulinemacco","id":"325032216"},{"start":54,"end":63,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"created_at":"2013-06-27T10:17:37.000Z","conversation_id":"350191962692919298","possibly_sensitive":false,"lang":"en","id":"350196209417322497","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"350195436017041408"}],"in_reply_to_user_id":"1216228962","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@paulinemacco @BushbyKate We don't deal with pricing or reimbursement - these are handled at a national level: http://t.co/Z7GrvbXFM6","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/Z7GrvbXFM6","expanded_url":"http://bit.ly/XSfuFS","display_url":"bit.ly/XSfuFS"}],"hashtags":{},"mentions":[{"start":0,"end":13,"username":"paulinemacco","id":"325032216"},{"start":14,"end":25,"username":"BushbyKate","id":"1216228962"}],"annotations":{}},"created_at":"2013-06-27T10:12:17.000Z","conversation_id":"350191962692919298","possibly_sensitive":false,"lang":"en","id":"350194869676945408","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"350193398646448128"}],"in_reply_to_user_id":"325032216","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Yesterday we published guidance on how to submit single-assessment periodic safety update reports (#PSURs): http://t.co/46L8k5sqaK","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/46L8k5sqaK","expanded_url":"http://bit.ly/12kOP2p","display_url":"bit.ly/12kOP2p"}],"hashtags":[{"start":99,"end":105,"tag":"PSURs"}],"mentions":{},"annotations":{}},"created_at":"2013-06-25T08:41:26.000Z","conversation_id":"349447228785573888","possibly_sensitive":false,"lang":"en","id":"349447228785573888","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"@EU_Commission has published its report on 5 years of the #Paediatric Regulation: http://t.co/HhqmUB0bvt","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/HhqmUB0bvt","expanded_url":"http://bit.ly/134VTaT","display_url":"bit.ly/134VTaT"}],"hashtags":[{"start":58,"end":69,"tag":"Paediatric"}],"mentions":[{"start":0,"end":14,"username":"EU_Commission","id":"157981564"}],"annotations":{}},"created_at":"2013-06-25T08:40:19.000Z","conversation_id":"349446946383069185","possibly_sensitive":false,"lang":"en","id":"349446946383069185","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"in_reply_to_user_id":"157981564","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"European Commission has just published its report on Paediatric Regulation: http://t.co/HhqmUB0bvt","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/HhqmUB0bvt","expanded_url":"http://bit.ly/134VTaT","display_url":"bit.ly/134VTaT"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":18,"probability":0.711,"type":"Organization","normalized_text":"European Commission"},{"start":53,"end":73,"probability":0.4186,"type":"Other","normalized_text":"Paediatric Regulation"}]},"created_at":"2013-06-24T13:11:14.000Z","conversation_id":"349152739596570624","possibly_sensitive":false,"lang":"en","id":"349152739596570624","author_id":"116716199","public_metrics":{"retweet_count":6,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @AEMPSGOB: Information day on new good distribution practice for human medicines http://t.co/Ad9pXgz7SH","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/Ad9pXgz7SH","expanded_url":"http://www.aemps.gob.es/eventosCongresos/inspe-Farma/2013/J_buena-practica-distribucion.htm","display_url":"aemps.gob.es/eventosCongres‚Ä¶"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"created_at":"2013-06-20T13:33:57.000Z","conversation_id":"347708905595469824","possibly_sensitive":false,"lang":"en","id":"347708905595469824","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC recommends the same cardiovascular precautions for #diclofenac as for selective COX-2 inhibitors: http://t.co/g9RgK87jfl","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/g9RgK87jfl","expanded_url":"http://bit.ly/ZOnpVU","display_url":"bit.ly/ZOnpVU"}],"hashtags":[{"start":56,"end":67,"tag":"diclofenac"}],"mentions":{},"annotations":{}},"created_at":"2013-06-14T11:53:39.000Z","conversation_id":"345509336476418048","possibly_sensitive":false,"lang":"en","id":"345509336476418048","author_id":"116716199","public_metrics":{"retweet_count":13,"reply_count":1,"like_count":4,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC recommends restricting the use of #codeine when used for pain relief in children: http://t.co/BN5Y9E2RBG","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/BN5Y9E2RBG","expanded_url":"http://bit.ly/153cYMW","display_url":"bit.ly/153cYMW"}],"hashtags":[{"start":39,"end":47,"tag":"codeine"}],"mentions":{},"annotations":{}},"created_at":"2013-06-14T11:58:02.000Z","conversation_id":"345510439532261376","possibly_sensitive":false,"lang":"en","id":"345510439532261376","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":2,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC recommends suspending marketing authorisations for infusion solutions containing #hydroxyethylstarch: http://t.co/1C4dAPuGrg","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/1C4dAPuGrg","expanded_url":"http://bit.ly/10hNhfb","display_url":"bit.ly/10hNhfb"}],"hashtags":[{"start":86,"end":105,"tag":"hydroxyethylstarch"}],"mentions":{},"annotations":{}},"created_at":"2013-06-14T12:01:11.000Z","conversation_id":"345511231257448448","possibly_sensitive":false,"lang":"en","id":"345511231257448448","author_id":"116716199","public_metrics":{"retweet_count":13,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @sanidadgob Reform of medicine laws will offer more safety to citizens &amp; eliminate falsified medicines http://t.co/RNssZcAMEv‚Ä¶","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/RNssZcAMEv","expanded_url":"http://msssi.es/gabinete/notas","display_url":"msssi.es/gabinete/notas"}],"hashtags":{},"mentions":[{"start":3,"end":14,"username":"sanidadgob","id":"232124120"}],"annotations":{}},"created_at":"2013-06-13T12:31:19.000Z","conversation_id":"345156426169200640","possibly_sensitive":false,"lang":"en","id":"345156426169200640","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're looking to #recruit a #scientist working in #quality of medicines. Apply by 12 July 2013: http://t.co/smbCJX2nuX #vacancy","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/smbCJX2nuX","expanded_url":"http://bit.ly/16dSsfC","display_url":"bit.ly/16dSsfC"}],"hashtags":[{"start":17,"end":25,"tag":"recruit"},{"start":28,"end":38,"tag":"scientist"},{"start":50,"end":58,"tag":"quality"},{"start":119,"end":127,"tag":"vacancy"}],"mentions":{},"annotations":{}},"created_at":"2013-06-12T15:47:08.000Z","conversation_id":"344843319605600256","possibly_sensitive":false,"lang":"en","id":"344843319605600256","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @AEMPSGOB: Problems with the supply of the medicine Epanutin (phenytoin) http://t.co/0w5TyABv65","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/0w5TyABv65","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/problemasSuministro/2013/NI-AEMPS_07-2013-epanutin.htm","display_url":"aemps.gob.es/informa/notasI‚Ä¶"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"created_at":"2013-06-12T15:52:04.000Z","conversation_id":"344844560914059265","possibly_sensitive":false,"lang":"en","id":"344844560914059265","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've published a revised guideline on #biosimilars containing biotechnology-derived proteins for consultation: http://t.co/q4niOGAnDE","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/q4niOGAnDE","expanded_url":"http://bit.ly/15PEmjK","display_url":"bit.ly/15PEmjK"}],"hashtags":[{"start":39,"end":51,"tag":"biosimilars"}],"mentions":{},"annotations":{}},"created_at":"2013-06-10T09:46:33.000Z","conversation_id":"344027796827426816","possibly_sensitive":false,"lang":"en","id":"344027796827426816","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":3,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @AEMPSGOB: Tetrazepam (Myolastan): suspension of marketing http://t.co/j6DMPwkovJ","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/j6DMPwkovJ","expanded_url":"http://www.aemps.gob.es/informa/notasInformativas/medicamentosUsoHumano/seguridad/2013/NI-MUH_FV_15-2013-myolastan.htm","display_url":"aemps.gob.es/informa/notasI‚Ä¶"}],"hashtags":{},"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"annotations":{}},"created_at":"2013-06-07T13:51:27.000Z","conversation_id":"343002267152171008","possibly_sensitive":false,"lang":"en","id":"343002267152171008","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We‚Äôve met with @EUnetHTA to discuss how regulators and health-technology-assessment bodies can work together: http://t.co/Vmqe4IioAT","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/Vmqe4IioAT","expanded_url":"http://bit.ly/11J4l7U","display_url":"bit.ly/11J4l7U"}],"hashtags":{},"mentions":[{"start":15,"end":24,"username":"EUnetHTA","id":"56493220"}],"annotations":{}},"created_at":"2013-06-07T09:24:28.000Z","conversation_id":"342935076029485056","possibly_sensitive":false,"lang":"en","id":"342935076029485056","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Amendments to #pharmacovigilance legislation apply for centrally authorised medicines: new notification requirements: http://t.co/r6RbmSEiik","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/r6RbmSEiik","expanded_url":"http://bit.ly/14w9Qc2","display_url":"bit.ly/14w9Qc2"}],"hashtags":[{"start":14,"end":32,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-06-06T08:23:07.000Z","conversation_id":"342557249912311808","possibly_sensitive":false,"lang":"en","id":"342557249912311808","author_id":"116716199","public_metrics":{"retweet_count":14,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"New notification requirements for companies now apply following amendments to the #pharmacovigilance legislation: http://t.co/r6RbmSEiik","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/r6RbmSEiik","expanded_url":"http://bit.ly/14w9Qc2","display_url":"bit.ly/14w9Qc2"}],"hashtags":[{"start":82,"end":100,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-06-05T15:36:27.000Z","conversation_id":"342303913128632320","possibly_sensitive":false,"lang":"en","id":"342303913128632320","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@trinevillemann We cannot see any emails from you in our press inbox. Please send your request to us again at press@ema.europa.eu.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":15,"username":"trinevillemann","id":"17966242"}],"annotations":{}},"created_at":"2013-06-05T13:53:36.000Z","conversation_id":"342270891427782656","possibly_sensitive":false,"lang":"en","id":"342278031471149056","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"342273297259569153"}],"in_reply_to_user_id":"17966242","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @Legemiddelinfo: Patients can report side effects through pharmacies, via doctor or even here: http://t.co/NX3vO5qUir #PasSem13","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/NX3vO5qUir","expanded_url":"http://bit.ly/X9GBaY","display_url":"bit.ly/X9GBaY"}],"hashtags":[{"start":121,"end":130,"tag":"PasSem13"}],"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"annotations":{}},"created_at":"2013-06-05T13:25:14.000Z","conversation_id":"342270891427782656","possibly_sensitive":false,"lang":"en","id":"342270891427782656","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our guideline on the use of #bovine #serum in the manufacture of human biological medicines is now available: http://t.co/bR86hsq6PB","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/bR86hsq6PB","expanded_url":"http://bit.ly/11oxOIj","display_url":"bit.ly/11oxOIj"}],"hashtags":[{"start":28,"end":35,"tag":"bovine"},{"start":36,"end":42,"tag":"serum"}],"mentions":{},"annotations":{}},"created_at":"2013-06-04T12:21:56.000Z","conversation_id":"341892572500873216","possibly_sensitive":false,"lang":"en","id":"341892572500873216","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"RT @URPLWMiPB: Information on the revocation of marketing authorisations for products containing almitrine http://t.co/bJnWZDH5to","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/bJnWZDH5to","expanded_url":"http://tnij.org/vwwd","display_url":"tnij.org/vwwd"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2013-06-03T15:40:16.000Z","conversation_id":"341580097653981185","possibly_sensitive":false,"lang":"en","id":"341580097653981185","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Fiouw We're afraid we can't release more details while the evaluation is ongoing. We will publish the outcome as soon as it's complete.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":6,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"created_at":"2013-05-16T08:07:22.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","id":"334943140853198848","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"334766728758308864"}],"in_reply_to_user_id":"1367162942","attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Meeting highlights from the Committee for Medicinal Products for Human Use (#CHMP) 18-21 March 2013:  http://t.co/0xguMT80eZ","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/0xguMT80eZ","expanded_url":"http://bit.ly/XuKjxf","display_url":"bit.ly/XuKjxf"}],"hashtags":[{"start":76,"end":81,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2013-03-22T12:17:41.000Z","conversation_id":"315074803528765440","possibly_sensitive":false,"lang":"en","id":"315074803528765440","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"Meeting highlights from April #CHMP meeting have now been published: http://t.co/R5jrTIX6A1","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/R5jrTIX6A1","expanded_url":"http://bit.ly/Y8Tjhj","display_url":"bit.ly/Y8Tjhj"}],"hashtags":[{"start":30,"end":35,"tag":"CHMP"}],"mentions":{},"annotations":{}},"created_at":"2013-04-26T11:12:40.000Z","conversation_id":"327742015964053504","possibly_sensitive":false,"lang":"en","id":"327742015964053504","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":2,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Two more weeks to comment on our guideline on #pharmacovigilance for #vaccines and its annex: http://t.co/H4zYBNPQyy http://t.co/PGApjXG98G","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/H4zYBNPQyy","expanded_url":"http://bit.ly/ZlR31d","display_url":"bit.ly/ZlR31d"},{"start":117,"end":139,"url":"http://t.co/PGApjXG98G","expanded_url":"http://bit.ly/132jcyo","display_url":"bit.ly/132jcyo"}],"hashtags":[{"start":46,"end":64,"tag":"pharmacovigilance"},{"start":69,"end":78,"tag":"vaccines"}],"mentions":{},"annotations":{}},"created_at":"2013-05-29T08:25:17.000Z","conversation_id":"339658692687454208","possibly_sensitive":false,"lang":"en","id":"339658692687454208","author_id":"116716199","public_metrics":{"retweet_count":10,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're inviting comments on our guideline on the efficacy of #veterinary #antimicrobials. Deadline is 30/11/2013: http://t.co/06HsjEajNf","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/06HsjEajNf","expanded_url":"http://bit.ly/111YtX6","display_url":"bit.ly/111YtX6"}],"hashtags":[{"start":60,"end":71,"tag":"veterinary"},{"start":72,"end":87,"tag":"antimicrobials"}],"mentions":{},"annotations":{}},"created_at":"2013-05-29T08:59:17.000Z","conversation_id":"339667250107805696","possibly_sensitive":false,"lang":"en","id":"339667250107805696","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"To help deal with the harm caused by #medicationerrors in the EU, we've issued six key recommendations: http://t.co/vTmcvhNZMb","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/vTmcvhNZMb","expanded_url":"http://bit.ly/16Q91kA","display_url":"bit.ly/16Q91kA"}],"hashtags":[{"start":37,"end":54,"tag":"medicationerrors"}],"mentions":{},"annotations":[{"start":62,"end":63,"probability":0.344,"type":"Place","normalized_text":"EU"}]},"created_at":"2013-05-23T11:06:03.000Z","conversation_id":"337524821703397377","possibly_sensitive":false,"lang":"en","id":"337524821703397377","author_id":"116716199","public_metrics":{"retweet_count":5,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"From March all applications for human medicines will need to use the #eSubmission Gateway or web client: http://t.co/YRzeY7uEBq","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/YRzeY7uEBq","expanded_url":"http://bit.ly/10LXhHt","display_url":"bit.ly/10LXhHt"}],"hashtags":[{"start":69,"end":81,"tag":"eSubmission"}],"mentions":{},"annotations":{}},"created_at":"2013-05-22T15:34:37.000Z","conversation_id":"337230023750737920","possibly_sensitive":false,"lang":"en","id":"337230023750737920","author_id":"116716199","public_metrics":{"retweet_count":4,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"Our #veterinary committee recommended the first vaccine for #footandmouth disease for authorisation last week: http://t.co/4O6hKdO0Af","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/4O6hKdO0Af","expanded_url":"http://bit.ly/13AYSVL","display_url":"bit.ly/13AYSVL"}],"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":60,"end":73,"tag":"footandmouth"}],"mentions":{},"annotations":{}},"created_at":"2013-05-21T08:13:06.000Z","conversation_id":"336756522304561152","possibly_sensitive":false,"lang":"en","id":"336756522304561152","author_id":"116716199","public_metrics":{"retweet_count":1,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"We published the full highlights from our #pharmacovigilance committee last Friday: http://t.co/oJ4Nmm5nhY","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/oJ4Nmm5nhY","expanded_url":"http://bit.ly/16pwHMT","display_url":"bit.ly/16pwHMT"}],"hashtags":[{"start":42,"end":60,"tag":"pharmacovigilance"}],"mentions":{},"annotations":{}},"created_at":"2013-05-21T08:12:19.000Z","conversation_id":"336756326862577664","possibly_sensitive":false,"lang":"en","id":"336756326862577664","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We've reiterated the PRAC's earlier recommendation on #Diane35 and its generics: http://t.co/6yLDCWGyAb","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/6yLDCWGyAb","expanded_url":"http://bit.ly/Z1MGOc","display_url":"bit.ly/Z1MGOc"}],"hashtags":[{"start":54,"end":62,"tag":"Diane35"}],"mentions":{},"annotations":{}},"created_at":"2013-05-17T20:12:37.000Z","conversation_id":"335488046277484544","possibly_sensitive":false,"lang":"en","id":"335488046277484544","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"EMA recommends first vaccine for foot-and-mouth disease for authorisation at EU level: http://t.co/4O6hKdO0Af","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/4O6hKdO0Af","expanded_url":"http://bit.ly/13AYSVL","display_url":"bit.ly/13AYSVL"}],"hashtags":{},"mentions":{},"annotations":[{"start":0,"end":2,"probability":0.363,"type":"Organization","normalized_text":"EMA"}]},"created_at":"2013-05-17T13:53:18.000Z","conversation_id":"335392584480468992","possibly_sensitive":false,"lang":"en","id":"335392584480468992","author_id":"116716199","public_metrics":{"retweet_count":3,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"PRAC recommends positive benefit/risk balance of #Diane 35 and generics in specific patient group http://t.co/nm2IYqoZNI","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/nm2IYqoZNI","expanded_url":"http://bit.ly/10CxqBy","display_url":"bit.ly/10CxqBy","status":429,"unwound_url":"https://www.ema.europa.eu/en/ema-redirect?redirect_type=jsp&curl=pages/news_and_events/news/2013/05/news_detail_001790.jsp&mid=WC0b01ac058004d5c1"}],"hashtags":[{"start":49,"end":55,"tag":"Diane"}],"mentions":{},"annotations":{}},"created_at":"2013-05-17T11:34:53.000Z","conversation_id":"335357753885331457","possibly_sensitive":false,"lang":"en","id":"335357753885331457","author_id":"116716199","public_metrics":{"retweet_count":7,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"bitly bitlink","text":"We're supporting International #ClinicalTrials Day on Monday: http://t.co/2GhdC2vNa1","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/2GhdC2vNa1","expanded_url":"http://bit.ly/10KaUYE","display_url":"bit.ly/10KaUYE"}],"hashtags":[{"start":31,"end":46,"tag":"ClinicalTrials"}],"mentions":{},"annotations":{}},"created_at":"2013-05-17T16:31:34.000Z","conversation_id":"335432413335416832","possibly_sensitive":false,"lang":"en","id":"335432413335416832","author_id":"116716199","public_metrics":{"retweet_count":8,"reply_count":1,"like_count":1,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@Fiouw We are still evaluating Scenesse; it's not refused. We will publish the outcome once we've finished assessing: http://t.co/1MKhhUqcDx","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/1MKhhUqcDx","expanded_url":"http://bit.ly/16wqT3M","display_url":"bit.ly/16wqT3M"}],"hashtags":{},"mentions":[{"start":0,"end":6,"username":"Fiouw","id":"1367162942"}],"annotations":{}},"created_at":"2013-05-14T08:38:40.000Z","conversation_id":"333531395681054720","possibly_sensitive":false,"lang":"en","id":"334226243912359936","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"333531395681054720"}],"in_reply_to_user_id":"1367162942","attachments":{"media_keys":{}}},{"source":"Twitter Web Client","text":"RT @URPLWMiPB: Cases of necrotising fasciitis due to the use of Avastin (bevacizumab): http://t.co/4nHzMdqxC8 ‚Ä¶","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/4nHzMdqxC8","expanded_url":"http://urpl.gov.pl/pl-komunikaty-bezp/przypadki-martwiczego-zapalenia-powiezi-w-zwiazku-z-zastosowaniem-produktu-avastin-bewacyzumab","display_url":"urpl.gov.pl/pl-komunikaty-‚Ä¶"}],"hashtags":{},"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"annotations":{}},"created_at":"2013-05-15T10:55:25.000Z","conversation_id":"334623043517304832","possibly_sensitive":false,"lang":"en","id":"334623043517304832","author_id":"116716199","public_metrics":{"retweet_count":2,"reply_count":1,"like_count":2,"quote_count":0},"referenced_tweets":{},"attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@URPLWMiPB The link in your tweet isn't working! @FrancoisMaignen","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":10,"username":"URPLWMiPB","id":"556679074"},{"start":49,"end":65,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"created_at":"2013-05-14T09:44:53.000Z","conversation_id":"334216509482213377","possibly_sensitive":false,"lang":"en","id":"334242906154098688","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"334216509482213377"}],"in_reply_to_user_id":"556679074","attachments":{"media_keys":{}}},{"source":"TweetDeck","text":"@FrancoisMaignen Thanks. We've let them know.","entities":{"urls":{},"hashtags":{},"mentions":[{"start":0,"end":16,"username":"FrancoisMaignen","id":"769373400"}],"annotations":{}},"created_at":"2013-05-14T09:45:51.000Z","conversation_id":"334223216191082496","possibly_sensitive":false,"lang":"en","id":"334243151164346369","author_id":"116716199","public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"334241896278941696"}],"in_reply_to_user_id":"769373400","attachments":{"media_keys":{}}}],"places":[{"name":"Harrow","full_name":"Harrow, England","id":"8907ab3ca1490878","country_code":"GB","country":"Verenigd Koninkrijk","place_type":"city","geo":{"type":"Feature","bbox":[-0.404,51.5531,-0.2701,51.6406],"properties":{}}},{"name":"Oslo","full_name":"Oslo, Norge","id":"e42ed02b50d62e29","country_code":"NO","country":"Noorwegen","place_type":"city","geo":{"type":"Feature","bbox":[10.4915,59.8098,10.9516,60.135],"properties":{}}},{"name":"Lucena","full_name":"Lucena, Espa√±a","id":"9c61116b741a2d09","country_code":"ES","country":"Spanje","place_type":"city","geo":{"type":"Feature","bbox":[-4.6836,37.2457,-4.4169,37.4637],"properties":{}}}]}
